PMID- 32282323
OWN - NLM
STAT- MEDLINE
DCOM- 20200605
LR  - 20201210
IS  - 1669-9106 (Electronic)
IS  - 0025-7680 (Linking)
VI  - 80
IP  - 2
DP  - 2020
TI  - [Measles].
PG  - 162-168
AB  - In April 2019, UNICEF denounced that more than 20 million children worldwide had not 
      been vaccinated and alerted on possible outbreaks of measles which, due to the high 
      transmissibility of this virus, is the first disease preventable by vaccination to 
      emerge. If the decline in vaccinations continues, pertussis, tetanus and other 
      diseases, which require less coverage to achieve population protection, may also 
      reappear. In Argentina, the current outbreak began in late August 2019. Measles 
      virus is transmitted by air, infects multiple organs, and is associated with 
      immunosuppression. Its genome consists of single stranded RNA. Genotyping is carried 
      out by sequencing a 450-nucleotide fragment of the N protein, which contains the 
      highest density of nucleotide variation. In South America, D8 is the circulating 
      genotype and in North America, B3 accounts for 8% of the cases. Each person with 
      measles infects, on average, another 12-18 people in a susceptible population. 
      Vaccination confers direct and indirect protection, and induces both antibodies and 
      cellular immunity. Newborns are protected by maternal antibodies transmitted via the 
      placenta, up to 6 months. In Argentina, the Vaccination Calendar includes two doses 
      of triple viral vaccine, at 12 months and 5 years, and a zero dose (6-11 months of 
      age) in districts with disease cases. The protection conferred by the vaccine is 93% 
      at 12 months with a dose, and with 2 doses 97% for life.
FAU - Lüthy, Isabel A
AU  - Lüthy IA
AD  - Instituto de Biología y Medicina Experimental, IBYME-CONICET, Buenos Aires, 
      Argentina. E-mail: isabel.luthy@gmail.com.
AD  - Comité de Redacción Medicina (B Aires), Buenos Aires, Argentina.
FAU - Kantor, Isabel N
AU  - Kantor IN
AD  - Comité de Redacción Medicina (B Aires), Buenos Aires, Argentina.
LA  - spa
PT  - Historical Article
PT  - Journal Article
TT  - Sarampión.
PL  - Argentina
TA  - Medicina (B Aires)
JT  - Medicina
JID - 0204271
RN  - 0 (Nucleocapsid Proteins)
RN  - 0 (Nucleoproteins)
RN  - 0 (Viral Proteins)
RN  - 0 (nucleoprotein, Measles virus)
SB  - IM
MH  - Argentina/epidemiology
MH  - Child, Preschool
MH  - Disease Outbreaks
MH  - Genotype
MH  - History, 19th Century
MH  - Humans
MH  - Infant
MH  - Measles/epidemiology/history/*prevention & control/virology
MH  - Nucleocapsid Proteins
MH  - Nucleoproteins
MH  - *Vaccination
MH  - Viral Proteins
OTO - NOTNLM
OT  - measles
OT  - outbreaks
OT  - prevention and control
OT  - vaccination
EDAT- 2020/04/14 06:00
MHDA- 2020/06/06 06:00
CRDT- 2020/04/14 06:00
PHST- 2020/04/14 06:00 [entrez]
PHST- 2020/04/14 06:00 [pubmed]
PHST- 2020/06/06 06:00 [medline]
PST - ppublish
SO  - Medicina (B Aires). 2020;80(2):162-168.

PMID- 31695230
OWN - NLM
STAT- MEDLINE
DCOM- 20200521
LR  - 20200521
IS  - 0016-3813 (Print)
IS  - 0016-3813 (Linking)
VI  - 155
IP  - 5
DP  - 2019
TI  - El riesgo de reintroducción del sarampión en México.
PG  - 455-456
LID - 10.24875/GMM.19005496 [doi]
FAU - Díaz-Quiñónez, José Alberto
AU  - Díaz-Quiñónez JA
AD  - División de Estudios de Posgrado, Facultad de Medicina, Universidad Nacional 
      Autónoma de México, Ciudad de México, México.
LA  - eng
PT  - Editorial
PL  - Mexico
TA  - Gac Med Mex
JT  - Gaceta medica de Mexico
JID - 0010333
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Disease Outbreaks
MH  - Humans
MH  - Measles/*epidemiology/prevention & control
MH  - Measles Vaccine/*administration & dosage
MH  - Mexico/epidemiology
EDAT- 2019/11/07 06:00
MHDA- 2020/05/22 06:00
CRDT- 2019/11/08 06:00
PHST- 2019/11/08 06:00 [entrez]
PHST- 2019/11/07 06:00 [pubmed]
PHST- 2020/05/22 06:00 [medline]
AID - j155/5/455 [pii]
AID - 10.24875/GMM.19005496 [doi]
PST - ppublish
SO  - Gac Med Mex. 2019;155(5):455-456. doi: 10.24875/GMM.19005496.

PMID- 30273528
OWN - NLM
STAT- MEDLINE
DCOM- 20181116
LR  - 20181116
IS  - 1853-0605 (Electronic)
IS  - 0014-6722 (Linking)
VI  - 75
IP  - 2
DP  - 2018 Jun 6
TI  - [Measles Outbreak].
PG  - 66
LID - 10.31053/1853.0605.v75.n2.21016 [doi]
FAU - Cuestas, Eduardo
AU  - Cuestas E
AD  - Hospital Privado Universitario de Córdoba - Facultad de Ciencias Médicas Universidad 
      Nacional de Córdoba.. eduardo.cuestas@gmail.com.
LA  - spa
PT  - Editorial
TT  - Brote de Sarampión.
DEP - 20180606
PL  - Argentina
TA  - Rev Fac Cien Med Univ Nac Cordoba
JT  - Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)
JID - 8303003
SB  - IM
MH  - Argentina/epidemiology
MH  - Brazil/epidemiology
MH  - *Disease Outbreaks
MH  - Humans
MH  - Mass Vaccination/organization & administration
MH  - Measles/*epidemiology/prevention & control
OTO - NOTNLM
OT  - *measles
OT  - *epidemiology
EDAT- 2018/10/03 06:00
MHDA- 2018/11/18 06:00
CRDT- 2018/10/02 06:00
PHST- 2018/08/27 00:00 [received]
PHST- 2018/10/02 06:00 [entrez]
PHST- 2018/10/03 06:00 [pubmed]
PHST- 2018/11/18 06:00 [medline]
AID - 10.31053/1853.0605.v75.n2.21016 [doi]
PST - epublish
SO  - Rev Fac Cien Med Univ Nac Cordoba. 2018 Jun 6;75(2):66. doi: 
      10.31053/1853.0605.v75.n2.21016.

PMID- 31695226
OWN - NLM
STAT- MEDLINE
DCOM- 20200330
LR  - 20200330
IS  - 0016-3813 (Print)
IS  - 0016-3813 (Linking)
VI  - 155
IP  - 5
DP  - 2019
TI  - Algoritmo diagnóstico para la confirmación de casos de sarampión y rubéola en 
      México.
PG  - 532-536
LID - 10.24875/GMM.19005497 [doi]
AB  - Due to the successful implementation of measles and rubella elimination strategies, 
      Mexico announced the interruption of endemic transmission of measles in 1996 and 
      that of rubella in 2008. After a verification process, the region of the Americas 
      was declared free of rubella and congenital rubella syndrome in 2015 and of measles 
      in 2016. In order to maintain the elimination status in Mexico, it is essential to 
      continue laboratory surveillance within the framework of the Global Measles and 
      Rubella Laboratory Network. The Institute of Epidemiological Diagnosis and 
      Reference, through the National Network of Public Health Laboratories, guarantees 
      timely and reliable results in view of the possible reintroduction of these and 
      other emerging pathogens.
CI  - Copyright: © 2019 Permanyer.
FAU - Román-Pedroza, Juan Francisco
AU  - Román-Pedroza JF
AD  - Instituto de Diagnóstico y Referencia Epidemiológicos "Dr. Manuel Martínez Báez", 
      México.
FAU - Cruz-Ramírez, Edith
AU  - Cruz-Ramírez E
AD  - Instituto de Diagnóstico y Referencia Epidemiológicos "Dr. Manuel Martínez Báez", 
      México.
FAU - Landín-Martínez, Kathia Elia
AU  - Landín-Martínez KE
AD  - Instituto de Diagnóstico y Referencia Epidemiológicos "Dr. Manuel Martínez Báez", 
      México.
FAU - Salas-García, Mónica
AU  - Salas-García M
AD  - Instituto de Diagnóstico y Referencia Epidemiológicos "Dr. Manuel Martínez Báez", 
      México.
FAU - López-Ortiz, Eduardo
AU  - López-Ortiz E
AD  - Universidad Nacional Autónoma de México, Facultad de Medicina, División de Estudios 
      de Posgrado. Ciudad de México, México.
FAU - Ramírez-González, José Ernesto
AU  - Ramírez-González JE
AD  - Instituto de Diagnóstico y Referencia Epidemiológicos "Dr. Manuel Martínez Báez", 
      México.
FAU - López-Martínez, Irma
AU  - López-Martínez I
AD  - Instituto de Diagnóstico y Referencia Epidemiológicos "Dr. Manuel Martínez Báez", 
      México.
FAU - Díaz-Quiñonez, José Alberto
AU  - Díaz-Quiñonez JA
AD  - Universidad Nacional Autónoma de México, Facultad de Medicina, División de Estudios 
      de Posgrado. Ciudad de México, México.
LA  - eng
PT  - Journal Article
PL  - Mexico
TA  - Gac Med Mex
JT  - Gaceta medica de Mexico
JID - 0010333
SB  - IM
MH  - *Algorithms
MH  - Disease Eradication
MH  - Humans
MH  - Measles/*diagnosis/prevention & control
MH  - Mexico
MH  - Rubella/*diagnosis/prevention & control
MH  - Rubella Syndrome, Congenital/diagnosis/prevention & control
MH  - Specimen Handling/methods
OTO - NOTNLM
OT  - Diagnosis
OT  - Diagnóstico
OT  - Measles
OT  - Mexico
OT  - México
OT  - Rubella
OT  - Rubéola
OT  - Sarampión
EDAT- 2019/11/07 06:00
MHDA- 2020/03/31 06:00
CRDT- 2019/11/08 06:00
PHST- 2019/11/08 06:00 [entrez]
PHST- 2019/11/07 06:00 [pubmed]
PHST- 2020/03/31 06:00 [medline]
AID - j155/5/532 [pii]
AID - 10.24875/GMM.19005497 [doi]
PST - ppublish
SO  - Gac Med Mex. 2019;155(5):532-536. doi: 10.24875/GMM.19005497.

PMID- 32044749
OWN - NLM
STAT- MEDLINE
DCOM- 20200330
LR  - 20200330
IS  - 1669-9106 (Electronic)
IS  - 0025-7680 (Linking)
VI  - 80
IP  - 1
DP  - 2020
TI  - [Vaccinating against measles].
PG  - 93-94
FAU - Lüthy, Isabel A
AU  - Lüthy IA
AD  - Instituto de Biología y Medicina Experimental - CONICET, Buenos Aires, Argentina. 
      E-mail: isabel.luthy@gmail.com.
LA  - spa
PT  - Editorial
TT  - Vacunar contra el sarampión.
PL  - Argentina
TA  - Medicina (B Aires)
JT  - Medicina
JID - 0204271
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Anti-Vaccination Movement
MH  - Humans
MH  - Mass Vaccination/*organization & administration
MH  - Measles/physiopathology/*prevention & control
MH  - Measles Vaccine/*administration & dosage
EDAT- 2020/02/12 06:00
MHDA- 2020/03/31 06:00
CRDT- 2020/02/12 06:00
PHST- 2020/02/12 06:00 [entrez]
PHST- 2020/02/12 06:00 [pubmed]
PHST- 2020/03/31 06:00 [medline]
PST - ppublish
SO  - Medicina (B Aires). 2020;80(1):93-94.

PMID- 30678886
OWN - NLM
STAT- MEDLINE
DCOM- 20200724
LR  - 20200724
IS  - 1578-8989 (Electronic)
IS  - 0025-7753 (Linking)
VI  - 152
IP  - 9
DP  - 2019 May 3
TI  - Is measles coming back?
PG  - 350-352
LID - S0025-7753(18)30757-7 [pii]
LID - 10.1016/j.medcli.2018.11.025 [doi]
FAU - Masa-Calles, Josefa
AU  - Masa-Calles J
AD  - Centro Nacional de Epidemiología, Instituto de Salud Carlos III. CIBERESP, Madrid, 
      España. Electronic address: jmasa@isciii.es.
LA  - eng
LA  - spa
PT  - Editorial
TT  - ¿Vuelve el sarampión?
DEP - 20190122
PL  - Spain
TA  - Med Clin (Barc)
JT  - Medicina clinica
JID - 0376377
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - *Disease Eradication
MH  - *Global Health
MH  - Humans
MH  - Measles/*epidemiology/*prevention & control
MH  - *Measles Vaccine
MH  - Spain/epidemiology
EDAT- 2019/01/27 06:00
MHDA- 2020/07/25 06:00
CRDT- 2019/01/26 06:00
PHST- 2018/11/05 00:00 [received]
PHST- 2018/11/22 00:00 [revised]
PHST- 2018/11/25 00:00 [accepted]
PHST- 2019/01/27 06:00 [pubmed]
PHST- 2020/07/25 06:00 [medline]
PHST- 2019/01/26 06:00 [entrez]
AID - S0025-7753(18)30757-7 [pii]
AID - 10.1016/j.medcli.2018.11.025 [doi]
PST - ppublish
SO  - Med Clin (Barc). 2019 May 3;152(9):350-352. doi: 10.1016/j.medcli.2018.11.025. Epub 
      2019 Jan 22.

PMID- 31344184
OWN - NLM
STAT- MEDLINE
DCOM- 20200116
LR  - 20200116
IS  - 0717-6228 (Electronic)
IS  - 0370-4106 (Linking)
VI  - 90
IP  - 3
DP  - 2019 Jun
TI  - [Measles: Historical background and current situation].
PG  - 253-259
LID - S0370-41062019005000807 [pii]
LID - 10.32641/rchped.v90i3.1231 [doi]
AB  - Measles is still a major cause of child morbidity and mortality. In recent years, it 
      has become a global public health problem, attributed to low vaccination coverage 
      observed in different countries. In order to control it, a highly effective live 
      virus vaccine is available, which was used for the first time in Chile in 1964, 
      covering practically the whole country in a short period of time. This was the first 
      world experience, which was later imitated by other countries leading to a 
      significant drop in mor bidity and mortality rates. Its effectiveness has been amply 
      demonstrated, but it requires coverage maintenance higher than 95%. In Chile, minor 
      endemic situation persisted until 1993. In recent years, there have been some 
      reduced outbreaks and sporadic cases linked to contacts with imported cases, 
      however, according to recent data, measles is now circulating in more than 160 
      countries at an unprecedented spread level, where infected travelers are the main 
      vehicle of transmission. In Chile, the Ministry of Health has decided to strengthen 
      and update the vaccination of susceptible groups, especially travelers. This update 
      reviews historical aspects and current information on this re-emer ging disease, 
      showing its high epidemiological impact on the pediatric and adult population 
      globally.
FAU - Fadic R, Ricardo
AU  - Fadic R R
AD  - Clínica Alemana, Facultad de Medicina, Universidad del Desarrollo, Chile.
FAU - Repetto D, Guillermo
AU  - Repetto D G
AD  - Facultad de Medicina, Pontificia Universidad Católica de Chile, Chile.
LA  - spa
PT  - Journal Article
PT  - Review
TT  - Sarampión: Antecedentes históricos y situación actual.
PL  - Chile
TA  - Rev Chil Pediatr
JT  - Revista chilena de pediatria
JID - 0404261
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Adult
MH  - Child
MH  - Chile/epidemiology
MH  - Disease Outbreaks/*prevention & control
MH  - Humans
MH  - Measles/*epidemiology/prevention & control
MH  - Measles Vaccine/*administration & dosage
MH  - Public Health
MH  - Vaccination/methods
EDAT- 2019/07/26 06:00
MHDA- 2020/01/17 06:00
CRDT- 2019/07/26 06:00
PHST- 2019/04/25 00:00 [received]
PHST- 2019/05/03 00:00 [accepted]
PHST- 2019/07/26 06:00 [entrez]
PHST- 2019/07/26 06:00 [pubmed]
PHST- 2020/01/17 06:00 [medline]
AID - S0370-41062019005000807 [pii]
AID - 10.32641/rchped.v90i3.1231 [doi]
PST - ppublish
SO  - Rev Chil Pediatr. 2019 Jun;90(3):253-259. doi: 10.32641/rchped.v90i3.1231.

PMID- 31526544
OWN - NLM
STAT- MEDLINE
DCOM- 20210514
LR  - 20210514
IS  - 1578-8989 (Electronic)
IS  - 0025-7753 (Linking)
VI  - 155
IP  - 3
DP  - 2020 Aug 14
TI  - Measles in a young adult.
PG  - 142
LID - S0025-7753(19)30531-7 [pii]
LID - 10.1016/j.medcli.2019.07.018 [doi]
FAU - Fernandez-Nieto, Diego
AU  - Fernandez-Nieto D
AD  - Servicio de Dermatología, Hospital Universitario Ramón y Cajal, Madrid, España. 
      Electronic address: fnietodiego@gmail.com.
FAU - Ortega-Quijano, Daniel
AU  - Ortega-Quijano D
AD  - Servicio de Dermatología, Hospital Universitario Ramón y Cajal, Madrid, España.
FAU - Jimenez-Cauhe, Juan
AU  - Jimenez-Cauhe J
AD  - Servicio de Dermatología, Hospital Universitario Ramón y Cajal, Madrid, España.
FAU - Diaz-Garcia, Noiva
AU  - Diaz-Garcia N
AD  - Servicio de Urgencias, Hospital Universitario Ramón y Cajal, Madrid, España.
LA  - eng
LA  - spa
PT  - Journal Article
TT  - Sarampión en un adulto joven.
DEP - 20190913
PL  - Spain
TA  - Med Clin (Barc)
JT  - Medicina clinica
JID - 0376377
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Disease Outbreaks
MH  - Humans
MH  - *Measles/diagnosis/epidemiology
MH  - Measles Vaccine
MH  - Measles virus/genetics
MH  - Young Adult
EDAT- 2019/09/19 06:00
MHDA- 2021/05/15 06:00
CRDT- 2019/09/19 06:00
PHST- 2019/06/26 00:00 [received]
PHST- 2019/07/09 00:00 [revised]
PHST- 2019/07/10 00:00 [accepted]
PHST- 2019/09/19 06:00 [pubmed]
PHST- 2021/05/15 06:00 [medline]
PHST- 2019/09/19 06:00 [entrez]
AID - S0025-7753(19)30531-7 [pii]
AID - 10.1016/j.medcli.2019.07.018 [doi]
PST - ppublish
SO  - Med Clin (Barc). 2020 Aug 14;155(3):142. doi: 10.1016/j.medcli.2019.07.018. Epub 
      2019 Sep 13.

PMID- 31344183
OWN - NLM
STAT- MEDLINE
DCOM- 20200311
LR  - 20200311
IS  - 0717-6228 (Electronic)
IS  - 0370-4106 (Linking)
VI  - 90
IP  - 3
DP  - 2019 Jun
TI  - [Resurgence of Measles in the 21st Century. The Return of the King].
PG  - 250-252
LID - S0370-41062019005000804 [pii]
LID - 10.32641/rchped.v90i3.1203 [doi]
FAU - Rodríguez T, Jaime
AU  - Rodríguez T J
AD  - Clínica Alemana de Santiago, Santiago, Chile.
LA  - spa
PT  - Editorial
PT  - Historical Article
TT  - Resurgimiento del Sarampión en el siglo 21. El retorno del Rey.
PL  - Chile
TA  - Rev Chil Pediatr
JT  - Revista chilena de pediatria
JID - 0404261
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Chile/epidemiology
MH  - Disease Outbreaks
MH  - Global Health
MH  - History, 21st Century
MH  - Humans
MH  - Measles/*epidemiology/history/prevention & control
MH  - Measles Vaccine
EDAT- 2019/07/26 06:00
MHDA- 2020/03/12 06:00
CRDT- 2019/07/26 06:00
PHST- 2019/07/26 06:00 [entrez]
PHST- 2019/07/26 06:00 [pubmed]
PHST- 2020/03/12 06:00 [medline]
AID - S0370-41062019005000804 [pii]
AID - 10.32641/rchped.v90i3.1203 [doi]
PST - ppublish
SO  - Rev Chil Pediatr. 2019 Jun;90(3):250-252. doi: 10.32641/rchped.v90i3.1203.

PMID- 20096973
OWN - NLM
STAT- MEDLINE
DCOM- 20100721
LR  - 20141120
IS  - 1578-1852 (Electronic)
IS  - 0213-005X (Linking)
VI  - 28
IP  - 2
DP  - 2010 Feb
TI  - [Measles at the point of being eliminated].
PG  - 73-4
LID - 10.1016/j.eimc.2009.12.002 [doi]
FAU - De Ory, Fernando
AU  - De Ory F
FAU - Peña-Rey, Isabel
AU  - Peña-Rey I
LA  - spa
PT  - Comment
PT  - Editorial
TT  - Sarampión en la línea de meta de la eliminación.
DEP - 20100122
PL  - Spain
TA  - Enferm Infecc Microbiol Clin
JT  - Enfermedades infecciosas y microbiologia clinica
JID - 9104081
RN  - 0 (Antibodies, Viral)
RN  - 0 (Immunoglobulin M)
RN  - 0 (Measles Vaccine)
RN  - 0 (Measles-Mumps-Rubella Vaccine)
SB  - IM
CON - Enferm Infecc Microbiol Clin. 2010 Feb;28(2):82-6. PMID: 19664857
MH  - Antibodies, Viral/blood
MH  - Disease Outbreaks
MH  - Global Health
MH  - Humans
MH  - Immunoglobulin M/blood
MH  - Infectious Disease Transmission, Professional-to-Patient/prevention & control
MH  - Laboratories/organization & administration
MH  - Measles/*epidemiology/prevention & control/transmission
MH  - Measles Vaccine
MH  - Measles virus/immunology
MH  - Measles-Mumps-Rubella Vaccine
MH  - National Health Programs/organization & administration
MH  - Population Surveillance
MH  - Rubella/epidemiology/prevention & control
MH  - Seroepidemiologic Studies
MH  - Spain/epidemiology
MH  - Vaccination
EDAT- 2010/01/26 06:00
MHDA- 2010/07/22 06:00
CRDT- 2010/01/26 06:00
PHST- 2009/12/15 00:00 [received]
PHST- 2009/12/22 00:00 [accepted]
PHST- 2010/01/26 06:00 [entrez]
PHST- 2010/01/26 06:00 [pubmed]
PHST- 2010/07/22 06:00 [medline]
AID - S0213-005X(09)00538-2 [pii]
AID - 10.1016/j.eimc.2009.12.002 [doi]
PST - ppublish
SO  - Enferm Infecc Microbiol Clin. 2010 Feb;28(2):73-4. doi: 10.1016/j.eimc.2009.12.002. 
      Epub 2010 Jan 22.

PMID- 26611100
OWN - NLM
STAT- MEDLINE
DCOM- 20170824
LR  - 20181202
IS  - 1578-1852 (Electronic)
IS  - 0213-005X (Linking)
VI  - 33
IP  - 10
DP  - 2015 Dec
TI  - [Measles, mumps, and rubella vaccine. Resurgence of measles in Europe].
PG  - 673-8
LID - S0213-005X(15)00385-7 [pii]
LID - 10.1016/j.eimc.2015.10.013 [doi]
AB  - Measles is a rash illness of moderate severity and high risk of serious 
      complications, with recovery in several weeks. It is a viral disease caused by one 
      of the most infectious and contagious pathogens that exists, whose only known 
      reservoir is human. In 1998, the European Region of the WHO set a target of 
      eliminating measles by 2010. This goal has not been achieved. Furthermore, it has 
      been observed the resurgence of the disease in some parts of Europe. We review the 
      disease and its vaccines as well as the epidemiological and social factors that have 
      so far prevented the total control of the disease.
CI  - Copyright © 2015 Elsevier España, S.L.U. y Sociedad Española de Enfermedades 
      Infecciosas y Microbiología Clínica. All rights reserved.
FAU - Garcés-Sánchez, María
AU  - Garcés-Sánchez M
AD  - Pediatría, Centro de Salud Nazaret, Valencia, España. Electronic address: 
      maria.garces.sanchez@gmail.com.
FAU - Renales-Toboso, María
AU  - Renales-Toboso M
AD  - Pediatría, Centro de Salud Nazaret, Valencia, España.
FAU - Bóveda-García, María
AU  - Bóveda-García M
AD  - Pediatría, Centro de Salud Nazaret, Valencia, España.
FAU - Díez-Domingo, Javier
AU  - Díez-Domingo J
AD  - Área de Vacunas, Fundación para el Fomento de la Investigación Sanitaria y Biomédica 
      de la Comunitat Valenciana (FISABIO), Valencia, España.
LA  - spa
PT  - Journal Article
PT  - Review
TT  - Vacuna triple vírica. Resurgimiento del sarampión en Europa.
DEP - 20151121
PL  - Spain
TA  - Enferm Infecc Microbiol Clin
JT  - Enfermedades infecciosas y microbiologia clinica
JID - 9104081
RN  - 0 (Measles Vaccine)
RN  - 0 (Measles-Mumps-Rubella Vaccine)
SB  - IM
MH  - Disease Eradication
MH  - *Disease Outbreaks
MH  - Europe/epidemiology
MH  - Global Health
MH  - Goals
MH  - Humans
MH  - Measles/*epidemiology/prevention & control
MH  - Measles Vaccine
MH  - *Measles-Mumps-Rubella Vaccine
MH  - Social Determinants of Health
MH  - Vaccination/*statistics & numerical data
MH  - World Health Organization
OTO - NOTNLM
OT  - Enfermedad vírica
OT  - Measles
OT  - Sarampión
OT  - Vaccines
OT  - Vacunas
OT  - Viral disease
EDAT- 2015/11/28 06:00
MHDA- 2017/08/25 06:00
CRDT- 2015/11/28 06:00
PHST- 2015/10/28 00:00 [received]
PHST- 2015/10/29 00:00 [accepted]
PHST- 2015/11/28 06:00 [entrez]
PHST- 2015/11/28 06:00 [pubmed]
PHST- 2017/08/25 06:00 [medline]
AID - S0213-005X(15)00385-7 [pii]
AID - 10.1016/j.eimc.2015.10.013 [doi]
PST - ppublish
SO  - Enferm Infecc Microbiol Clin. 2015 Dec;33(10):673-8. doi: 
      10.1016/j.eimc.2015.10.013. Epub 2015 Nov 21.

PMID- 26580788
OWN - NLM
STAT- MEDLINE
DCOM- 20160628
LR  - 20151120
IS  - 2173-9110 (Electronic)
IS  - 1135-5727 (Linking)
VI  - 89
IP  - 4
DP  - 2015 Jul-Aug
TI  - [Seminar on the Elimination of Measles and Rubella in Spain].
PG  - 343-4
LID - S1135-57272015000400001 [pii]
LID - 10.4321/S1135-57272015000400001 [doi]
FAU - Castrodeza Sanz, José Javier
AU  - Castrodeza Sanz JJ
LA  - spa
PT  - Editorial
TT  - Seminario sobre la eliminación del sarampión y la rubeola en España.
PL  - Spain
TA  - Rev Esp Salud Publica
JT  - Revista espanola de salud publica
JID - 9600212
SB  - IM
MH  - *Disease Eradication
MH  - Humans
MH  - Measles/*prevention & control
MH  - Rubella/*prevention & control
MH  - Spain
EDAT- 2015/11/19 06:00
MHDA- 2016/06/29 06:00
CRDT- 2015/11/19 06:00
PHST- 2015/11/19 06:00 [entrez]
PHST- 2015/11/19 06:00 [pubmed]
PHST- 2016/06/29 06:00 [medline]
AID - S1135-57272015000400001 [pii]
AID - 10.4321/S1135-57272015000400001 [doi]
PST - ppublish
SO  - Rev Esp Salud Publica. 2015 Jul-Aug;89(4):343-4. doi: 
      10.4321/S1135-57272015000400001.

PMID- 32061460
OWN - NLM
STAT- MEDLINE
DCOM- 20201208
LR  - 20201214
IS  - 1578-8865 (Electronic)
IS  - 1138-3593 (Linking)
VI  - 46
IP  - 2
DP  - 2020 Mar
TI  - [The Spain profile of measles: Cases in adults, imported-related and associated to 
      health care].
PG  - 77-80
LID - S1138-3593(20)30014-9 [pii]
LID - 10.1016/j.semerg.2019.12.012 [doi]
FAU - Masa-Calles, J
AU  - Masa-Calles J
AD  - Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, España; 
      CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, 
      España. Electronic address: jmasa@isciii.es.
FAU - López-Perea, N
AU  - López-Perea N
AD  - Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, España; 
      CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, 
      España.
FAU - Godoy, P
AU  - Godoy P
AD  - Servei de Vigilància Epidemiològica i Resposta a Emergències de Salut Pública a 
      Lleida i Alt Pirineu i Aran, Agència de Salut Pública de Catalunya, Departament de 
      Salut, Generalitat de Catalunya, Lleida, España; CIBER de Epidemiología y Salud 
      Pública, Instituto de Salud Carlos III, Madrid, España.
LA  - spa
PT  - Editorial
TT  - Perfil epidemiológico del sarampión en España: casos en adultos, secundarios a la 
      importación y asociados con la asistencia sanitaria.
DEP - 20200212
PL  - Spain
TA  - Semergen
JT  - Semergen
JID - 9610769
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Adult
MH  - Delivery of Health Care/organization & administration
MH  - Humans
MH  - Measles/*epidemiology
MH  - Measles Vaccine/*administration & dosage
MH  - Spain/epidemiology
MH  - *Vaccination
EDAT- 2020/02/18 06:00
MHDA- 2020/12/15 06:00
CRDT- 2020/02/17 06:00
PHST- 2019/12/05 00:00 [received]
PHST- 2019/12/16 00:00 [revised]
PHST- 2019/12/21 00:00 [accepted]
PHST- 2020/02/18 06:00 [pubmed]
PHST- 2020/12/15 06:00 [medline]
PHST- 2020/02/17 06:00 [entrez]
AID - S1138-3593(20)30014-9 [pii]
AID - 10.1016/j.semerg.2019.12.012 [doi]
PST - ppublish
SO  - Semergen. 2020 Mar;46(2):77-80. doi: 10.1016/j.semerg.2019.12.012. Epub 2020 Feb 12.

PMID- 31344196
OWN - NLM
STAT- MEDLINE
DCOM- 20200311
LR  - 20200311
IS  - 0717-6228 (Electronic)
IS  - 0370-4106 (Linking)
VI  - 90
IP  - 3
DP  - 2019 Jun
TI  - [Prevention of measles outbreak in National Orphans House. Published in Revista 
      Chilena de Pediatría the year 1933].
PG  - 343-350
LID - S0370-41062019005000803 [pii]
LID - 10.32641/rchped.v90i3.1202 [doi]
FAU - Ariztía, Anibal
AU  - Ariztía A
AD  - Casa Nacional del Niño, Chile.
FAU - Schonhaut B, Luisa
AU  - Schonhaut B L
AD  - Clínica Alemana, Facultad de Medicina, Universidad del Desarrollo, Santiago, Chile.
FAU - Repetto D, Guillermo
AU  - Repetto D G
AD  - Facultad de Medicina, Pontificia Universidad Católica de Chile, Chile.
LA  - spa
PT  - Editorial
PT  - Historical Article
TT  - Prevención de una epidemia de sarampión en la Casa Nacional del Niño. Publicado en 
      Revista Chilena de Pediatría el año 1933.
PL  - Chile
TA  - Rev Chil Pediatr
JT  - Revista chilena de pediatria
JID - 0404261
SB  - IM
MH  - Child
MH  - Child, Orphaned
MH  - Chile/epidemiology
MH  - Disease Outbreaks/*history
MH  - History, 20th Century
MH  - Humans
MH  - Measles/epidemiology/*history/prevention & control
MH  - Orphanages/*history
MH  - Periodicals as Topic
EDAT- 2019/07/26 06:00
MHDA- 2020/03/12 06:00
CRDT- 2019/07/26 06:00
PHST- 2019/07/26 06:00 [entrez]
PHST- 2019/07/26 06:00 [pubmed]
PHST- 2020/03/12 06:00 [medline]
AID - S0370-41062019005000803 [pii]
AID - 10.32641/rchped.v90i3.1202 [doi]
PST - ppublish
SO  - Rev Chil Pediatr. 2019 Jun;90(3):343-350. doi: 10.32641/rchped.v90i3.1202.

PMID- 32057635
OWN - NLM
STAT- MEDLINE
DCOM- 20201208
LR  - 20201214
IS  - 1578-8865 (Electronic)
IS  - 1138-3593 (Linking)
VI  - 46
IP  - 2
DP  - 2020 Mar
TI  - [The resurgence of measles: A call to prevention].
PG  - e11-e12
LID - S1138-3593(20)30003-4 [pii]
LID - 10.1016/j.semerg.2019.12.004 [doi]
FAU - López Gobernado, M
AU  - López Gobernado M
AD  - Servicio de Estudios, Documentación y Estadística, Consejería de Sanidad, Junta de 
      Castilla y León, Valladolid, España. Electronic address: 
      mlopezgob@saludcastillayleon.es.
FAU - Pérez-Rubio, A
AU  - Pérez-Rubio A
AD  - Dirección Médica, Hospital Clínico Universitario de Valladolid, Valladolid, España.
FAU - Bachiller Luque, M R
AU  - Bachiller Luque MR
AD  - Centro de Salud Pilarica, Área de Salud Valladolid-Este, Valladolid, España.
FAU - Eiros Bouza, J M
AU  - Eiros Bouza JM
AD  - Servicio de Microbiología, Hospital Universitario Río Hortega, Valladolid, España.
LA  - spa
PT  - Letter
TT  - Resurgir del sarampión: una llamada a la prevención.
DEP - 20200210
PL  - Spain
TA  - Semergen
JT  - Semergen
JID - 9610769
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Humans
MH  - Measles/*epidemiology/prevention & control
MH  - Measles Vaccine/*administration & dosage
MH  - Spain/epidemiology
MH  - *Vaccination
EDAT- 2020/02/15 06:00
MHDA- 2020/12/15 06:00
CRDT- 2020/02/15 06:00
PHST- 2019/12/19 00:00 [received]
PHST- 2019/12/24 00:00 [accepted]
PHST- 2020/02/15 06:00 [pubmed]
PHST- 2020/12/15 06:00 [medline]
PHST- 2020/02/15 06:00 [entrez]
AID - S1138-3593(20)30003-4 [pii]
AID - 10.1016/j.semerg.2019.12.004 [doi]
PST - ppublish
SO  - Semergen. 2020 Mar;46(2):e11-e12. doi: 10.1016/j.semerg.2019.12.004. Epub 2020 Feb 
      10.

PMID- 34705394
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20211027
IS  - 2448-5667 (Electronic)
IS  - 0443-5117 (Linking)
VI  - 58
IP  - 6
DP  - 2020 Nov 4
TI  - [Measles: a millennial itch in the COVID-19 era].
PG  - 644-647
LID - 10.24875/RMIMSS.M20000095 [doi]
AB  - Measles is a viral disease with an ample clinical spectrum that can range from 
      fever, cough and rash, to death. It is the most contagious human disease known. In 
      the last 50 years, mainly due to vaccination, its mortality has decreased by more 
      than 90%. However, in the last five years the cases of Measles have increased 
      significantly, causing 144,000 deaths in 2019. In Mexico, the arrival of COVID-19 
      represents a serious threat to immunization programs because it converges in time 
      with the worst measles outbreak since 1994.
CI  - Copyright: © 2020 Revista Medica del Instituto Mexicano del Seguro Social.
FAU - Rincón-León, Héctor Armando
AU  - Rincón-León HA
AD  - Instituto Mexicano del Seguro Social, Órgano de Operación Administrativa 
      Desconcentrada Estatal en Chiapas, Coordinación Auxiliar de Investigación en Salud.
FAU - Navarro-Fuentes, Karla Reyna
AU  - Navarro-Fuentes KR
AD  - Instituto Mexicano del Seguro Social, Unidad de Medicina Familiar No. 11, 
      Departamento de Epidemiología. Tapachula, Chiapas, México.
LA  - spa
PT  - Journal Article
TT  - Sarampión: un prurito milenario en tiempos de COVID-19.
PL  - Mexico
TA  - Rev Med Inst Mex Seguro Soc
JT  - Revista medica del Instituto Mexicano del Seguro Social
JID - 101243727
SB  - IM
OTO - NOTNLM
OT  - *COVID-19
OT  - *Disease Eradication
OT  - *Disease Outbreaks
OT  - *Mass Vaccination
OT  - *Measles
EDAT- 2020/01/01 00:00
MHDA- 2020/01/01 00:01
CRDT- 2021/10/27 16:17
PHST- 2021/10/27 16:17 [entrez]
PHST- 2020/01/01 00:00 [pubmed]
PHST- 2020/01/01 00:01 [medline]
AID - j58/6/644 [pii]
AID - 10.24875/RMIMSS.M20000095 [doi]
PST - ppublish
SO  - Rev Med Inst Mex Seguro Soc. 2020 Nov 4;58(6):644-647. doi: 
      10.24875/RMIMSS.M20000095.

PMID- 26436786
OWN - NLM
STAT- MEDLINE
DCOM- 20160519
LR  - 20151006
IS  - 0716-1018 (Print)
IS  - 0716-1018 (Linking)
VI  - 32
IP  - 4
DP  - 2015 Aug
TI  - [Measles: the disease, epidemiology, history and vaccination programs in Chile].
PG  - 417-29
LID - S0716-10182015000500008 [pii]
LID - 10.4067/S0716-10182015000500008 [doi]
AB  - Measles, one of most important inmuno-preventable diseases, remains as a worldwide 
      concern issue with an important morbidity and mortality. Particularly in the America 
      region declared free of measles in 2010 by WHO, they still appear imported cases 
      that origin outbreaks of variable magnitude in susceptible subjects usually none 
      vaccinated which is the current situation in Santiago, the capital city of Chile. In 
      this review we present characteristics of the etiological agent, the disease, 
      epidemiological aspects with national historical focus, impact of immunization 
      programs and outbreaks in Chile, in order to contribute to knowledge and management 
      of this always present public health problem.
FAU - Delpiano, Luis
AU  - Delpiano L
FAU - Astroza, Leonor
AU  - Astroza L
FAU - Toro, Jorge
AU  - Toro J
LA  - spa
PT  - English Abstract
PT  - Journal Article
PT  - Review
TT  - Sarampión: la enfermedad, epidemiología, historia y los programas de vacunación en 
      Chile.
PL  - Chile
TA  - Rev Chilena Infectol
JT  - Revista chilena de infectologia : organo oficial de la Sociedad Chilena de 
      Infectologia
JID - 9305754
SB  - IM
MH  - Chile/epidemiology
MH  - Disease Notification/statistics & numerical data
MH  - Disease Outbreaks/statistics & numerical data
MH  - Health Promotion
MH  - Humans
MH  - Incidence
MH  - Mass Vaccination/methods
MH  - *Measles/epidemiology/pathology/therapy
MH  - Morbillivirus/immunology/pathogenicity
MH  - Public Health/statistics & numerical data
EDAT- 2015/10/06 06:00
MHDA- 2016/05/20 06:00
CRDT- 2015/10/06 06:00
PHST- 2015/07/17 00:00 [received]
PHST- 2015/07/24 00:00 [accepted]
PHST- 2015/10/06 06:00 [entrez]
PHST- 2015/10/06 06:00 [pubmed]
PHST- 2016/05/20 06:00 [medline]
AID - S0716-10182015000500008 [pii]
AID - 10.4067/S0716-10182015000500008 [doi]
PST - ppublish
SO  - Rev Chilena Infectol. 2015 Aug;32(4):417-29. doi: 10.4067/S0716-10182015000500008.

PMID- 9796389
OWN - NLM
STAT- MEDLINE
DCOM- 19981110
LR  - 20190607
IS  - 1020-4989 (Print)
IS  - 1020-4989 (Linking)
VI  - 4
IP  - 3
DP  - 1998 Sep
TI  - [Eradication of measles in Cuba].
PG  - 171-7
AB  - The vaccine against measles came into use in Cuba in 1971. During the seventies, a 
      new early strategy for measles control was established, and it was followed by 
      further efforts in the early eighties. Despite improvements to the control program, 
      disease outbreaks continued to occur. In 1986, after examining the experience 
      acquired through the control initiatives that were already in place, a new measles 
      vaccination strategy was adopted. In time, the new vaccination strategy against 
      measles came to have three main components: first, a single vaccination 
      "catching-up" campaign targeting children 1 to 14 years of age. Second, efforts were 
      made to achieve and maintain high vaccine coverage through mandatory vaccination 
      services for 12-month-old children ("maintenance vaccination"). Finally, periodic 
      "follow-up" campaigns were carried out for children 2 to 6 years of age. Steps were 
      taken, for the purpose of monitoring the progress made so far toward eliminating 
      measles, to strengthen disease surveillance systems, including the screening of 
      suspected cases. The "catching-up" and "follow-up" campaigns both achieved greater 
      than 98% coverage within targeted age groups. The routine vaccination program has 
      also maintained high coverage. The high population immunity against measles that has 
      been attained through these vaccination strategies has resulted in a rapid decrease 
      in the incidence of the disease. From 1989 to 1992, less than 20 
      laboratory-confirmed cases were reported annually. In Cuba, the last case confirmed 
      through serologic screening was reported in July 1993. Cuba's strategy for measles 
      elimination has interrupted disease transmission and kept the causal virus from 
      circulating on the island. Cuba's experience with measles elimination suggests that 
      if an appropriate vaccination strategy is applied, measles can be globally 
      eradicated.
FAU - Galindo, M A
AU  - Galindo MA
AD  - Instituto Pedro Kourí, La Habana, Cuba.
FAU - Santín, M
AU  - Santín M
FAU - Resik, S
AU  - Resik S
FAU - Ribas, M A
AU  - Ribas MA
FAU - Guzmán, M
AU  - Guzmán M
FAU - Mas Lago, P
AU  - Mas Lago P
FAU - Strassburg, M
AU  - Strassburg M
FAU - Hersh, B S
AU  - Hersh BS
FAU - de Quadros, C A
AU  - de Quadros CA
LA  - spa
PT  - English Abstract
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Review
TT  - La eliminación del sarampión en Cuba.
PL  - United States
TA  - Rev Panam Salud Publica
JT  - Revista panamericana de salud publica = Pan American journal of public health
JID - 9705400
RN  - 0 (Measles Vaccine)
SB  - IM
EIN - Rev Panam Salud Publica 1998 Nov;4(5):345
MH  - Adolescent
MH  - Child
MH  - Child, Preschool
MH  - Cuba/epidemiology
MH  - Female
MH  - Humans
MH  - Immunization Schedule
MH  - Infant
MH  - Male
MH  - Measles/*epidemiology/immunology/prevention & control
MH  - Measles Vaccine/*administration & dosage
RF  - 23
EDAT- 1998/10/31 00:00
MHDA- 1998/10/31 00:01
CRDT- 1998/10/31 00:00
PHST- 1998/10/31 00:00 [pubmed]
PHST- 1998/10/31 00:01 [medline]
PHST- 1998/10/31 00:00 [entrez]
AID - S1020-49891998000900004 [pii]
AID - 10.1590/s1020-49891998000900004 [doi]
PST - ppublish
SO  - Rev Panam Salud Publica. 1998 Sep;4(3):171-7. doi: 10.1590/s1020-49891998000900004.

PMID- 33064699
OWN - NLM
STAT- MEDLINE
DCOM- 20201027
LR  - 20201218
IS  - 1665-1146 (Electronic)
IS  - 0539-6115 (Linking)
VI  - 77
IP  - 5
DP  - 2020
TI  - Measles outbreak during the COVID-19 pandemic in Mexico.
PG  - 282-286
LID - 10.24875/BMHIM.20000173 [doi]
AB  - Measles is an exanthematous disease caused by a virus of the Morbillivirus genus. On 
      February 23, 2020, the exanthema began in the first confirmed case of measles this 
      year. At the same time, on February 28, 2020, the first case of the new coronavirus 
      disease (COVID-19) was confirmed. Up to June 6, 2020, 176 measles cases have been 
      confirmed: 137 in Mexico City, 37 in the state of Mexico, and two in the state of 
      Campeche. In Mexico City, municipalities with more cases were Gustavo A. Madero, 
      Miguel Hidalgo, and Iztapalapa; in the State of Mexico were Ecatepec, Tlalnepantla, 
      and Netzahualcoyotl; in Campeche, there are only two cases reported. On the other 
      hand, 7,065,133 cases of COVID-19 have been registered worldwide with a global case 
      fatality rate of 5.7%. In Mexico, there have been 113,619 confirmed cases and 13,511 
      deaths, while in Mexico City, there have been 30,223 cases and 3062 deaths. 
      Iztapalapa and Gustavo A. Madero are the locations with more cases reported. Hence, 
      a campaign of social distancing started as part of the strategies to control the 
      spread of the infection. The potential threat is that as social confinement measures 
      are relaxed and mobility is initiated, both viruses could continue to spread. It is 
      expected that due to the time that has passed since the last reported measles case, 
      control of this disease will be achieved.
CI  - Copyright: © 2020 Permanyer.
FAU - Solórzano-Santos, Fortino
AU  - Solórzano-Santos F
AD  - Unidad de Investigación en Enfermedades Infecciosas, Hospital Infantil de México 
      Federico Gómez. Mexico City, Mexico.
FAU - Garduño-Espinoza, Juan
AU  - Garduño-Espinoza J
AD  - Dirección de Investigación, Hospital Infantil de México Federico Gómez. Mexico City, 
      Mexico.
FAU - Muñoz-Hernández, Onofre
AU  - Muñoz-Hernández O
AD  - Comisión Nacional de Arbitraje Médico, Secretaría de Salud. Mexico City, Mexico.
LA  - eng
PT  - Journal Article
TT  - Brote de sarampión durante la pandemia de COVID-19 en México.
PL  - Mexico
TA  - Bol Med Hosp Infant Mex
JT  - Boletin medico del Hospital Infantil de Mexico
JID - 0414106
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - COVID-19
MH  - Child
MH  - Child, Preschool
MH  - Coronavirus Infections/*epidemiology/prevention & control
MH  - *Disease Outbreaks
MH  - Female
MH  - Humans
MH  - Infant
MH  - Male
MH  - Measles/*epidemiology/prevention & control
MH  - Mexico/epidemiology
MH  - Middle Aged
MH  - Pandemics/prevention & control
MH  - Pneumonia, Viral/*epidemiology/prevention & control
MH  - Social Isolation
MH  - Young Adult
OTO - NOTNLM
OT  - *COVID-19
OT  - *Coronavirus disease-19
OT  - *Measles
OT  - *Sarampión
OT  - *Vaccination
OT  - *Vacunación
EDAT- 2020/10/17 06:00
MHDA- 2020/10/28 06:00
CRDT- 2020/10/16 17:10
PHST- 2020/10/16 17:10 [entrez]
PHST- 2020/10/17 06:00 [pubmed]
PHST- 2020/10/28 06:00 [medline]
AID - j77/5/282 [pii]
AID - 10.24875/BMHIM.20000173 [doi]
PST - ppublish
SO  - Bol Med Hosp Infant Mex. 2020;77(5):282-286. doi: 10.24875/BMHIM.20000173.

PMID- 34991849
OWN - NLM
STAT- In-Data-Review
LR  - 20220107
IS  - 2529-993X (Electronic)
IS  - 2529-993X (Linking)
VI  - 40
IP  - 1
DP  - 2022 Jan
TI  - Comparative evaluation of assays for IgM detection of rubella and measles 
      infections.
PG  - 22-27
LID - S2529-993X(21)00245-8 [pii]
LID - 10.1016/j.eimce.2020.06.020 [doi]
AB  - BACKGROUND: Serological diagnosis of infections due to measles and rubella viruses 
      is done by IgM detection. The aim of this study was to comparatively evaluate 
      commercial systems for detecting IgM against both viruses, including those of ELISA, 
      in indirect and capture formats, chemiluminescence and electrochemiluminescence. 
      METHODS: Seven (for rubella) and six (for measles) assays were studied. One hundred 
      and sixty two samples were included in the study (from 90 rubella and 72 measles 
      cases), and all were analyzed in all the assays. RESULTS: The ranges of sensitivity, 
      specificity and agreement for rubella were 94.8-100%, 52.4-100% and 75.5-98.1%, 
      respectively. The corresponding ranges for measles assays were 87.0-100%, 53.3-100%, 
      and 73.0-99.4%. CONCLUSION: The best-performing assays were chemiluminescence (for 
      measles and rubella IgM), and electrochemiluminescence (for rubella IgM).
CI  - Copyright © 2020 Sociedad Española de Enfermedades Infecciosas y Microbiología 
      Clínica. Published by Elsevier España, S.L.U. All rights reserved.
FAU - Pérez Olmeda, Mayte
AU  - Pérez Olmeda M
AD  - Laboratorio de Serología, Centro Nacional de Microbiología, Instituto de Salud 
      Carlos III, Majadahonda, Spain.
FAU - Balfagón, Pilar
AU  - Balfagón P
AD  - Laboratorio de Serología, Centro Nacional de Microbiología, Instituto de Salud 
      Carlos III, Majadahonda, Spain.
FAU - Camacho, Juan
AU  - Camacho J
AD  - Laboratorio de Serología, Centro Nacional de Microbiología, Instituto de Salud 
      Carlos III, Majadahonda, Spain.
FAU - Dafouz, Desirée
AU  - Dafouz D
AD  - Laboratorio de Serología, Centro Nacional de Microbiología, Instituto de Salud 
      Carlos III, Majadahonda, Spain.
FAU - de la Fuente, Jesús
AU  - de la Fuente J
AD  - Laboratorio de Serología, Centro Nacional de Microbiología, Instituto de Salud 
      Carlos III, Majadahonda, Spain.
FAU - Murillo, María Ángeles
AU  - Murillo MÁ
AD  - Laboratorio de Serología, Centro Nacional de Microbiología, Instituto de Salud 
      Carlos III, Majadahonda, Spain.
FAU - Muñoz, José Luis
AU  - Muñoz JL
AD  - Laboratorio de Serología, Centro Nacional de Microbiología, Instituto de Salud 
      Carlos III, Majadahonda, Spain.
FAU - Fernández García, Aurora
AU  - Fernández García A
AD  - Laboratorio de Aislamiento Viral, Centro Nacional de Microbiología, Instituto de 
      Salud Carlos III, Majadahonda, Spain; Centro de Investigación Biomédica en Red en 
      Epidemiología y Salud Pública (CiberESP), Instituto de Salud Carlos III, Madrid, 
      Spain.
FAU - Sanz, Juan Carlos
AU  - Sanz JC
AD  - Laboratorio Regional de Salud Pública de la Comunidad de Madrid, Madrid, Spain; 
      Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública 
      (CiberESP), Instituto de Salud Carlos III, Madrid, Spain.
FAU - de Ory, Fernando
AU  - de Ory F
AD  - Laboratorio de Serología, Centro Nacional de Microbiología, Instituto de Salud 
      Carlos III, Majadahonda, Spain; Centro de Investigación Biomédica en Red en 
      Epidemiología y Salud Pública (CiberESP), Instituto de Salud Carlos III, Madrid, 
      Spain. Electronic address: fernandodeorym@gmail.com.
LA  - eng
PT  - Journal Article
PL  - Spain
TA  - Enferm Infecc Microbiol Clin (Engl Ed)
JT  - Enfermedades infecciosas y microbiologia clinica (English ed.)
JID - 101777541
SB  - IM
OTO - NOTNLM
OT  - Chemiluminescent immunoassay
OT  - Electrochemiluminescent immunoassay
OT  - Enzyme immunoassay
OT  - Inmunoensayo electroquimioluminiscente
OT  - Inmunoensayo enzimático
OT  - Inmunoensayo quimioluminiscente
OT  - Measles virus
OT  - Rubella virus
OT  - Virus rubéola
OT  - Virus sarampión
EDAT- 2022/01/08 06:00
MHDA- 2022/01/08 06:00
CRDT- 2022/01/07 05:53
PHST- 2020/04/15 00:00 [received]
PHST- 2020/06/23 00:00 [accepted]
PHST- 2022/01/07 05:53 [entrez]
PHST- 2022/01/08 06:00 [pubmed]
PHST- 2022/01/08 06:00 [medline]
AID - S2529-993X(21)00245-8 [pii]
AID - 10.1016/j.eimce.2020.06.020 [doi]
PST - ppublish
SO  - Enferm Infecc Microbiol Clin (Engl Ed). 2022 Jan;40(1):22-27. doi: 
      10.1016/j.eimce.2020.06.020.

PMID- 32376054
OWN - NLM
STAT- MEDLINE
DCOM- 20210929
LR  - 20210929
IS  - 1578-1275 (Electronic)
IS  - 0212-6567 (Print)
IS  - 0212-6567 (Linking)
VI  - 52
IP  - 10
DP  - 2020 Dec
TI  - [Is it necessary to change the measles case definition?].
PG  - 805-807
LID - S0212-6567(20)30076-7 [pii]
LID - 10.1016/j.aprim.2019.11.013 [doi]
FAU - Losada-Castillo, Isabel
AU  - Losada-Castillo I
AD  - Servizo de Epidemioloxía. Dirección Xeral de Saúde Pública. Consellería de Sanidade, 
      Xunta de Galicia, Santiago de Compostela, A Coruña, España. Electronic address: 
      isabel.losada.castillo@sergas.es.
FAU - Abraira-García, Luisa
AU  - Abraira-García L
AD  - Servizo de Alertas Epidemiolóxicas. Xefatura Territorial de Lugo. Consellería de 
      Sanidade, Xunta de Galicia, Santiago de Compostela, A Coruña, España.
FAU - Purriños-Hermida, María Jesús
AU  - Purriños-Hermida MJ
AD  - Servizo de Epidemioloxía. Dirección Xeral de Saúde Pública. Consellería de Sanidade, 
      Xunta de Galicia, Santiago de Compostela, A Coruña, España.
FAU - González-Villar, Ana Isabel
AU  - González-Villar AI
AD  - Servizo de Alertas Epidemiolóxicas. Xefatura Territorial de Ourense. Consellería de 
      Sanidade, Xunta de Galicia, Santiago de Compostela, A Coruña, España.
LA  - spa
PT  - Letter
TT  - ¿Necesidad de cambio en la definición de caso del sarampión?
DEP - 20200504
TA  - Aten Primaria
JT  - Atencion primaria
JID - 9111075
SB  - IM
MH  - Humans
MH  - Infant
MH  - *Measles/diagnosis/epidemiology/prevention & control
MH  - Sensitivity and Specificity
PMC - PMC8054288
EDAT- 2020/05/08 06:00
MHDA- 2021/09/30 06:00
CRDT- 2020/05/08 06:00
PHST- 2019/10/16 00:00 [received]
PHST- 2019/11/05 00:00 [accepted]
PHST- 2020/05/08 06:00 [pubmed]
PHST- 2021/09/30 06:00 [medline]
PHST- 2020/05/08 06:00 [entrez]
AID - S0212-6567(20)30076-7 [pii]
AID - 10.1016/j.aprim.2019.11.013 [doi]
PST - ppublish
SO  - Aten Primaria. 2020 Dec;52(10):805-807. doi: 10.1016/j.aprim.2019.11.013. Epub 2020 
      May 4.

PMID- 31859898
OWN - NLM
STAT- MEDLINE
DCOM- 20200122
LR  - 20200122
IS  - 0717-6163 (Electronic)
IS  - 0034-9887 (Linking)
VI  - 147
IP  - 5
DP  - 2019 May
TI  - [Calculating the risk of acquiring measles of chileans traveling abroad].
PG  - 650-657
LID - S0034-98872019000500650 [pii]
LID - 10.4067/S0034-98872019000500650 [doi]
AB  - BACKGROUND: There is always a risk of importing infectious diseases when travelling 
      abroad. AIM: To estimate the effective risk of a Chilean of acquiring measles during 
      a travel by countries where measles outbreaks have been reported, considering the 
      present level of immunity in the country. MATERIAL AND METHODS: Previously 
      established mathematical models using differential equations were applied to 
      calculate the risk of acquiring measles of people traveling to endemic areas. 
      RESULTS: The probability of acquiring measles of a voyager is 8.11 x 10-8. 
      CONCLUSIONS: These estimations help decision making about preventive measures for 
      travelers to endemic measles areas.
FAU - Canals, Mauricio
AU  - Canals M
AD  - Departamento de Medicina, Facultad de Medicina, Universidad de Chile, Santiago, 
      Chile.
FAU - Rojas, Camila
AU  - Rojas C
AD  - Departamento de Inmunizaciones, DIPRECE, Ministerio de Salud, Santiago, Chile.
FAU - Avendaño, Luis Fidel
AU  - Avendaño LF
AD  - Facultad de. Medicina, Universidad de Chile, Santiago, Chile.
LA  - spa
PT  - Journal Article
TT  - Riesgo de contagio de sarampion para un viajero chileno en 2017.
PL  - Chile
TA  - Rev Med Chil
JT  - Revista medica de Chile
JID - 0404312
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Chile/epidemiology
MH  - Disease Outbreaks
MH  - Humans
MH  - Measles/epidemiology/prevention & control/*transmission
MH  - Measles Vaccine
MH  - *Models, Theoretical
MH  - Probability
MH  - Risk Assessment/*methods
MH  - Risk Factors
MH  - Time Factors
MH  - *Travel-Related Illness
MH  - Vaccination
EDAT- 2019/12/21 06:00
MHDA- 2020/01/23 06:00
CRDT- 2019/12/21 06:00
PHST- 2019/12/21 06:00 [entrez]
PHST- 2019/12/21 06:00 [pubmed]
PHST- 2020/01/23 06:00 [medline]
AID - S0034-98872019000500650 [pii]
AID - 10.4067/S0034-98872019000500650 [doi]
PST - ppublish
SO  - Rev Med Chil. 2019 May;147(5):650-657. doi: 10.4067/S0034-98872019000500650.

PMID- 32853313
OWN - NLM
STAT- MEDLINE
DCOM- 20200831
LR  - 20200831
IS  - 0717-6341 (Electronic)
IS  - 0716-1018 (Linking)
VI  - 37
IP  - 3
DP  - 2020 Jun
TI  - [Estimation of the effective reproduction number of measles 2018-2019 in Chile].
PG  - 231-236
LID - S0716-10182020000300231 [pii]
LID - 10.4067/s0716-10182020000300231 [doi]
AB  - BACKGROUND: Measles cases are reemerging in many countries across the globe. There 
      was an outbreak of imported measles between November 2018 and February 2019 in 
      Chile, raising concern among the public and health authorities. Many were worried 
      about the Chilean measles herd immunity, a factor that relates to the reproductive 
      capacity of the virus (measure of transmissibility of a pathogen). AIM: Here we 
      estimate the effective reproductive number (Re) of this measles outbreak. RESULTS: 
      Although the estimate is highly uncertain due to the low number of cases and the 
      absence of homogeneous mixing of the population, we found Re was approximately 1.5. 
      DISCUSSION AND CONCLUSIONS: Consequently we estimated about 90,3 % had measles 
      immunity, consistent with administrative estimates from the Ministry of Health. 
      These results suggest the Chilean population has established herd immunity against 
      the introduction of imported measles cases, reflecting adequate preventive 
      management of this disease.
FAU - Canals, Mauricio
AU  - Canals M
AD  - Departamento de Medicina, Facultad de Medicina, Universidad de Chile, Chile.
FAU - Gallegos, Doris
AU  - Gallegos D
AD  - Departamento de Epidemiología, Sub secretaría de Salud Pública, Ministerio de Salud, 
      Chile.
FAU - Avendaño, L Fidel
AU  - Avendaño LF
AD  - ICBM, Facultad de. Medicina, Universidad de Chile, Chile.
LA  - spa
PT  - Journal Article
TT  - Estimación del número reproductivo efectivo del brote de sarampión 2018-2019 en 
      Chile.
PL  - Chile
TA  - Rev Chilena Infectol
JT  - Revista chilena de infectologia : organo oficial de la Sociedad Chilena de 
      Infectologia
JID - 9305754
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Chile
MH  - Disease Outbreaks
MH  - Humans
MH  - Immunity, Herd
MH  - *Measles
MH  - Measles Vaccine
MH  - *Vaccination
EDAT- 2020/08/28 06:00
MHDA- 2020/09/01 06:00
CRDT- 2020/08/28 06:00
PHST- 2019/08/21 00:00 [received]
PHST- 2020/05/04 00:00 [accepted]
PHST- 2020/08/28 06:00 [entrez]
PHST- 2020/08/28 06:00 [pubmed]
PHST- 2020/09/01 06:00 [medline]
AID - S0716-10182020000300231 [pii]
AID - 10.4067/s0716-10182020000300231 [doi]
PST - ppublish
SO  - Rev Chilena Infectol. 2020 Jun;37(3):231-236. doi: 10.4067/s0716-10182020000300231.

PMID- 33477302
OWN - NLM
STAT- MEDLINE
DCOM- 20210225
LR  - 20210225
IS  - 1999-4915 (Electronic)
IS  - 1999-4915 (Linking)
VI  - 13
IP  - 1
DP  - 2021 Jan 17
TI  - Environmental Surveillance through Next-Generation Sequencing to Unveil the 
      Diversity of Human Enteroviruses beyond the Reported Clinical Cases.
LID - 10.3390/v13010120 [doi]
LID - 120
AB  - The knowledge about circulation of Human Enteroviruses (EVs) obtained through 
      medical diagnosis in Argentina is scarce. Wastewater samples monthly collected in 
      Córdoba, Argentina during 2011-2012, and then in 2017-2018 were retrospectively 
      studied to assess the diversity of EVs in the community. Partial VP1 gene was 
      amplified by PCR from wastewater concentrates, and amplicons were subject of 
      next-generation sequencing and genetic analyses. There were 41 EVs detected, from 
      which ~50% had not been previously reported in Argentina. Most of the characterized 
      EVs (60%) were detected at both sampling periods, with similar values of intratype 
      nucleotide diversity. Exceptions were enterovirus A71, coxsackievirus B4, echovirus 
      14, and echovirus 30, which diversified in 2017-2018. There was a predominance of 
      types from EV-C in 2017-2018, evidencing a common circulation of these types 
      throughout the year in the community. Interestingly, high genetic similarity was 
      evidenced among environmental strains of echovirus 30 circulating in 2011-2012 and 
      co-temporal isolates obtained from patients suffering aseptic meningitis in 
      different locations of Argentina. This study provides an updated insight about EVs 
      circulating in an important region of South America, and suggests a valuable role of 
      wastewater-based epidemiology in predicting outbreaks before the onset of cases in 
      the community.
FAU - Lizasoain, Andrés
AU  - Lizasoain A
AUID- ORCID: 0000-0001-8062-6916
AD  - Laboratorio de Virología Molecular, Departamento de Ciencias Biológicas, Centro 
      Universitario Regional del Litoral Norte, Universidad de la República, Salto 50000, 
      Uruguay.
FAU - Mir, Daiana
AU  - Mir D
AD  - Unidad de Genómica y Bioinformática, Departamento de Ciencias Biológicas, Centro 
      Universitario Regional del Litoral Norte, Universidad de la República, Salto 50000, 
      Uruguay.
FAU - Masachessi, Gisella
AU  - Masachessi G
AD  - Laboratorio de Gastroenteritis Virales y Sarampión, Instituto de Virología Dr. J. M. 
      Vanella, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba 
      5000, Argentina.
FAU - Farías, Adrián
AU  - Farías A
AD  - Laboratorio de Gastroenteritis Virales y Sarampión, Instituto de Virología Dr. J. M. 
      Vanella, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba 
      5000, Argentina.
FAU - Rodríguez-Osorio, Nélida
AU  - Rodríguez-Osorio N
AD  - Unidad de Genómica y Bioinformática, Departamento de Ciencias Biológicas, Centro 
      Universitario Regional del Litoral Norte, Universidad de la República, Salto 50000, 
      Uruguay.
FAU - Victoria, Matías
AU  - Victoria M
AD  - Laboratorio de Virología Molecular, Departamento de Ciencias Biológicas, Centro 
      Universitario Regional del Litoral Norte, Universidad de la República, Salto 50000, 
      Uruguay.
FAU - Nates, Silvia
AU  - Nates S
AD  - Laboratorio de Gastroenteritis Virales y Sarampión, Instituto de Virología Dr. J. M. 
      Vanella, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba 
      5000, Argentina.
FAU - Colina, Rodney
AU  - Colina R
AD  - Laboratorio de Virología Molecular, Departamento de Ciencias Biológicas, Centro 
      Universitario Regional del Litoral Norte, Universidad de la República, Salto 50000, 
      Uruguay.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20210117
TA  - Viruses
JT  - Viruses
JID - 101509722
RN  - 0 (Waste Water)
SB  - IM
MH  - Argentina/epidemiology
MH  - Computational Biology/methods
MH  - Enterovirus/classification/*genetics/isolation & purification
MH  - Enterovirus Infections/*epidemiology/*virology
MH  - *Environmental Microbiology
MH  - *Environmental Monitoring
MH  - *Genetic Variation
MH  - High-Throughput Nucleotide Sequencing
MH  - Humans
MH  - Phylogeny
MH  - Public Health Surveillance
MH  - Viral Load
MH  - Waste Water/microbiology/virology
PMC - PMC7829892
OTO - NOTNLM
OT  - *aseptic meningitis
OT  - *coxsackievirus
OT  - *echovirus
OT  - *enterovirus
OT  - *next-generation sequencing
OT  - *outbreak
OT  - *phylogenetic analysis
OT  - *poliovirus
OT  - *surveillance
OT  - *wastewater-based epidemiology
COIS- The authors declare no conflict of interest. The funders had no role in the design 
      of the study; in the collection, analyses, or interpretation of data; in the writing 
      of the manuscript; or in the decision to publish the results.
EDAT- 2021/01/23 06:00
MHDA- 2021/02/26 06:00
CRDT- 2021/01/22 01:01
PHST- 2020/12/19 00:00 [received]
PHST- 2021/01/13 00:00 [revised]
PHST- 2021/01/15 00:00 [accepted]
PHST- 2021/01/22 01:01 [entrez]
PHST- 2021/01/23 06:00 [pubmed]
PHST- 2021/02/26 06:00 [medline]
AID - v13010120 [pii]
AID - viruses-13-00120 [pii]
AID - 10.3390/v13010120 [doi]
PST - epublish
SO  - Viruses. 2021 Jan 17;13(1):120. doi: 10.3390/v13010120.

PMID- 32828554
OWN - NLM
STAT- Publisher
LR  - 20210521
IS  - 2529-993X (Electronic)
IS  - 2529-993X (Linking)
DP  - 2020 Aug 19
TI  - Comparative evaluation of assays for IgM detection of rubella and measles 
      infections.
LID - S0213-005X(20)30256-1 [pii]
LID - 10.1016/j.eimc.2020.06.019 [doi]
AB  - BACKGROUND: Serological diagnosis of infections due to measles and rubella viruses 
      is done by IgM detection. The aim of this study was to comparatively evaluate 
      commercial systems for detecting IgM against both viruses, including those of ELISA, 
      in indirect and capture formats, chemiluminescence and electrochemiluminescence. 
      METHODS: Seven (for rubella) and six (for measles) assays were studied. One hundred 
      and sixty two samples were included in the study (from 90 rubella and 72 measles 
      cases), and all were analyzed in all the assays. RESULTS: The ranges of sensitivity, 
      specificity and agreement for rubella were 94.8-100%, 52.4-100% and 75.5-98.1%, 
      respectively. The corresponding ranges for measles assays were 87.0-100%, 53.3-100%, 
      and 73.0-99.4%. CONCLUSION: The best-performing assays were chemiluminescence (for 
      measles and rubella IgM), and electrochemiluminescence (for rubella IgM).
CI  - Copyright © 2020 Sociedad Española de Enfermedades Infecciosas y Microbiología 
      Clínica. Publicado por Elsevier España, S.L.U. All rights reserved.
FAU - Pérez Olmeda, Mayte
AU  - Pérez Olmeda M
AD  - Laboratorio de Serología, Centro Nacional de Microbiología, Instituto de Salud 
      Carlos III, Majadahonda, Spain.
FAU - Balfagón, Pilar
AU  - Balfagón P
AD  - Laboratorio de Serología, Centro Nacional de Microbiología, Instituto de Salud 
      Carlos III, Majadahonda, Spain.
FAU - Camacho, Juan
AU  - Camacho J
AD  - Laboratorio de Serología, Centro Nacional de Microbiología, Instituto de Salud 
      Carlos III, Majadahonda, Spain.
FAU - Dafouz, Desirée
AU  - Dafouz D
AD  - Laboratorio de Serología, Centro Nacional de Microbiología, Instituto de Salud 
      Carlos III, Majadahonda, Spain.
FAU - de la Fuente, Jesús
AU  - de la Fuente J
AD  - Laboratorio de Serología, Centro Nacional de Microbiología, Instituto de Salud 
      Carlos III, Majadahonda, Spain.
FAU - Murillo, María Ángeles
AU  - Murillo MÁ
AD  - Laboratorio de Serología, Centro Nacional de Microbiología, Instituto de Salud 
      Carlos III, Majadahonda, Spain.
FAU - Muñoz, José Luis
AU  - Muñoz JL
AD  - Laboratorio de Serología, Centro Nacional de Microbiología, Instituto de Salud 
      Carlos III, Majadahonda, Spain.
FAU - Fernández García, Aurora
AU  - Fernández García A
AD  - Laboratorio de Aislamiento Viral, Centro Nacional de Microbiología, Instituto de 
      Salud Carlos III, Majadahonda, Spain; Centro de Investigación Biomédica en Red en 
      Epidemiología y Salud Pública (CiberESP), Instituto de Salud Carlos III, Madrid, 
      Spain.
FAU - Sanz, Juan Carlos
AU  - Sanz JC
AD  - Laboratorio Regional de Salud Pública de la Comunidad de Madrid, Madrid, Spain; 
      Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública 
      (CiberESP), Instituto de Salud Carlos III, Madrid, Spain.
FAU - de Ory, Fernando
AU  - de Ory F
AD  - Laboratorio de Serología, Centro Nacional de Microbiología, Instituto de Salud 
      Carlos III, Majadahonda, Spain; Centro de Investigación Biomédica en Red en 
      Epidemiología y Salud Pública (CiberESP), Instituto de Salud Carlos III, Madrid, 
      Spain. Electronic address: fernandodeorym@gmail.com.
LA  - eng
LA  - spa
PT  - Journal Article
DEP - 20200819
PL  - Spain
TA  - Enferm Infecc Microbiol Clin (Engl Ed)
JT  - Enfermedades infecciosas y microbiologia clinica (English ed.)
JID - 101777541
SB  - IM
OTO - NOTNLM
OT  - Chemiluminescent immunoassay
OT  - Electrochemiluminescent immunoassay
OT  - Enzyme immunoassay
OT  - Inmunoensayo electroquimioluminiscente
OT  - Inmunoensayo enzimático
OT  - Inmunoensayo quimioluminiscente
OT  - Measles virus
OT  - Rubella virus
OT  - Virus rubéola
OT  - Virus sarampión
EDAT- 2020/08/24 06:00
MHDA- 2020/08/24 06:00
CRDT- 2020/08/24 06:00
PHST- 2020/04/15 00:00 [received]
PHST- 2020/06/18 00:00 [revised]
PHST- 2020/06/23 00:00 [accepted]
PHST- 2020/08/24 06:00 [entrez]
PHST- 2020/08/24 06:00 [pubmed]
PHST- 2020/08/24 06:00 [medline]
AID - S0213-005X(20)30256-1 [pii]
AID - 10.1016/j.eimc.2020.06.019 [doi]
PST - aheadofprint
SO  - Enferm Infecc Microbiol Clin (Engl Ed). 2020 Aug 19:S0213-005X(20)30256-1. doi: 
      10.1016/j.eimc.2020.06.019.

PMID- 25728852
OWN - NLM
STAT- MEDLINE
DCOM- 20170419
LR  - 20181203
IS  - 1578-1852 (Electronic)
IS  - 0213-005X (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun-Jul
TI  - [Measles epidemics and effectiveness of measles vaccinations].
PG  - 432
LID - S0213-005X(15)00054-3 [pii]
LID - 10.1016/j.eimc.2015.01.011 [doi]
FAU - Arnedo-Pena, Alberto
AU  - Arnedo-Pena A
AD  - Sección de Epidemiología, Centro de Salud Pública de Castellón, Castellón, España.
FAU - Pardo Serrano, Francisco
AU  - Pardo Serrano F
AD  - Servicio de Microbiología, Hospital General Universitario de Castellón, Castellón, 
      España. Electronic address: pardo_fra@gva.es.
LA  - spa
PT  - Comment
PT  - Letter
TT  - Epidemias de sarampión y efectividad de la vacunación anti-sarampión.
DEP - 20150226
PL  - Spain
TA  - Enferm Infecc Microbiol Clin
JT  - Enfermedades infecciosas y microbiologia clinica
JID - 9104081
SB  - IM
CON - Enferm Infecc Microbiol Clin. 2014 Feb;32 Suppl 1:43-50. PMID: 24630583
MH  - *Epidemics
MH  - Humans
MH  - Measles/*epidemiology
MH  - Vaccination
EDAT- 2015/03/03 06:00
MHDA- 2017/04/20 06:00
CRDT- 2015/03/03 06:00
PHST- 2015/01/13 00:00 [received]
PHST- 2015/01/15 00:00 [accepted]
PHST- 2015/03/03 06:00 [entrez]
PHST- 2015/03/03 06:00 [pubmed]
PHST- 2017/04/20 06:00 [medline]
AID - S0213-005X(15)00054-3 [pii]
AID - 10.1016/j.eimc.2015.01.011 [doi]
PST - ppublish
SO  - Enferm Infecc Microbiol Clin. 2015 Jun-Jul;33(6):432. doi: 
      10.1016/j.eimc.2015.01.011. Epub 2015 Feb 26.

PMID- 27262819
OWN - NLM
STAT- MEDLINE
DCOM- 20190124
LR  - 20190124
IS  - 1578-1852 (Electronic)
IS  - 0213-005X (Linking)
VI  - 35
IP  - 9
DP  - 2017 Nov
TI  - Epidemiology of measles in vaccinated people, Spain 2003-2014.
PG  - 569-573
LID - S0213-005X(16)30106-9 [pii]
LID - 10.1016/j.eimc.2016.05.001 [doi]
AB  - INTRODUCTION: During the final phase of measles elimination rigorous investigation 
      of each individual case becomes fundamental to confirm or discard cases, 
      particularly among vaccinated people, since they experience a milder disease, and 
      laboratory diagnosis is more complex. Our study focused in the epidemiology of 
      measles in vaccinated people. METHODS: Longitudinal study on measles cases in two 
      dose vaccinated people in Spain from 2003 to 2014. RESULTS: We confirmed 138 measles 
      cases (90 of them, laboratory confirmed) in people with two doses of vaccine. The 
      median of time from last vaccination to rash onset showed a lineal trend (P<.001), 
      in parallel with the number of doses of vaccine received (0, 1, 2 doses). Among 
      confirmed cases, the hospitalization risk decreased inversely proportional to the 
      number of administered vaccine doses (linear trend, P<.001). Only in 23.9% of 
      confirmed cases and 50% of discarded cases the guidelines about sample taking were 
      fulfilled. 50% of samples in two dose vaccinated people were taken without 
      fulfilling time delay criteria. 16.7% (36/215) of discarded cases with a negative 
      IgM result did correspond to samples taken early (first 72h after rash) and could 
      represent false negatives. CONCLUSION: Our results highlight the importance of 
      fulfilling properly the guidelines for laboratory diagnosis in order to confirm or 
      discard every measles case, especially in two dose vaccinated people. When a 
      negative IgM result is obtained in early samples a new IgM test should be practiced, 
      as well as a PCR test, in order to avoid infra-detection of cases.
CI  - Copyright © 2016 Elsevier España, S.L.U. and Sociedad Española de Enfermedades 
      Infecciosas y Microbiología Clínica. All rights reserved.
FAU - Risco-Risco, Carlos
AU  - Risco-Risco C
AD  - Unidad de Medicina Preventiva y Salud Pública, Hospital Universitario Fundación 
      Alcorcón, Alcorcón, Madrid, España. Electronic address: carlosriscorisco@yahoo.es.
FAU - Masa-Calles, Josefa
AU  - Masa-Calles J
AD  - Centro Nacional de Epidemiología, CIBERESP, Instituto de Salud Carlos III, Madrid, 
      España.
FAU - López-Perea, Noemí
AU  - López-Perea N
AD  - Centro Nacional de Epidemiología, CIBERESP, Instituto de Salud Carlos III, Madrid, 
      España.
FAU - Echevarría, Juan Emilio
AU  - Echevarría JE
AD  - Laboratorio de Referencia e Investigación en Enfermedades Víricas Inmunoprevenibles, 
      Unidad de Aislamiento y Detección de Virus, Centro Nacional de Microbiología, 
      Instituto de Salud Carlos III, Majadahonda, Madrid, España.
FAU - Rodríguez-Caravaca, Gil
AU  - Rodríguez-Caravaca G
AD  - Unidad de Medicina Preventiva y Salud Pública, Hospital Universitario Fundación 
      Alcorcón, Alcorcón, Madrid, España.
LA  - eng
LA  - spa
PT  - Journal Article
TT  - Epidemiología del sarampión en personas vacunadas, España 2003-2014.
DEP - 20160601
PL  - Spain
TA  - Enferm Infecc Microbiol Clin
JT  - Enfermedades infecciosas y microbiologia clinica
JID - 9104081
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Adolescent
MH  - Child
MH  - Child, Preschool
MH  - Cohort Studies
MH  - Humans
MH  - Longitudinal Studies
MH  - Measles/*epidemiology/*prevention & control
MH  - *Measles Vaccine
MH  - Spain/epidemiology
MH  - Time Factors
MH  - Young Adult
OTO - NOTNLM
OT  - Diagnosis
OT  - Diagnóstico
OT  - Eliminación
OT  - Elimination
OT  - Evanescencia
OT  - Fallo vacunal secundario
OT  - Measles
OT  - Sarampión
OT  - Secondary vaccine failure
OT  - Surveillance
OT  - Vigilancia
OT  - Waning immunity
EDAT- 2016/06/06 06:00
MHDA- 2019/01/25 06:00
CRDT- 2016/06/06 06:00
PHST- 2016/02/05 00:00 [received]
PHST- 2016/05/02 00:00 [revised]
PHST- 2016/05/02 00:00 [accepted]
PHST- 2016/06/06 06:00 [pubmed]
PHST- 2019/01/25 06:00 [medline]
PHST- 2016/06/06 06:00 [entrez]
AID - S0213-005X(16)30106-9 [pii]
AID - 10.1016/j.eimc.2016.05.001 [doi]
PST - ppublish
SO  - Enferm Infecc Microbiol Clin. 2017 Nov;35(9):569-573. doi: 
      10.1016/j.eimc.2016.05.001. Epub 2016 Jun 1.

PMID- 28928057
OWN - NLM
STAT- MEDLINE
DCOM- 20190606
LR  - 20190606
IS  - 1578-1283 (Electronic)
IS  - 0213-9111 (Linking)
VI  - 32
IP  - 6
DP  - 2018 Nov-Dec
TI  - [Measles in Europe: necessity of global and local action to achieve its 
      eradication].
PG  - 590-591
LID - S0213-9111(17)30181-4 [pii]
LID - 10.1016/j.gaceta.2017.06.010 [doi]
FAU - González-Marrón, Adrián
AU  - González-Marrón A
AD  - Grupo de Evaluación de Determinantes de Salud y Políticas Sanitarias, Facultad de 
      Medicina y Ciencias de la Salud, Universidad Internacional de Cataluña, Sant Cugat 
      del Vallés (Barcelona), España. Electronic address: agonzalezm@uic.es.
FAU - Martínez-Sánchez, José M
AU  - Martínez-Sánchez JM
AD  - Grupo de Evaluación de Determinantes de Salud y Políticas Sanitarias, Facultad de 
      Medicina y Ciencias de la Salud, Universidad Internacional de Cataluña, Sant Cugat 
      del Vallés (Barcelona), España.
LA  - spa
PT  - Letter
TT  - Sarampión en Europa: necesidad de acción global y local para su erradicación.
DEP - 20170918
PL  - Spain
TA  - Gac Sanit
JT  - Gaceta sanitaria
JID - 8901623
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Communicable Diseases, Emerging/prevention & control
MH  - *Disease Eradication
MH  - Europe/epidemiology
MH  - Global Health
MH  - Health Promotion
MH  - Humans
MH  - Measles/epidemiology/*prevention & control
MH  - Measles Vaccine
MH  - Vaccination
MH  - World Health Organization
EDAT- 2017/09/21 06:00
MHDA- 2019/06/07 06:00
CRDT- 2017/09/21 06:00
PHST- 2017/05/28 00:00 [received]
PHST- 2017/06/01 00:00 [accepted]
PHST- 2017/09/21 06:00 [pubmed]
PHST- 2019/06/07 06:00 [medline]
PHST- 2017/09/21 06:00 [entrez]
AID - S0213-9111(17)30181-4 [pii]
AID - 10.1016/j.gaceta.2017.06.010 [doi]
PST - ppublish
SO  - Gac Sanit. 2018 Nov-Dec;32(6):590-591. doi: 10.1016/j.gaceta.2017.06.010. Epub 2017 
      Sep 18.

PMID- 33675515
OWN - NLM
STAT- MEDLINE
DCOM- 20210923
LR  - 20210923
IS  - 1867-0342 (Electronic)
IS  - 1867-0334 (Linking)
VI  - 13
IP  - 2
DP  - 2021 Jun
TI  - Human Enterovirus Diversity by Next-Generation Sequencing Analysis in Urban Sewage 
      Samples From Buenos Aires Metropolitan Area, Argentina: A Retrospective Study.
PG  - 259-269
LID - 10.1007/s12560-021-09468-y [doi]
AB  - Human Enteroviruses (hEVs) are responsible for a wide variety of human diseases. 
      During hEVs infection, virions are excreted in human feces and the fecal-oral route 
      is the primary pathway for person-to-person transmission. Sewage surveillance could 
      help in monitoring hEVs circulation and describing their diversity in a specific 
      population. In this study, sewage samples collected in Buenos Aires Metropolitan 
      Area (Argentina) were retrospectively studied through an amplicon-deep sequencing 
      approach and phylogenetic analyses to characterize hEVs spread. We identified 17 
      different hEVs types belonging to A, B, and C species. To the best of our knowledge, 
      this is the first report in Buenos Aires for 7 identified hEV-C types. Phylogenetic 
      analyses suggest several introductions of coxsackievirus B4, echovirus 1, and 
      echovirus 9 in the country, along with the national spread reached by some variants. 
      Besides, well-supported monophyletic groups of Argentine, Uruguayan, and Brazilian 
      strains unveiled regional circulation patterns for some variants. These results 
      extend our knowledge about hEVs circulation in Buenos Aires and might exhort 
      authorities to implement more active sewage surveillance in the region.
FAU - Lizasoain, A
AU  - Lizasoain A
AUID- ORCID: 0000-0001-8062-6916
AD  - Laboratorio de Virología Molecular, Departamento de Ciencias Biológicas, Centro 
      Universitario Regional del Litoral Norte. Universidad de La República, 1350 Gral. 
      Rivera St. Salto, 50000, Salto, Uruguay.
FAU - Mir, D
AU  - Mir D
AD  - Unidad de Genómica y Bioinformática. Departamento de Ciencias Biológicas, Centro 
      Universitario Regional del Litoral Norte. Universidad de La República, Salto, 
      Uruguay.
FAU - Victoria, M
AU  - Victoria M
AD  - Laboratorio de Virología Molecular, Departamento de Ciencias Biológicas, Centro 
      Universitario Regional del Litoral Norte. Universidad de La República, 1350 Gral. 
      Rivera St. Salto, 50000, Salto, Uruguay.
FAU - Barrios, M E
AU  - Barrios ME
AD  - Cátedra de Virología, Instituto de Investigaciones en Bacteriología y Virología 
      Molecular. Facultad de Farmacia Y Bioquímica, Universidad de Buenos Aires, Ciudad 
      Autónoma de Buenos Aires, Argentina.
FAU - Blanco-Fernández, M D
AU  - Blanco-Fernández MD
AD  - Cátedra de Virología, Instituto de Investigaciones en Bacteriología y Virología 
      Molecular. Facultad de Farmacia Y Bioquímica, Universidad de Buenos Aires, Ciudad 
      Autónoma de Buenos Aires, Argentina.
FAU - Rodríguez-Osorio, N
AU  - Rodríguez-Osorio N
AD  - Unidad de Genómica y Bioinformática. Departamento de Ciencias Biológicas, Centro 
      Universitario Regional del Litoral Norte. Universidad de La República, Salto, 
      Uruguay.
FAU - Nates, S
AU  - Nates S
AD  - Laboratorio de Gastroenteritis Virales y Sarampión. Instituto de Virología Dr. J. M. 
      Vanella. Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, 
      Argentina.
FAU - Cisterna, D
AU  - Cisterna D
AD  - Servicio de Neurovirosis, Departamento de Virología, Instituto Nacional de 
      Enfermedades Infecciosas. Administración Nacional de Laboratorios e Institutos de 
      Salud Dr. Carlos G. Malbrán, Buenos Aires, Argentina.
FAU - Mbayed, V A
AU  - Mbayed VA
AD  - Cátedra de Virología, Instituto de Investigaciones en Bacteriología y Virología 
      Molecular. Facultad de Farmacia Y Bioquímica, Universidad de Buenos Aires, Ciudad 
      Autónoma de Buenos Aires, Argentina.
FAU - Colina, R
AU  - Colina R
AUID- ORCID: 0000-0003-3731-5383
AD  - Laboratorio de Virología Molecular, Departamento de Ciencias Biológicas, Centro 
      Universitario Regional del Litoral Norte. Universidad de La República, 1350 Gral. 
      Rivera St. Salto, 50000, Salto, Uruguay. rodneycolina1@gmail.com.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20210306
PL  - United States
TA  - Food Environ Virol
JT  - Food and environmental virology
JID - 101483831
RN  - 0 (Sewage)
SB  - IM
MH  - Argentina/epidemiology
MH  - Biodiversity
MH  - Enterovirus/classification/*genetics/growth & development/isolation & purification
MH  - Enterovirus Infections/epidemiology/transmission/*virology
MH  - High-Throughput Nucleotide Sequencing
MH  - Humans
MH  - Phylogeny
MH  - Retrospective Studies
MH  - Sewage/*virology
MH  - Urban Health
OTO - NOTNLM
OT  - *Deep Sequencing
OT  - *Enterovirus
OT  - *Environment
OT  - *Health
OT  - *Sewage
EDAT- 2021/03/07 06:00
MHDA- 2021/09/24 06:00
CRDT- 2021/03/06 12:07
PHST- 2020/10/30 00:00 [received]
PHST- 2021/02/20 00:00 [accepted]
PHST- 2021/03/07 06:00 [pubmed]
PHST- 2021/09/24 06:00 [medline]
PHST- 2021/03/06 12:07 [entrez]
AID - 10.1007/s12560-021-09468-y [pii]
AID - 10.1007/s12560-021-09468-y [doi]
PST - ppublish
SO  - Food Environ Virol. 2021 Jun;13(2):259-269. doi: 10.1007/s12560-021-09468-y. Epub 
      2021 Mar 6.

PMID- 32591202
OWN - NLM
STAT- MEDLINE
DCOM- 20211006
LR  - 20211006
IS  - 2529-993X (Electronic)
IS  - 2529-993X (Linking)
VI  - 39
IP  - 3
DP  - 2021 Mar
TI  - Valuation of a commercialized RT-PCR kit for the diagnosis of infection caused by 
      the measles virus.
PG  - 155-156
LID - S0213-005X(20)30211-1 [pii]
LID - 10.1016/j.eimc.2020.05.014 [doi]
FAU - Sanz, Juan Carlos
AU  - Sanz JC
AD  - Laboratorio Regional de Salud Pública de la Comunidad de Madrid, Dirección General 
      de Salud Pública, Consejería de Sanidad Comunidad de Madrid, Madrid, España; 
      Consorcio de Investigación Biomédica de Epidemiología y Salud Pública (CIBERESP), 
      España. Electronic address: juan.sanz@salud.madrid.org.
FAU - Fernández-García, Aurora
AU  - Fernández-García A
AD  - Consorcio de Investigación Biomédica de Epidemiología y Salud Pública (CIBERESP), 
      España; Laboratorio de Referencia e Investigación en Enfermedades Víricas 
      Inmunoprevenibles, Centro Nacional de Microbiología, Instituto de Salud Carlos III, 
      Madrid, España.
FAU - Echevarría, Juan Emilio
AU  - Echevarría JE
AD  - Consorcio de Investigación Biomédica de Epidemiología y Salud Pública (CIBERESP), 
      España; Laboratorio de Referencia e Investigación en Enfermedades Víricas 
      Inmunoprevenibles, Centro Nacional de Microbiología, Instituto de Salud Carlos III, 
      Madrid, España.
FAU - de Ory, Fernando
AU  - de Ory F
AD  - Consorcio de Investigación Biomédica de Epidemiología y Salud Pública (CIBERESP), 
      España; Laboratorio de Referencia e Investigación en Enfermedades Víricas 
      Inmunoprevenibles, Centro Nacional de Microbiología, Instituto de Salud Carlos III, 
      Madrid, España.
LA  - eng
LA  - spa
PT  - Case Reports
PT  - Letter
TT  - Valoración de un kit comercializado de RT-PCR para el diagnóstico de la infección 
      por el virus del sarampión.
DEP - 20200624
PL  - Spain
TA  - Enferm Infecc Microbiol Clin (Engl Ed)
JT  - Enfermedades infecciosas y microbiologia clinica (English ed.)
JID - 101777541
RN  - 0 (RNA, Viral)
SB  - IM
MH  - Humans
MH  - *Measles/diagnosis
MH  - *Measles virus/genetics
MH  - RNA, Viral
MH  - Reverse Transcriptase Polymerase Chain Reaction
EDAT- 2020/06/28 06:00
MHDA- 2021/10/07 06:00
CRDT- 2020/06/28 06:00
PHST- 2020/05/06 00:00 [received]
PHST- 2020/05/24 00:00 [revised]
PHST- 2020/05/25 00:00 [accepted]
PHST- 2020/06/28 06:00 [pubmed]
PHST- 2021/10/07 06:00 [medline]
PHST- 2020/06/28 06:00 [entrez]
AID - S0213-005X(20)30211-1 [pii]
AID - 10.1016/j.eimc.2020.05.014 [doi]
PST - ppublish
SO  - Enferm Infecc Microbiol Clin (Engl Ed). 2021 Mar;39(3):155-156. doi: 
      10.1016/j.eimc.2020.05.014. Epub 2020 Jun 24.

PMID- 34429225
OWN - NLM
STAT- Publisher
LR  - 20211007
IS  - 2529-993X (Electronic)
IS  - 2529-993X (Linking)
DP  - 2021 Aug 21
TI  - Measles outbreak in the sanitary area of Guadalajara (Spain): Difficulty in 
      microbiological diagnosis in the era of its elimination.
LID - S0213-005X(21)00232-9 [pii]
LID - 10.1016/j.eimc.2021.07.011 [doi]
AB  - INTRODUCTION: In Spain, like in other countries where endemic measles has been 
      eliminated, there is a need for available diagnostic tools for confirming any cases 
      in order to prevent and control its transmission. We describe the different 
      microbiological tests used for the diagnosis of measles during an outbreak that 
      occurred in 2019 in the province of Guadalajara (Spain). METHODS: Serological and 
      molecular tests were performed at the Microbiology laboratory of the Guadalajara 
      University Hospital and at the National Center for Microbiology of the Carlos III 
      Health Institute (Majadahonda, Spain). Patient data were obtained from the 
      surveillance system. RESULTS: A total of 43 patients had a laboratory diagnosis of 
      measles: 29 cases by PCR (pharyngeal exudate or urine) and positive specific IgM, 11 
      cases by PCR, and 3 cases only by a positive IgM. Genotype D8 was identified in 35 
      confirmed cases and genotype A in 2 that were discarded as post-vaccination cases. 
      PCR was positive in the acute sera of 11 out of 14 patients with a negative IgM. 
      Eleven confirmed cases had recieved one or 2 vaccine doses. Twelve adult patients 
      were hospitalizated, all of them with a diagnostic of hepatitis. CONCLUSIONS: The 
      combination of molecular tests and the presence of specific IgG and IgM are 
      necessary for a correct diagnosis of measles and also to classify patients with a 
      breakthrough infection or vaccine failures (primary or secondary). Genotyping is 
      essential for the correct classification of the patients in the context of a measles 
      elimination program.
CI  - Copyright © 2021 Sociedad Española de Enfermedades Infecciosas y Microbiología 
      Clínica. Publicado por Elsevier España, S.L.U. All rights reserved.
FAU - González-Praetorius, Alejandro
AU  - González-Praetorius A
AD  - Sección de Microbiología, Hospital Universitario de Guadalajara, Guadalajara, 
      España. Electronic address: agonzalezp@sescam.jccm.es.
FAU - Fernández-García, Aurora
AU  - Fernández-García A
AD  - Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 
      Madrid, España; Centro de Investigación Biomédica en Red de Epidemiología y Salud 
      Pública (CIBERESP), Madrid, España.
FAU - Pérez-Olmeda, Mayte
AU  - Pérez-Olmeda M
AD  - Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 
      Madrid, España.
FAU - García-Rivera, M Victoria
AU  - García-Rivera MV
AD  - Servicio de Epidemiología, Dirección General de Salud Pública de Castilla-La Mancha, 
      Toledo, España.
FAU - Caballero-López, Begoña
AU  - Caballero-López B
AD  - Sección de Microbiología, Hospital Universitario de Guadalajara, Guadalajara, 
      España.
FAU - Gilaberte-Reyzabal, Sergio
AU  - Gilaberte-Reyzabal S
AD  - Servicio de Medicina Interna, Hospital Universitario de Guadalajara, Guadalajara, 
      España.
FAU - Román-Marcos, Elena
AU  - Román-Marcos E
AD  - Servicio de Epidemiología, Dirección General de Salud Pública de Castilla-La Mancha, 
      Toledo, España.
FAU - de Ory-Machón, Fernando
AU  - de Ory-Machón F
AD  - Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 
      Madrid, España; Centro de Investigación Biomédica en Red de Epidemiología y Salud 
      Pública (CIBERESP), Madrid, España.
FAU - Echevarría-Mayo, Juan Emilio
AU  - Echevarría-Mayo JE
AD  - Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 
      Madrid, España; Centro de Investigación Biomédica en Red de Epidemiología y Salud 
      Pública (CIBERESP), Madrid, España.
LA  - eng
LA  - spa
PT  - Journal Article
TT  - Brote de sarampión en el área sanitaria de Guadalajara (España): dificultad en el 
      diagnóstico microbiológico en la era de su eliminación.
DEP - 20210821
PL  - Spain
TA  - Enferm Infecc Microbiol Clin (Engl Ed)
JT  - Enfermedades infecciosas y microbiologia clinica (English ed.)
JID - 101777541
OTO - NOTNLM
OT  - Diagnosis
OT  - Diagnóstico
OT  - Hepatitis
OT  - Measles
OT  - Sarampión
OT  - Vaccine
OT  - Vacuna
EDAT- 2021/08/26 06:00
MHDA- 2021/08/26 06:00
CRDT- 2021/08/25 05:42
PHST- 2021/05/19 00:00 [received]
PHST- 2021/07/13 00:00 [revised]
PHST- 2021/07/20 00:00 [accepted]
PHST- 2021/08/25 05:42 [entrez]
PHST- 2021/08/26 06:00 [pubmed]
PHST- 2021/08/26 06:00 [medline]
AID - S0213-005X(21)00232-9 [pii]
AID - 10.1016/j.eimc.2021.07.011 [doi]
PST - aheadofprint
SO  - Enferm Infecc Microbiol Clin (Engl Ed). 2021 Aug 21:S0213-005X(21)00232-9. doi: 
      10.1016/j.eimc.2021.07.011.

PMID- 34383835
OWN - NLM
STAT- MEDLINE
DCOM- 20211209
LR  - 20211214
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 16
IP  - 8
DP  - 2021
TI  - First evidence of enterovirus A71 and echovirus 30 in Uruguay and genetic 
      relationship with strains circulating in the South American region.
PG  - e0255846
LID - 10.1371/journal.pone.0255846 [doi]
LID - e0255846
AB  - Human enteroviruses (EVs) comprise more than 100 types of coxsackievirus, echovirus, 
      poliovirus and numbered enteroviruses, which are mainly transmitted by the 
      faecal-oral route leading to diverse diseases such as aseptic meningitis, 
      encephalitis, and acute flaccid paralysis, among others. Since enteroviruses are 
      excreted in faeces, wastewater-based epidemiology approaches are useful to describe 
      EV diversity in a community. In Uruguay, knowledge about enteroviruses is extremely 
      limited. This study assessed the diversity of enteroviruses through Illumina 
      next-generation sequencing of VP1-amplicons obtained by RT-PCR directly applied to 
      viral concentrates of 84 wastewater samples collected in Uruguay during 2011-2012 
      and 2017-2018. Fifty out of the 84 samples were positive for enteroviruses. There 
      were detected 27 different types belonging to Enterovirus A species (CVA2-A6, A10, 
      A16, EV-A71, A90), Enterovirus B species (CVA9, B1-B5, E1, E6, E11, E14, E21, E30) 
      and Enterovirus C species (CVA1, A13, A19, A22, A24, EV-C99). Enterovirus A71 
      (EV-A71) and echovirus 30 (E30) strains were studied more in depth through 
      phylogenetic analysis, together with some strains previously detected by us in 
      Argentina. Results unveiled that EV-A71 sub-genogroup C2 circulates in both 
      countries at least since 2011-2012, and that the C1-like emerging variant recently 
      entered in Argentina. We also confirmed the circulation of echovirus 30 genotypes E 
      and F in Argentina, and reported the detection of genotype E in Uruguay. To the best 
      of our knowledge this is the first report of the EV-A71 C1-like emerging variant in 
      South-America, and the first report of EV-A71 and E30 in Uruguay.
FAU - Lizasoain, Andrés
AU  - Lizasoain A
AUID- ORCID: 0000-0001-8062-6916
AD  - Laboratorio de Virología Molecular, Departamento de Ciencias Biológicas, Centro 
      Universitario Regional Litoral Norte, Universidad de la República, Salto, Uruguay.
FAU - Mir, Daiana
AU  - Mir D
AD  - Unidad de Genómica y Bioinformática, Departamento de Ciencias Biológicas, Centro 
      Universitario Regional Litoral Norte, Universidad de la República, Salto, Uruguay.
FAU - Salvo, Matías
AU  - Salvo M
AD  - Laboratorio de Virología Molecular, Departamento de Ciencias Biológicas, Centro 
      Universitario Regional Litoral Norte, Universidad de la República, Salto, Uruguay.
FAU - Bortagaray, Viviana
AU  - Bortagaray V
AD  - Laboratorio de Virología Molecular, Departamento de Ciencias Biológicas, Centro 
      Universitario Regional Litoral Norte, Universidad de la República, Salto, Uruguay.
FAU - Masachessi, Gisela
AU  - Masachessi G
AD  - Laboratorio de Gastroenteritis Virales y Sarampión, Instituto de Virología Dr. J. M. 
      Vanella, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, 
      Argentina.
FAU - Farías, Adrián
AU  - Farías A
AD  - Laboratorio de Gastroenteritis Virales y Sarampión, Instituto de Virología Dr. J. M. 
      Vanella, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, 
      Argentina.
FAU - Rodríguez-Osorio, Nélida
AU  - Rodríguez-Osorio N
AD  - Unidad de Genómica y Bioinformática, Departamento de Ciencias Biológicas, Centro 
      Universitario Regional Litoral Norte, Universidad de la República, Salto, Uruguay.
FAU - Nates, Silvia
AU  - Nates S
AD  - Laboratorio de Gastroenteritis Virales y Sarampión, Instituto de Virología Dr. J. M. 
      Vanella, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, 
      Argentina.
FAU - Victoria, Matías
AU  - Victoria M
AD  - Laboratorio de Virología Molecular, Departamento de Ciencias Biológicas, Centro 
      Universitario Regional Litoral Norte, Universidad de la República, Salto, Uruguay.
FAU - Colina, Rodney
AU  - Colina R
AD  - Laboratorio de Virología Molecular, Departamento de Ciencias Biológicas, Centro 
      Universitario Regional Litoral Norte, Universidad de la República, Salto, Uruguay.
LA  - eng
SI  - figshare/10.6084/m9.figshare.14331215.v2
SI  - figshare/10.6084/m9.figshare.14854437.v1
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20210812
TA  - PLoS One
JT  - PloS one
JID - 101285081
RN  - 0 (Capsid Proteins)
RN  - 0 (RNA, Viral)
RN  - 0 (Waste Water)
SB  - IM
MH  - Capsid Proteins/genetics/metabolism
MH  - Enterovirus A, Human/classification/*genetics/isolation & purification
MH  - Enterovirus B, Human/classification/*genetics/isolation & purification
MH  - Enterovirus C, Human/classification/genetics/isolation & purification
MH  - Genetic Linkage/*genetics
MH  - Genotype
MH  - Humans
MH  - Phylogeny
MH  - RNA, Viral/chemistry/genetics/metabolism
MH  - Seasons
MH  - South America
MH  - Uruguay
MH  - Waste Water/virology
PMC - PMC8360592
COIS- The authors have declared that no competing interests exist.
EDAT- 2021/08/13 06:00
MHDA- 2021/12/15 06:00
CRDT- 2021/08/12 17:27
PHST- 2021/04/12 00:00 [received]
PHST- 2021/07/24 00:00 [accepted]
PHST- 2021/08/12 17:27 [entrez]
PHST- 2021/08/13 06:00 [pubmed]
PHST- 2021/12/15 06:00 [medline]
AID - PONE-D-21-12184 [pii]
AID - 10.1371/journal.pone.0255846 [doi]
PST - epublish
SO  - PLoS One. 2021 Aug 12;16(8):e0255846. doi: 10.1371/journal.pone.0255846. eCollection 
      2021.

PMID- 26580794
OWN - NLM
STAT- MEDLINE
DCOM- 20160628
LR  - 20181202
IS  - 2173-9110 (Electronic)
IS  - 1135-5727 (Linking)
VI  - 89
IP  - 4
DP  - 2015 Jul-Aug
TI  - [Plan for the Elimination of Measles and Rubella in Spain].
PG  - 393-6
LID - S1135-57272015000400007 [pii]
LID - 10.4321/S1135-57272015000400007 [doi]
AB  - The current Plan for the elimination of measles and rubella is made of the Plan for 
      the elimination of measles in Spain, set up in 2001, and the Surveillance protocol 
      of rubella and congenital rubella syndrome in the phase of elimination, established 
      in 2007. The monitoring of the elimination of both diseases conducted from the 
      European Region of World Health Organization (WHO) has been reinforced since 2010. 
      An annual report with information on the situation of measles and rubella in The 
      Member Estates is being requested since 2013. The Ministry of Health, Social 
      Services and Equality nominated a National Committee for Verification of Measles and 
      Rubella Elimination in 2013, for the review and delivery of the requested 
      information. The strategies and activities currently recommended from the WHO 
      European Region, the verification process in Spain, and the steps to follow for the 
      updating of the Plan for the elimination of measles and rubella in Spain are 
      mentioned in this article.
FAU - Limia Sánchez, Aurora
AU  - Limia Sánchez A
LA  - spa
PT  - Journal Article
TT  - Plan para la eliminación del sarampión y la rubeola en España.
PL  - Spain
TA  - Rev Esp Salud Publica
JT  - Revista espanola de salud publica
JID - 9600212
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Disease Eradication/*organization & administration
MH  - Humans
MH  - Measles/epidemiology/*prevention & control
MH  - Measles Vaccine
MH  - Rubella/epidemiology/*prevention & control
MH  - Rubella Syndrome, Congenital/epidemiology
MH  - Spain
MH  - World Health Organization
EDAT- 2015/11/19 06:00
MHDA- 2016/06/29 06:00
CRDT- 2015/11/19 06:00
PHST- 2015/11/19 06:00 [entrez]
PHST- 2015/11/19 06:00 [pubmed]
PHST- 2016/06/29 06:00 [medline]
AID - S1135-57272015000400007 [pii]
AID - 10.4321/S1135-57272015000400007 [doi]
PST - ppublish
SO  - Rev Esp Salud Publica. 2015 Jul-Aug;89(4):393-6. doi: 
      10.4321/S1135-57272015000400007.

PMID- 30833540
OWN - NLM
STAT- MEDLINE
DCOM- 20190425
LR  - 20190425
IS  - 2173-9110 (Electronic)
IS  - 1135-5727 (Linking)
VI  - 93
DP  - 2019 Mar 5
TI  - [Study of prevalence of protection against measles in health workers of Murcia 
      Health Service].
LID - e201903009 [pii]
AB  - OBJECTIVE: In the month of April 2017, two cases of measles were reported in one of 
      the basic health zones (ZBS) of the Region of Murcia. The Occupational Risk 
      Prevention Services of the Murcian Health Service (SMS) were urged to review the 
      immunological status of health workers, born as of 1971, from Primary Care Centers, 
      referral hospitals and emergency services that cover the affected area with the 
      general objective of preventing the appearance of a possible outbreak of measles in 
      this personnel, checking the protection of these workers against this disease (the 
      vaccine status and / or the serological status (IgG)) and offering the vaccine to 
      non-immune workers. METHODS: A descriptive study of the prevalence of protection 
      against measles of this group of workers during the period from January to February 
      2017 was carried out. Initially, the stories of the workers for whom data were 
      available were reviewed, and cited for the provision of vaccine data (90) or 
      extraction of serology to those for whom data were not available (138). RESULTS: 408 
      medical records / workers were reviewed. At the end of the study, we did have data 
      about the vaccination of 22.1% of the workers and serology of the 33.8%. 91.5% of 
      the workers for whom we had data were protected against measles. CONCLUSIONS: We can 
      conclude that the coverage among our workers is lower than that proposed by the 
      Measles and Rubella Elimination Plan, so a program to promote vaccination against 
      this disease among health personnel would be advisable.
FAU - Galián Muñoz, Inmaculada
AU  - Galián Muñoz I
AD  - Servicio de Prevención de Riesgos Laborales del Servicio Murciano de Salud. Murcia. 
      España.
FAU - Gómez Pellicer, María Dolores
AU  - Gómez Pellicer MD
AD  - Servicio de Prevención de Riesgos Laborales del Servicio Murciano de Salud. Murcia. 
      España.
FAU - Grau Polán, Marina
AU  - Grau Polán M
AD  - Servicio de Prevención de Riesgos Laborales del Servicio Murciano de Salud. Murcia. 
      España.
FAU - Llorach Asunción, Isabel Mª
AU  - Llorach Asunción IM
AD  - Servicio de Prevención de Riesgos Laborales del Servicio Murciano de Salud. Murcia. 
      España.
LA  - spa
PT  - Journal Article
TT  - Estudio de prevalencia de protección frente a sarampión en trabajadores sanitarios 
      del Servicio Murciano de Salud.
DEP - 20190305
PL  - Spain
TA  - Rev Esp Salud Publica
JT  - Revista espanola de salud publica
JID - 9600212
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Adult
MH  - Disease Outbreaks/prevention & control
MH  - Female
MH  - *Health Personnel
MH  - Humans
MH  - Male
MH  - Measles/*immunology/prevention & control
MH  - Measles Vaccine/*administration & dosage/immunology
MH  - Middle Aged
MH  - Occupational Diseases/*immunology/prevention & control
MH  - Rubella/prevention & control
MH  - Spain/epidemiology
MH  - Vaccination/*statistics & numerical data
MH  - Young Adult
OTO - NOTNLM
OT  - Protection
OT  - Health workers
OT  - Measles
OT  - Spain
COIS- Disclosure The authors report no conflicts of interest in this work.
EDAT- 2019/03/06 06:00
MHDA- 2019/04/26 06:00
CRDT- 2019/03/06 06:00
PHST- 2018/10/03 00:00 [received]
PHST- 2019/01/21 00:00 [accepted]
PHST- 2019/03/06 06:00 [entrez]
PHST- 2019/03/06 06:00 [pubmed]
PHST- 2019/04/26 06:00 [medline]
AID - e201903009 [pii]
PST - epublish
SO  - Rev Esp Salud Publica. 2019 Mar 5;93:e201903009.

PMID- 31735578
OWN - NLM
STAT- MEDLINE
DCOM- 20201208
LR  - 20201214
IS  - 1578-8865 (Electronic)
IS  - 1138-3593 (Linking)
VI  - 46
IP  - 2
DP  - 2020 Mar
TI  - [Measles is back. Report of 3 cases seen in the Emergency Department].
PG  - 145-147
LID - S1138-3593(19)30369-7 [pii]
LID - 10.1016/j.semerg.2019.09.008 [doi]
FAU - Fernandez-Nieto, D
AU  - Fernandez-Nieto D
AD  - Servicio de Dermatología, Hospital Universitario Ramón y Cajal, Madrid, España. 
      Electronic address: fnietodiego@gmail.com.
FAU - Jimenez-Cauhe, J
AU  - Jimenez-Cauhe J
AD  - Servicio de Dermatología, Hospital Universitario Ramón y Cajal, Madrid, España.
FAU - Diaz-Guimaraens, B
AU  - Diaz-Guimaraens B
AD  - Servicio de Dermatología, Hospital Universitario Ramón y Cajal, Madrid, España.
FAU - Diaz-Garcia, N
AU  - Diaz-Garcia N
AD  - Servicio de Urgencias, Hospital Universitario Ramón y Cajal, Madrid, España.
FAU - Ortega-Quijano, D
AU  - Ortega-Quijano D
AD  - Servicio de Dermatología, Hospital Universitario Ramón y Cajal, Madrid, España.
LA  - spa
PT  - Case Reports
PT  - Journal Article
TT  - El sarampión ha vuelto. Reporte de 3 casos atendidos en el Servicio de Urgencias.
DEP - 20191115
PL  - Spain
TA  - Semergen
JT  - Semergen
JID - 9610769
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Adult
MH  - Emergency Service, Hospital
MH  - Female
MH  - Humans
MH  - Male
MH  - Measles/*diagnosis/prevention & control
MH  - Measles Vaccine/*administration & dosage
MH  - Spain
MH  - Young Adult
EDAT- 2019/11/19 06:00
MHDA- 2020/12/15 06:00
CRDT- 2019/11/19 06:00
PHST- 2019/06/26 00:00 [received]
PHST- 2019/09/06 00:00 [revised]
PHST- 2019/09/13 00:00 [accepted]
PHST- 2019/11/19 06:00 [pubmed]
PHST- 2020/12/15 06:00 [medline]
PHST- 2019/11/19 06:00 [entrez]
AID - S1138-3593(19)30369-7 [pii]
AID - 10.1016/j.semerg.2019.09.008 [doi]
PST - ppublish
SO  - Semergen. 2020 Mar;46(2):145-147. doi: 10.1016/j.semerg.2019.09.008. Epub 2019 Nov 
      15.

PMID- 15105009
OWN - NLM
STAT- MEDLINE
DCOM- 20040727
LR  - 20190917
IS  - 1695-4033 (Print)
IS  - 1695-4033 (Linking)
VI  - 60
IP  - 5
DP  - 2004 May
TI  - [Measles outbreak in Saharan refugee camps].
PG  - 483-4
FAU - Martín Díaz, Ma J
AU  - Martín Díaz MJ
FAU - Espejo Moreno, L
AU  - Espejo Moreno L
FAU - Hernández Caballero, Ma J
AU  - Hernández Caballero MJ
FAU - Díaz Pinazo, M
AU  - Díaz Pinazo M
FAU - Pérez Martínez, A
AU  - Pérez Martínez A
LA  - spa
PT  - Letter
TT  - Brote de sarampión en los campamentos de refugiados saharauis.
PL  - Spain
TA  - An Pediatr (Barc)
JT  - Anales de pediatria (Barcelona, Spain : 2003)
JID - 101162596
SB  - IM
MH  - Africa, Northern/epidemiology
MH  - *Disease Outbreaks
MH  - Humans
MH  - Measles/*epidemiology
MH  - *Refugees
EDAT- 2004/04/24 05:00
MHDA- 2004/07/28 05:00
CRDT- 2004/04/24 05:00
PHST- 2004/04/24 05:00 [pubmed]
PHST- 2004/07/28 05:00 [medline]
PHST- 2004/04/24 05:00 [entrez]
AID - 13059657 [pii]
AID - 10.1016/s1695-4033(04)78313-7 [doi]
PST - ppublish
SO  - An Pediatr (Barc). 2004 May;60(5):483-4. doi: 10.1016/s1695-4033(04)78313-7.

PMID- 27717100
OWN - NLM
STAT- MEDLINE
DCOM- 20170710
LR  - 20180129
IS  - 1365-3156 (Electronic)
IS  - 1360-2276 (Linking)
VI  - 22
IP  - 1
DP  - 2017 Jan
TI  - Household experience and costs of seeking measles vaccination in rural 
      Guinea-Bissau.
PG  - 12-20
LID - 10.1111/tmi.12793 [doi]
AB  - OBJECTIVES: Children younger than 12 months of age are eligible for childhood 
      vaccines through the public health system in Guinea-Bissau. To limit open vial 
      wastage, a restrictive vial opening policy has been implemented; 10-dose measles 
      vaccine vials are only opened if six or more children aged 9-11 months are present 
      at the vaccination post. Consequently, mothers who bring their child for measles 
      vaccination can be told to return another day. We aimed to describe the household 
      experience and estimate household costs of seeking measles vaccination in rural 
      Guinea-Bissau. METHODS: Within a national sample of village clusters under 
      demographic surveillance, we interviewed mothers of children aged 9-21 months about 
      their experience with seeking measles vaccination. From information about time and 
      money spent, we calculated household costs of seeking measles vaccination. RESULTS: 
      We interviewed mothers of 1308 children of whom 1043 (80%) had sought measles 
      vaccination at least once. Measles vaccination coverage was 70% (910/1308). Coverage 
      decreased with increasing distance to the health centre. On average, mothers who had 
      taken their child for vaccination took their child 1.4 times. Mean costs of 
      achieving 70% coverage were 2.04 USD (SD 3.86) per child taken for vaccination. Half 
      of the mothers spent more than 2 h seeking vaccination and 11% spent money on 
      transportation. CONCLUSIONS: We found several indications of missed opportunities 
      for measles vaccination resulting in suboptimal coverage. The household costs 
      comprised 3.3% of the average monthly income and should be taken into account when 
      assessing the costs of delivering vaccinations.
CI  - © 2016 John Wiley & Sons Ltd.
FAU - Byberg, S
AU  - Byberg S
AD  - Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau.
AD  - Bandim Health Project, Research Center for Vitamins and Vaccines, Statens Serum 
      Institut, Copenhagen S, Denmark.
AD  - Odense Patient data Explorative Network, University of Southern Denmark, Odense, 
      Denmark.
FAU - Fisker, A B
AU  - Fisker AB
AD  - Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau.
AD  - Bandim Health Project, Research Center for Vitamins and Vaccines, Statens Serum 
      Institut, Copenhagen S, Denmark.
AD  - Odense Patient data Explorative Network, University of Southern Denmark, Odense, 
      Denmark.
FAU - Rodrigues, A
AU  - Rodrigues A
AD  - Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau.
FAU - Balde, I
AU  - Balde I
AD  - Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau.
FAU - Enemark, U
AU  - Enemark U
AD  - Centre for Global Health, Department of Public Health, Aarhus University, Aarhus, 
      Denmark.
FAU - Aaby, P
AU  - Aaby P
AD  - Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau.
AD  - Bandim Health Project, Research Center for Vitamins and Vaccines, Statens Serum 
      Institut, Copenhagen S, Denmark.
FAU - Benn, C S
AU  - Benn CS
AD  - Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau.
AD  - Bandim Health Project, Research Center for Vitamins and Vaccines, Statens Serum 
      Institut, Copenhagen S, Denmark.
AD  - Odense Patient data Explorative Network, University of Southern Denmark, Odense, 
      Denmark.
FAU - Griffiths, U K
AU  - Griffiths UK
AD  - Department of Global Health and Development, London School of Hygiene and Tropical 
      Medicine, London, UK.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20161028
PL  - England
TA  - Trop Med Int Health
JT  - Tropical medicine & international health : TM & IH
JID - 9610576
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Developing Countries
MH  - Financing, Personal
MH  - Guinea-Bissau/epidemiology
MH  - Health Services Accessibility/economics/*statistics & numerical data
MH  - Humans
MH  - Immunization Programs/economics/*statistics & numerical data
MH  - Infant
MH  - Interviews as Topic
MH  - Measles Vaccine/*administration & dosage
MH  - Mothers
MH  - Residence Characteristics/*statistics & numerical data
MH  - Rural Population/*statistics & numerical data
MH  - Time Factors
MH  - Transportation
OTO - NOTNLM
OT  - *Guinea-Bissau
OT  - *Guinée-Bissau
OT  - *costes para el hogar
OT  - *coûts pour les ménages
OT  - *household costs
OT  - *measles vaccine
OT  - *missed opportunities
OT  - *occasions manquées
OT  - *oportunidades perdidas
OT  - *vaccin antirougeoleux
OT  - *vacuna de sarampión
EDAT- 2016/10/30 06:00
MHDA- 2017/07/14 06:00
CRDT- 2016/10/08 06:00
PHST- 2016/10/30 06:00 [pubmed]
PHST- 2017/07/14 06:00 [medline]
PHST- 2016/10/08 06:00 [entrez]
AID - 10.1111/tmi.12793 [doi]
PST - ppublish
SO  - Trop Med Int Health. 2017 Jan;22(1):12-20. doi: 10.1111/tmi.12793. Epub 2016 Oct 28.

PMID- 29105452
OWN - NLM
STAT- MEDLINE
DCOM- 20180205
LR  - 20180210
IS  - 2386-5857 (Electronic)
IS  - 1137-6821 (Linking)
VI  - 28
IP  - 3
DP  - 2016 Jun
TI  - [Reemergence of measles in vaccinated patients: report of 6 cases and proposals for 
      prevention].
PG  - 146-152
AB  - A 2014 measles outbreak in Catalonia affected 131 persons. We describe a series of 6 
      cases diagnosed in our emergency department. All the patients were under 31 years of 
      age and complained of flu-like symptoms, including high fever and rash. Five had 
      been properly vaccinated and one was a health care worker. A firm diagnosis of 
      measles need not be made in the emergency department, but a high level of suspicion 
      is important for ruling out complications, isolating the patient, and protecting 
      health care staff at high risk for exposure. We found that 6% of the staff of our 
      emergency department had a low level of immunity to measles. Given our findings, we 
      suggest that preventive treatment is necessary when health care staff have been 
      exposed to measles and their vaccination status is unknown.
FAU - Agut-Busquet, Eugènia
AU  - Agut-Busquet E
AD  - Servicio de Dermatología, Parc Taulí Sabadell, Hospital Universitari, Sabadell, 
      Barcelona, España.
FAU - Gené Tous, Emili
AU  - Gené Tous E
AD  - Servicio de Urgencias, Parc Taulí Sabadell, Hospital Universitari, Sabadell, 
      Barcelona.
FAU - Navarro, Gemma
AU  - Navarro G
AD  - Departament de Medicina Universitat Internacional de Catalunya, Institut 
      Universitari Parc Taulí, Universitat Autònoma de Barcelona, España.
FAU - González, Araceli
AU  - González A
AD  - Unitat d'Epidemiologia i Avaluació. Parc Taulí Sabadell. Hospital Universitari. 
      Institut Universitari Parc Taulí. Universitat Autònoma de Barcelona, España.
LA  - spa
PT  - Journal Article
TT  - Reemergencia del sarampión en pacientes vacunados: descripción de seis casos y 
      propuesta para su prevención.
PL  - Spain
TA  - Emergencias
JT  - Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias
JID - 9805751
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Child
MH  - Child, Preschool
MH  - Disease Outbreaks/*prevention & control/statistics & numerical data
MH  - Emergency Service, Hospital
MH  - Female
MH  - Humans
MH  - Infant
MH  - Male
MH  - Measles/diagnosis/*epidemiology/prevention & control
MH  - *Measles Vaccine
MH  - Spain/epidemiology
MH  - Young Adult
OTO - NOTNLM
OT  - *Emergency health services
OT  - *Measles
OT  - *Sarampión
OT  - *Servicio de urgencias
OT  - *Vaccination
OT  - *Vacuna
EDAT- 2016/06/01 00:00
MHDA- 2018/02/06 06:00
CRDT- 2017/11/07 06:00
PHST- 2017/11/07 06:00 [entrez]
PHST- 2016/06/01 00:00 [pubmed]
PHST- 2018/02/06 06:00 [medline]
PST - ppublish
SO  - Emergencias. 2016 Jun;28(3):146-152.

PMID- 23245535
OWN - NLM
STAT- MEDLINE
DCOM- 20140204
LR  - 20181202
IS  - 1578-8989 (Electronic)
IS  - 0025-7753 (Linking)
VI  - 140
IP  - 12
DP  - 2013 Jun 18
TI  - [Measles in adults in the XXI century].
PG  - 567-8
LID - S0025-7753(12)00818-4 [pii]
LID - 10.1016/j.medcli.2012.09.024 [doi]
FAU - Muñoz-Sanz, Agustín
AU  - Muñoz-Sanz A
FAU - Rodríguez-Vidigal, Francisco Félix
AU  - Rodríguez-Vidigal FF
FAU - Nogales-Muñoz, Nieves
AU  - Nogales-Muñoz N
FAU - Vera-Tomé, Araceli
AU  - Vera-Tomé A
LA  - spa
PT  - Case Reports
PT  - Letter
TT  - Sarampión del adulto en el siglo XXI.
DEP - 20121212
PL  - Spain
TA  - Med Clin (Barc)
JT  - Medicina clinica
JID - 0376377
RN  - 0 (Antibodies, Viral)
RN  - 0 (Immunoglobulin G)
RN  - 0 (Immunoglobulin M)
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Age of Onset
MH  - Antibodies, Viral/blood/immunology
MH  - Antibody Specificity
MH  - Bronchial Spasm/etiology
MH  - Cross Infection/epidemiology/virology
MH  - *Disease Outbreaks
MH  - Female
MH  - Humans
MH  - Immunocompetence
MH  - Immunoglobulin G/blood/immunology
MH  - Immunoglobulin M/blood/immunology
MH  - Male
MH  - Measles/diagnosis/*epidemiology/ethnology/prevention & control
MH  - Measles Vaccine
MH  - Measles virus/immunology
MH  - Roma
MH  - Spain/epidemiology
MH  - Symptom Assessment
MH  - Vaccination/statistics & numerical data
MH  - Young Adult
EDAT- 2012/12/19 06:00
MHDA- 2014/02/05 06:00
CRDT- 2012/12/19 06:00
PHST- 2012/06/28 00:00 [received]
PHST- 2012/09/07 00:00 [revised]
PHST- 2012/09/13 00:00 [accepted]
PHST- 2012/12/19 06:00 [entrez]
PHST- 2012/12/19 06:00 [pubmed]
PHST- 2014/02/05 06:00 [medline]
AID - S0025-7753(12)00818-4 [pii]
AID - 10.1016/j.medcli.2012.09.024 [doi]
PST - ppublish
SO  - Med Clin (Barc). 2013 Jun 18;140(12):567-8. doi: 10.1016/j.medcli.2012.09.024. Epub 
      2012 Dec 12.

PMID- 10650751
OWN - NLM
STAT- MEDLINE
DCOM- 20000210
LR  - 20191103
IS  - 1135-5727 (Print)
IS  - 1135-5727 (Linking)
VI  - 73
IP  - 5
DP  - 1999 Sep-Oct
TI  - [Molecular epidemiology of measles virus].
PG  - 605-8
FAU - Fernández-Muñoz, R
AU  - Fernández-Muñoz R
AD  - Hospital Ramón y Cajal, Madrid.
FAU - Carabaña, J
AU  - Carabaña J
FAU - Caballero, M
AU  - Caballero M
FAU - Liton, P B
AU  - Liton PB
FAU - Duque, B M
AU  - Duque BM
FAU - García-Villalón, M D
AU  - García-Villalón MD
FAU - Celma, M L
AU  - Celma ML
LA  - spa
PT  - Comparative Study
PT  - Journal Article
TT  - Epidemiología molecular del virus del sarampión.
PL  - Spain
TA  - Rev Esp Salud Publica
JT  - Revista espanola de salud publica
JID - 9600212
RN  - 0 (RNA, Viral)
SB  - IM
MH  - Genes, Viral/genetics
MH  - Genotype
MH  - Humans
MH  - Measles/*epidemiology
MH  - Measles virus/*genetics
MH  - Molecular Epidemiology
MH  - Mutation
MH  - RNA, Viral
MH  - Spain
EDAT- 2000/01/29 00:00
MHDA- 2000/01/29 00:01
CRDT- 2000/01/29 00:00
PHST- 2000/01/29 00:00 [pubmed]
PHST- 2000/01/29 00:01 [medline]
PHST- 2000/01/29 00:00 [entrez]
AID - 10.1590/s1135-57271999000500010 [doi]
PST - ppublish
SO  - Rev Esp Salud Publica. 1999 Sep-Oct;73(5):605-8. doi: 
      10.1590/s1135-57271999000500010.

PMID- 30517514
OWN - NLM
STAT- MEDLINE
DCOM- 20191008
LR  - 20191008
IS  - 1726-4642 (Electronic)
IS  - 1726-4634 (Linking)
VI  - 35
IP  - 3
DP  - 2018 Jul-Sep
TI  - [Genetic characterization of varicella Zoster virus isolated from complicated 
      clinical cases in Peru in 2016 and 2017].
PG  - 533-534
LID - S1726-46342018000300533 [pii]
LID - 10.17843/rpmesp.2018.353.3706 [doi]
FAU - Condori-Yujra, Fredy J
AU  - Condori-Yujra FJ
AD  - Laboratorio Nacional de Sarampión y Rubeola, Centro de Nacional de Salud Pública, 
      Instituto Nacional de Salud. Lima, Perú.
FAU - Jimenez-Vasquez, Víctor A
AU  - Jimenez-Vasquez VA
AD  - Facultad de Ciencias Biológicas, Escuela Profesional de Ciencias Biológicas, Unidad 
      de Sistemática Molecular y Filogeografía. Universidad Nacional Mayor de San Marcos. 
      Lima, Perú.
FAU - Enríquez-Alva, Giancarlo W
AU  - Enríquez-Alva GW
AD  - Facultad de Ciencias Naturales y Matemáticas, Escuela Profesional de Biología, 
      Universidad Nacional Federico Villareal. Lima, Perú.
FAU - Cabezudo-Pillpe, Néstor E
AU  - Cabezudo-Pillpe NE
AD  - Laboratorio Nacional de Sarampión y Rubeola, Centro de Nacional de Salud Pública, 
      Instituto Nacional de Salud. Lima, Perú.
LA  - spa
PT  - Letter
TT  - Caracterización genética del virus de varicela Zoster aislados de casos clínicos 
      complicados en Perú en 2016 Y 2017.
PL  - Peru
TA  - Rev Peru Med Exp Salud Publica
JT  - Revista peruana de medicina experimental y salud publica
JID - 101227566
SB  - IM
MH  - Chickenpox/*virology
MH  - Enzyme-Linked Immunosorbent Assay
MH  - Genotype
MH  - Herpesvirus 3, Human/genetics/*isolation & purification
MH  - Humans
MH  - Peru
MH  - Polymerase Chain Reaction
EDAT- 2018/12/06 06:00
MHDA- 2019/10/09 06:00
CRDT- 2018/12/06 06:00
PHST- 2018/05/28 00:00 [received]
PHST- 2018/08/15 00:00 [accepted]
PHST- 2018/12/06 06:00 [entrez]
PHST- 2018/12/06 06:00 [pubmed]
PHST- 2019/10/09 06:00 [medline]
AID - S1726-46342018000300533 [pii]
AID - 10.17843/rpmesp.2018.353.3706 [doi]
PST - ppublish
SO  - Rev Peru Med Exp Salud Publica. 2018 Jul-Sep;35(3):533-534. doi: 
      10.17843/rpmesp.2018.353.3706.

PMID- 26580796
OWN - NLM
STAT- MEDLINE
DCOM- 20160628
LR  - 20181202
IS  - 2173-9110 (Electronic)
IS  - 1135-5727 (Linking)
VI  - 89
IP  - 4
DP  - 2015 Jul-Aug
TI  - [Outbreaks of Measles in Andalusia, Spain, during the Period 2010-2015].
PG  - 407-18
LID - S1135-57272015000400009 [pii]
LID - 10.4321/S1135-57272015000400009 [doi]
AB  - The Andalusian Surveillance Epidemiological System (SVEA) controls and investigates 
      any notification of measles or any other communicable disease. The aim of this 
      article is to describe the epidemiological characteristics of measles outbreaks 
      occurred in Andalusia in the last five years (2010-2015) and their control measures. 
      In this period three outbreaks were reported: the first one started in Granada in 
      2010 in a community of objectors to vaccination. Control measures of measles 
      protocol of SVEA were adopted (case isolation, identification and contacts 
      immunization), including judicial measures among the group who refused the 
      vaccination. The second outbreak started in Seville in 2011 in an "area in need of 
      social transformation" and it spread throughout the region. The routine vaccination 
      coverage review was introduced within the surveillance system after those outbreaks, 
      identifying the most vulnerable people. During the first six months of 2015, a small 
      outbreak, of 15 cases, occurred in Granada. The outbreak was controlled mainly due 
      to the early intervention, the health measures adopted in the schools and health 
      centres involved and the high vaccination coverage achieved in the population.
FAU - Montaño Remacha, Carmen
AU  - Montaño Remacha C
FAU - Gallardo García, Virtudes
AU  - Gallardo García V
FAU - Mochón Ochoa, M Mar
AU  - Mochón Ochoa MM
FAU - García Fernández, Marcelino
AU  - García Fernández M
FAU - Mayoral Cortés, José María
AU  - Mayoral Cortés JM
FAU - Ruiz Fernández, Josefa
AU  - Ruiz Fernández J
LA  - spa
PT  - Journal Article
TT  - Brotes epidémicos de sarampión en Andalucía durante el período 2010-2015.
PL  - Spain
TA  - Rev Esp Salud Publica
JT  - Revista espanola de salud publica
JID - 9600212
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Age Distribution
MH  - Aged
MH  - Child
MH  - Child, Preschool
MH  - Disease Outbreaks/*statistics & numerical data
MH  - *Epidemiological Monitoring
MH  - Female
MH  - Humans
MH  - Incidence
MH  - Male
MH  - Measles/*epidemiology
MH  - Measles Vaccine/administration & dosage
MH  - Middle Aged
MH  - Residence Characteristics
MH  - Schools
MH  - Spain/epidemiology
MH  - Vaccination
EDAT- 2015/11/19 06:00
MHDA- 2016/06/29 06:00
CRDT- 2015/11/19 06:00
PHST- 2015/11/19 06:00 [entrez]
PHST- 2015/11/19 06:00 [pubmed]
PHST- 2016/06/29 06:00 [medline]
AID - S1135-57272015000400009 [pii]
AID - 10.4321/S1135-57272015000400009 [doi]
PST - ppublish
SO  - Rev Esp Salud Publica. 2015 Jul-Aug;89(4):407-18. doi: 
      10.4321/S1135-57272015000400009.

PMID- 17598636
OWN - NLM
STAT- MEDLINE
DCOM- 20070830
LR  - 20070629
IS  - 0535-5133 (Print)
IS  - 0535-5133 (Linking)
VI  - 48
IP  - 2
DP  - 2007 Jun
TI  - [Towards the elimination of measles in Venezuela].
PG  - 135-7
AB  - In spite of the existence of an effective vaccine and the systematic programs of 
      vaccination applied in many countries, measles continues being an important cause of 
      mortality and morbidity in the world. The efforts for the eradication of measles 
      must have a certain global character, since although certain geographic areas can 
      arrive at a situation of elimination and absence of transmission, there exists the 
      possibility of viral reintroduction by import from other countries. Measles is one 
      of the most contagious diseases. The epidemiology has changed in developed and 
      developing countries and a significant diminution has been observed, due to the 
      increase in the vaccination coverage. Measles has returned after four years of 
      absence in Venezuela, possibly as a result of the inadequate coverage of vaccination 
      in children and the accumulation of susceptibles in other ages. Due to this 
      outbreak, the Venezuelan health authorities made campaigns of massive vaccination 
      and reinforced the surveillance through diverse actions to avoid imports and the 
      risk of a great epidemy. It is a priority to eradicate measles in Venezuela and the 
      world in the next few years.
FAU - Nereida, Valero
AU  - Nereida V
FAU - Gotera, Jennifer
AU  - Gotera J
LA  - spa
PT  - Editorial
PT  - English Abstract
TT  - Hacia la eliminación del sarampión en Venezuela.
PL  - Venezuela
TA  - Invest Clin
JT  - Investigacion clinica
JID - 0421531
SB  - IM
MH  - Humans
MH  - Measles/*prevention & control
MH  - Venezuela
EDAT- 2007/06/30 09:00
MHDA- 2007/08/31 09:00
CRDT- 2007/06/30 09:00
PHST- 2007/06/30 09:00 [pubmed]
PHST- 2007/08/31 09:00 [medline]
PHST- 2007/06/30 09:00 [entrez]
PST - ppublish
SO  - Invest Clin. 2007 Jun;48(2):135-7.

PMID- 30653865
OWN - NLM
STAT- MEDLINE
DCOM- 20190822
LR  - 20190822
IS  - 2590-7379 (Electronic)
IS  - 0120-4157 (Linking)
VI  - 38
IP  - 4
DP  - 2018 Dec 1
TI  - The frequency of allergic reactions to the triple viral vaccine in 94 patients with 
      egg allergy.
PG  - 514-520
LID - 10.7705/biomedica.v38i4.3779 [doi]
AB  - Introduction: Vaccination is the most effective public health intervention of all 
      times, reducing the death and morbidity rates derived from multiple infectious 
      diseases. In many cases, the administration and reception of vaccines is delayed due 
      to the fear of allergic reactions; this is frequent among patients with allergy to 
      egg who need the triple viral vaccine. Objective: To evaluate the frequency of 
      reactions after the administration of triple viral vaccine (Measles, Mumps and 
      Rubella, MMR) in an egg-allergic population. Materials and methods: We conducted a 
      multi-center retrospective study (2014-2016) including patients with egg allergy who 
      visited an allergology center and required the administration of the triple viral 
      vaccine. Results: A total of 94 patients met the selection criteria. From these 
      patients, 68.2% had cutaneous symptoms, 22.3% had an anaphylactic reaction, 5.3% had 
      gastrointestinal symptoms, and 4.2% had respiratory egg-related symptoms. Regardless 
      of the severity of their reaction to egg, all patients received the triple viral 
      vaccine and in 100% of the cases, it was well tolerated. Conclusion: Although egg 
      allergy is common in childhood, the risk of allergic reactions during the MMR 
      vaccination in this population was similar to that in the general population, 
      therefore, its use should not be deferred even in patients with a history of severe 
      egg-related allergic reactions.
FAU - Sánchez, Jorge
AU  - Sánchez J
AD  - Grupo de Alergología Clínica y Experimental, IPS Universitaria, Universidad de 
      Antioquia, Medellín, Colombia Fundación para el Desarrollo de las Ciencias Médicas y 
      Biológicas (FUNDEMEB), Cartagena, Colombia Instituto de Investigaciones 
      Inmunológicas, Universidad de Cartagena, Cartagena, Colombia. jotamsc@yahoo.com.
FAU - Ramírez, Ruth
AU  - Ramírez R
FAU - Cardona, Ricardo
AU  - Cardona R
LA  - eng
LA  - spa
PT  - Journal Article
PT  - Multicenter Study
TT  - Frecuencia de las reacciones alérgicas a la vacuna triple viral en pacientes con 
      alergia al huevo.
DEP - 20181201
PL  - Colombia
TA  - Biomedica
JT  - Biomedica : revista del Instituto Nacional de Salud
JID - 8205605
RN  - 0 (Measles-Mumps-Rubella Vaccine)
MH  - Child, Preschool
MH  - Egg Hypersensitivity/*complications
MH  - Female
MH  - Humans
MH  - Hypersensitivity/*epidemiology/*etiology
MH  - Infant
MH  - Male
MH  - Measles-Mumps-Rubella Vaccine/*adverse effects
MH  - Retrospective Studies
OTO - NOTNLM
OT  - *anafilaxia
OT  - *hipersensibilidad al huevo
OT  - *vacuna contra el sarampión-parotiditis-rubéola
OT  - *vacunación
EDAT- 2019/01/18 06:00
MHDA- 2019/08/23 06:00
CRDT- 2019/01/18 06:00
PHST- 2017/01/26 00:00 [received]
PHST- 2018/05/08 00:00 [revised]
PHST- 2019/01/18 06:00 [entrez]
PHST- 2019/01/18 06:00 [pubmed]
PHST- 2019/08/23 06:00 [medline]
AID - 10.7705/biomedica.v38i4.3779 [doi]
PST - epublish
SO  - Biomedica. 2018 Dec 1;38(4):514-520. doi: 10.7705/biomedica.v38i4.3779.

PMID- 32118395
OWN - NLM
STAT- MEDLINE
DCOM- 20210120
LR  - 20210120
IS  - 1988-9518 (Electronic)
IS  - 0214-3429 (Print)
IS  - 0214-3429 (Linking)
VI  - 33
IP  - 2
DP  - 2020 Apr
TI  - [Seroprevalence of antibodies against measles virus in Galicia: trends during the 
      last ten years depending on age and sex].
PG  - 116-121
LID - costa02mar2020 [pii]
LID - 10.37201/req/108.2019 [doi]
AB  - OBJECTIVE: In 1998, the Europe Region of the World Health Organization set the goal 
      of eliminating measles. In this study, the prevalence of immunity against measles 
      virus in the population of the health area of Santiago de Compostela was analyzed 
      based on data obtained between 2008-2018. METHODS: A total of 7,150 different 
      patients were studied and divided into groups according to their year of birth: 
      2010-2017, 2000-2009, 1990-1999, 1980-1989, 1953-1979 and <1953. The serum 
      determination of IgG against measles virus was performed using a commercialized 
      chemiluminescent immunoassay. RESULTS: A minimum (76%) was observed for measles 
      virus protection rates in those born between 1990-1999. By age group it was seen 
      that in all groups the women presented a higher percentage of antibodies against 
      measles. In a logistic regression model with year of birth and sex, an odds ratio of 
      1.06 (p<0.001) was obtained for the year of birth and of 0.82 (p=0.0013) for sex. 
      CONCLUSIONS: It was observed lower seroprevalences from the implantation of the 
      vaccine and a more pronounced change during the implantation period. From the 
      vaccination plan for measles of the year 2000 in Galicia, the rates of protection 
      against the virus of the measles have been increasing in our area. Although there is 
      a greater proportion of women protected against men, these differences are small.
CI  - ©The Author 2020. Published by Sociedad Española de Quimioterapia. This article is 
      distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 
      International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).
FAU - Costa-Alcalde, J J
AU  - Costa-Alcalde JJ
AD  - José Javier Costa Alcalde, Servicio de Microbiología. Hospital Clínico Universitario 
      de Santiago de Compostela. Travesía de Choupana s/n, 15706, Santiago de Compostela, 
      A Coruña, Spain. xosexabier@gmail.com.
FAU - Trastoy-Pena, R
AU  - Trastoy-Pena R
FAU - Barbeito-Castiñeiras, G
AU  - Barbeito-Castiñeiras G
FAU - Navarro de la Cruz, D
AU  - Navarro de la Cruz D
FAU - Mejuto, B
AU  - Mejuto B
FAU - Aguilera, A
AU  - Aguilera A
LA  - spa
PT  - Journal Article
PT  - Observational Study
TT  - Seroprevalencia de anticuerpos frente al virus del sarampión en Galicia: tendencias 
      durante los últimos diez años en función de la edad y sexo.
DEP - 20200302
TA  - Rev Esp Quimioter
JT  - Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de 
      Quimioterapia
JID - 9108821
RN  - 0 (Antibodies, Viral)
RN  - 0 (Immunoglobulin G)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Age Factors
MH  - Aged
MH  - Aged, 80 and over
MH  - Antibodies, Viral/*blood
MH  - Child
MH  - Child, Preschool
MH  - Cross-Sectional Studies
MH  - Female
MH  - Humans
MH  - Immunoglobulin G/*blood
MH  - Infant
MH  - Logistic Models
MH  - Male
MH  - Measles/*immunology
MH  - Measles virus/*immunology
MH  - Middle Aged
MH  - Odds Ratio
MH  - Seroepidemiologic Studies
MH  - Sex Factors
MH  - Spain
MH  - Young Adult
PMC - PMC7111243
OAB - Publisher: Abstract available from the publisher.
OABL- spa
OTO - NOTNLM
OT  - Galicia
OT  - Spain
OT  - age
OT  - immunity
OT  - measles
OT  - serology
OT  - sex
COIS- Los autores declaran no tener conflictos de interés.
EDAT- 2020/03/03 06:00
MHDA- 2021/01/21 06:00
CRDT- 2020/03/03 06:00
PHST- 2020/03/03 06:00 [pubmed]
PHST- 2021/01/21 06:00 [medline]
PHST- 2020/03/03 06:00 [entrez]
AID - costa02mar2020 [pii]
AID - revespquimioter-33-116 [pii]
AID - 10.37201/req/108.2019 [doi]
PST - ppublish
SO  - Rev Esp Quimioter. 2020 Apr;33(2):116-121. doi: 10.37201/req/108.2019. Epub 2020 Mar 
      2.

PMID- 33030820
OWN - NLM
STAT- MEDLINE
DCOM- 20210831
LR  - 20210831
IS  - 2590-7379 (Electronic)
IS  - 0120-4157 (Print)
IS  - 0120-4157 (Linking)
VI  - 40
IP  - 3
DP  - 2020 Sep 1
TI  - De curandis hominum morbis: An 18th century medical prescription for measles and 
      smallpox in the Nuevo Reino de Granada.
PG  - 427-437
LID - 10.7705/biomedica.4995 [doi]
AB  - A collection of more than one hundred medical recipes from the late 18th century was 
      donated by Presbyter Cipriano Rodríguez Santa María, institutional eponym of the 
      collection at the Historical Archive “Octavio Arizmendi Posada” of the library of 
      the Universidad de La Sabana in Colombia. These texts represent an important 
      historical and medical legacy and they constitute an important basis for 
      understanding the colonial and traditional therapeutics related to various diseases. 
      In this article, we describe one of these recipes for the treatment of smallpox and 
      measles as a contribution to the history of medicine in Colombia.
FAU - Lozano, Alejandra
AU  - Lozano A
AD  - Grupo de Genética Humana, Universidad de La Sabana, Chía, Colombia. 
      biomedica@ins.gov.co.
FAU - Martínez, Julio César
AU  - Martínez JC
AD  - Grupo de Genética Humana, Universidad de La Sabana, Chía, Colombia. 
      biomedica@ins.gov.co.
FAU - Uribe, Jorge
AU  - Uribe J
AD  - Facultad de Ciencias Sociales, Pontificia Universidad Javeriana, Bogotá, D.C., 
      Colombia. biomedica@ins.gov.co.
FAU - Gómez, Alberto
AU  - Gómez A
AD  - Instituto de Genética Humana, Facultad de Medicina, Pontificia Universidad 
      Javeriana, Bogotá, D.C., Colombia. biomedica@ins.gov.co.
FAU - Figueredo, Sneider Alberto
AU  - Figueredo SA
AD  - Grupo de Genética Humana, Universidad de La Sabana, Chía, Colombia. 
      biomedica@ins.gov.co.
FAU - Briceño, Ignacio
AU  - Briceño I
AD  - Grupo de Genética Humana, Universidad de La Sabana, Chía, Colombia. 
      ignaciobricenob@hotmail.com.
LA  - eng
LA  - spa
PT  - Historical Article
PT  - Journal Article
TT  - De curandis hominum morbis: una receta médica del siglo XVIII para el sarampión y 
      las viruelas en el Nuevo Reino de Granada.
DEP - 20200901
TA  - Biomedica
JT  - Biomedica : revista del Instituto Nacional de Salud
JID - 8205605
RN  - 059QF0KO0R (Water)
SB  - IM
MH  - Colombia
MH  - History, 18th Century
MH  - Humans
MH  - Measles/*history/therapy
MH  - Medicine, Traditional/*history
MH  - Prescriptions/*history
MH  - Smallpox/*history/therapy
MH  - Water/administration & dosage
PMC - PMC7666863
OAB - A collection of more than one hundred medical recipes from the late 18th century was 
      donated by Presbyter Cipriano Rodríguez Santa María, institutional eponym of the 
      collection at the Historical Archive “Octavio Arizmendi Posada” of the library of 
      the Universidad de La Sabana in Colombia. These texts represent an important 
      historical and medical legacy and they constitute an important basis for 
      understanding the colonial and traditional therapeutics related to various diseases. 
      In this article, we describe one of these recipes for the treatment of smallpox and 
      measles as a contribution to the history of medicine in Colombia.
OABL- eng
OTO - NOTNLM
OT  - *History of medicine
OT  - *measles
OT  - *smallpox
OT  - *medical records
OT  - *natural history
OT  - *prescriptions
OT  - *traditional
EDAT- 2020/10/09 06:00
MHDA- 2021/09/01 06:00
CRDT- 2020/10/08 12:25
PHST- 2019/03/21 00:00 [received]
PHST- 2020/10/08 12:25 [entrez]
PHST- 2020/10/09 06:00 [pubmed]
PHST- 2021/09/01 06:00 [medline]
AID - 10.7705/biomedica.4995 [doi]
PST - epublish
SO  - Biomedica. 2020 Sep 1;40(3):427-437. doi: 10.7705/biomedica.4995.

PMID- 30857795
OWN - NLM
STAT- MEDLINE
DCOM- 20201005
LR  - 20201005
IS  - 1578-8989 (Electronic)
IS  - 0025-7753 (Linking)
VI  - 153
IP  - 7
DP  - 2019 Oct 11
TI  - Impact of the MMR vaccine on the incidence of mumps in the Community of Madrid and 
      evaluation of the effectiveness of the Jeryl-Lynn strain. Years 1998-2016.
PG  - 276-280
LID - S0025-7753(19)30058-2 [pii]
LID - 10.1016/j.medcli.2019.01.012 [doi]
AB  - INTRODUCTION: Mumps is characterised by parotid inflammation and fever and is 
      preventable by vaccination with MMR vaccine. The objective of the study is to assess 
      the impact and effectiveness of the vaccine. MATERIAL AND METHODS: Cases notified to 
      the Notifiable Disease System between 1998 and 2016 were used for the study. The 
      vaccine effectiveness (VE) was calculated in cohorts vaccinated with two doses of 
      Jeryl-Lynn, and the impact was calculated by comparing incidences by age and by 
      Rubini (1995-1998) and Jeryl-Lynn (1999-2002) cohorts during the periods 1998-2004, 
      2005-2009 and 2010-2015. The incidences for age group and period were compared with 
      the previous period and the incidences for cohorts were compared within a period 
      with incidence ratios (IR) using Poisson models. The VE was estimated using the 
      screening method using logistic regression models. RESULTS: 13,816 cases were 
      reported. The incidence in 2005-2009 was higher than in 1998-2004 (IR: 1.46, 95% CI: 
      1.40-1.53), and it remained stable in 2010-2015 (IR: 0.99, 95% CI: 0.95-1.03). The 
      average incidence rate of the Rubini cohort was 69.43 and the Jeryl-Lynn cohort was 
      32.24. The IR was 0.25 (95% CI: 0.22-0.29), 0.55 (95% CI: 0.49-0.61) and 0.88 (95% 
      CI: 0.76-1.00) for each period respectively. 2,574 cases were included in the VE 
      study. EV decreased over time reaching not significant values after seven years of 
      follow-up (VE: 55%, 95% CI: 82 to -12%). CONCLUSIONS: Parotiditis behavior is 
      characterised by fluctuations, changes in presentation and a decrease in VE.
CI  - Copyright © 2019 Elsevier España, S.L.U. All rights reserved.
FAU - Latasa, Pello
AU  - Latasa P
AD  - Subdirección General de Epidemiología, Dirección General de Salud Pública de la 
      Comunidad de Madrid, Madrid, España. Electronic address: latasa@salud.madrid.org.
FAU - Ordobás, María
AU  - Ordobás M
AD  - Subdirección General de Epidemiología, Dirección General de Salud Pública de la 
      Comunidad de Madrid, Madrid, España.
FAU - Garrido-Estepa, Macarena
AU  - Garrido-Estepa M
AD  - Agencia de Evaluación de Tecnologías Sanitarias, Instituto de Salud Carlos III, 
      Madrid, España.
FAU - Sanz, Juan Carlos
AU  - Sanz JC
AD  - Laboratorio Regional de Salud Pública, Dirección General de Salud Pública de la 
      Comunidad de Madrid, Madrid, España.
FAU - Gil de Miguel, Angel
AU  - Gil de Miguel A
AD  - Departamento de Salud Pública, Universidad Rey Juan Carlos, Madrid, España.
FAU - García-Comas, Luis
AU  - García-Comas L
AD  - Subdirección General de Epidemiología, Dirección General de Salud Pública de la 
      Comunidad de Madrid, Madrid, España.
LA  - eng
LA  - spa
PT  - Journal Article
TT  - Impacto de la vacuna triple vírica sobre la incidencia de la parotiditis en la 
      Comunidad de Madrid y evaluación de la efectividad de la cepa Jeryl-Lynn entre 1998 
      y 2016.
DEP - 20190308
PL  - Spain
TA  - Med Clin (Barc)
JT  - Medicina clinica
JID - 0376377
RN  - 0 (Measles-Mumps-Rubella Vaccine)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Age Distribution
MH  - Aged
MH  - Child
MH  - Child, Preschool
MH  - Cohort Studies
MH  - Disease Outbreaks/statistics & numerical data
MH  - Humans
MH  - Immunization Schedule
MH  - Incidence
MH  - Infant
MH  - Logistic Models
MH  - Measles-Mumps-Rubella Vaccine/*administration & dosage
MH  - Middle Aged
MH  - Mumps/*epidemiology/prevention & control
MH  - Mumps virus/immunology
MH  - Poisson Distribution
MH  - Spain/epidemiology
MH  - Time Factors
MH  - Treatment Outcome
MH  - Young Adult
OTO - NOTNLM
OT  - *Efectividad
OT  - *Effectiveness
OT  - *Epidemiology
OT  - *Epidemiología
OT  - *Measles-mumps-rubella vaccine
OT  - *Mumps
OT  - *Paperas
OT  - *Public health surveillance
OT  - *Vacuna contra el sarampión-parotiditis-rubéola
OT  - *Vigilancia en salud pública
EDAT- 2019/03/13 06:00
MHDA- 2020/10/06 06:00
CRDT- 2019/03/13 06:00
PHST- 2018/09/12 00:00 [received]
PHST- 2018/12/21 00:00 [revised]
PHST- 2019/01/10 00:00 [accepted]
PHST- 2019/03/13 06:00 [pubmed]
PHST- 2020/10/06 06:00 [medline]
PHST- 2019/03/13 06:00 [entrez]
AID - S0025-7753(19)30058-2 [pii]
AID - 10.1016/j.medcli.2019.01.012 [doi]
PST - ppublish
SO  - Med Clin (Barc). 2019 Oct 11;153(7):276-280. doi: 10.1016/j.medcli.2019.01.012. Epub 
      2019 Mar 8.

PMID- 26580791
OWN - NLM
STAT- MEDLINE
DCOM- 20160628
LR  - 20181202
IS  - 2173-9110 (Electronic)
IS  - 1135-5727 (Linking)
VI  - 89
IP  - 4
DP  - 2015 Jul-Aug
TI  - [Immunization Programme and Coverage against Measles and Rubella in Spain. 
      Challenges for Achieving their Elimination].
PG  - 357-64
LID - S1135-57272015000400004 [pii]
LID - 10.4321/S1135-57272015000400004 [doi]
AB  - The World Health Organization had established the achievement and sustainability of 
      very high coverage with two doses of vaccine against measles and at least one 
      against rubella as one of the key strategies for the elimination of both measles and 
      rubella. The current immunization programme in Spain includes the immunization with 
      two doses of combined vaccine against measles, mumps and rubella at 12 months and 
      3-4 years of age. Since 2000 coverage with first dose is over the target of 95% but 
      the coverage with the second dose remains between 90 and 95%. In 2014, at 
      subnational level three regions had coverage below the objective and only eight 
      regions achieved the objective for the second dose. The challenges and some 
      activities to strengthen the immunization programme in order to achieve the 
      elimination of measles and rubella are discussed.
FAU - Limia Sánchez, Aurora
AU  - Limia Sánchez A
FAU - Molina Olivas, Marta
AU  - Molina Olivas M
LA  - spa
PT  - Journal Article
TT  - Programa y coberturas de vacunación frente a sarampión y rubeola en España. Retos 
      para alcanzar su eliminación.
PL  - Spain
TA  - Rev Esp Salud Publica
JT  - Revista espanola de salud publica
JID - 9600212
RN  - 0 (Measles Vaccine)
RN  - 0 (Measles-Mumps-Rubella Vaccine)
RN  - 0 (Rubella Vaccine)
SB  - IM
MH  - *Disease Eradication
MH  - Humans
MH  - Immunization
MH  - *Immunization Programs
MH  - Immunization, Secondary/statistics & numerical data
MH  - Measles/*prevention & control
MH  - Measles Vaccine/administration & dosage
MH  - Measles-Mumps-Rubella Vaccine
MH  - Mumps/prevention & control
MH  - Rubella/*prevention & control
MH  - Rubella Vaccine/administration & dosage
MH  - Spain
MH  - Vaccination/statistics & numerical data
MH  - World Health Organization
EDAT- 2015/11/19 06:00
MHDA- 2016/06/29 06:00
CRDT- 2015/11/19 06:00
PHST- 2015/11/19 06:00 [entrez]
PHST- 2015/11/19 06:00 [pubmed]
PHST- 2016/06/29 06:00 [medline]
AID - S1135-57272015000400004 [pii]
AID - 10.4321/S1135-57272015000400004 [doi]
PST - ppublish
SO  - Rev Esp Salud Publica. 2015 Jul-Aug;89(4):357-64. doi: 
      10.4321/S1135-57272015000400004.

PMID- 27869413
OWN - NLM
STAT- MEDLINE
DCOM- 20180129
LR  - 20180129
IS  - 1668-3501 (Electronic)
IS  - 0325-0075 (Linking)
VI  - 114
IP  - 6
DP  - 2016 Dec 1
TI  - Humoral immunity to tetanus, measles and rubella in children with acute 
      lymphoblastic leukemia after chemotherapy.
PG  - 549-552
LID - 10.5546/aap.2016.eng.549 [doi]
AB  - Chemotherapy regimens and clinical support advances have improved survival in 
      children with acute lymphoblastic leukemia. The after-effects of treatment are a 
      reason for concern, including damage to the immune system induced by 
      immunosuppressive therapy which is reflected in the loss of antibody protection 
      provided by prior immunizations. Our goal was to assess the presence of measles, 
      rubella, and tetanus protective antibody titers among patients with acute 
      lymphoblastic leukemia after completing chemotherapy. Sixty-one children with acute 
      lymphoblastic leukemia seen at the Hospital Garrahan were included; patients had 
      finished their chemotherapy at least 6 months earlier and had a complete 
      immunization schedule before diagnosis. The rates of protective antibodies were 46% 
      (CI: 32-59) for measles, 53% (CI 40-67) for tetanus, and 60% (CI 47-63) for rubella. 
      These results strengthen the need to reconsider revaccination in this group of 
      patients.
CI  - Sociedad Argentina de Pediatría.
FAU - Onorateli, Myriam
AU  - Onorateli M
AD  - Hospital de Pediatría SAMIC "Prof. Dr. Juan P. Garrahan", Ciudad Autónoma de Buenos 
      Aires, Argentina. noratelli@yahoo.com.ar.
FAU - Botana, Claudia
AU  - Botana C
AD  - Hospital de Pediatría SAMIC "Prof. Dr. Juan P. Garrahan", Ciudad Autónoma de Buenos 
      Aires, Argentina.
FAU - Peralta, Laura
AU  - Peralta L
AD  - Hospital de Pediatría SAMIC "Prof. Dr. Juan P. Garrahan", Ciudad Autónoma de Buenos 
      Aires, Argentina.
FAU - Rebollo, Magali
AU  - Rebollo M
AD  - Hospital de Pediatría SAMIC "Prof. Dr. Juan P. Garrahan", Ciudad Autónoma de Buenos 
      Aires, Argentina.
FAU - Ruvinsky, Silvina
AU  - Ruvinsky S
AD  - Hospital de Pediatría SAMIC "Prof. Dr. Juan P. Garrahan", Ciudad Autónoma de Buenos 
      Aires, Argentina.
FAU - Guitter, Myriam
AU  - Guitter M
AD  - Hospital de Pediatría SAMIC "Prof. Dr. Juan P. Garrahan", Ciudad Autónoma de Buenos 
      Aires, Argentina.
FAU - Felice, Maria S
AU  - Felice MS
AD  - Hospital de Pediatría SAMIC "Prof. Dr. Juan P. Garrahan", Ciudad Autónoma de Buenos 
      Aires, Argentina.
FAU - Posadas, Mercedes
AU  - Posadas M
AD  - Hospital de Pediatría SAMIC "Prof. Dr. Juan P. Garrahan", Ciudad Autónoma de Buenos 
      Aires, Argentina.
FAU - Evangelista, Silvina
AU  - Evangelista S
AD  - Hospital de Pediatría SAMIC "Prof. Dr. Juan P. Garrahan", Ciudad Autónoma de Buenos 
      Aires, Argentina.
FAU - Villar, Maria V
AU  - Villar MV
AD  - Hospital de Pediatría SAMIC "Prof. Dr. Juan P. Garrahan", Ciudad Autónoma de Buenos 
      Aires, Argentina.
FAU - Golluscio, Mariana
AU  - Golluscio M
AD  - Hospital de Pediatría SAMIC "Prof. Dr. Juan P. Garrahan", Ciudad Autónoma de Buenos 
      Aires, Argentina.
FAU - Molina, Agustina
AU  - Molina A
AD  - Hospital de Pediatría SAMIC "Prof. Dr. Juan P. Garrahan", Ciudad Autónoma de Buenos 
      Aires, Argentina.
FAU - Fraquelli, Lidia
AU  - Fraquelli L
AD  - Hospital de Pediatría SAMIC "Prof. Dr. Juan P. Garrahan", Ciudad Autónoma de Buenos 
      Aires, Argentina.
LA  - eng
LA  - spa
PT  - Journal Article
PT  - Observational Study
TT  - Inmunidad humoral a tétanos, sarampión y rubéola en niños con leucemia linfoblástica 
      aguda luego del tratamiento quimioterápico.
PL  - Argentina
TA  - Arch Argent Pediatr
JT  - Archivos argentinos de pediatria
JID - 0372460
RN  - 0 (Antibodies)
SB  - IM
MH  - Adolescent
MH  - Antibodies/blood
MH  - Child
MH  - Child, Preschool
MH  - Cross-Sectional Studies
MH  - Female
MH  - Humans
MH  - *Immunity, Humoral
MH  - Male
MH  - Measles/blood/*immunology
MH  - Precursor Cell Lymphoblastic Leukemia-Lymphoma/blood/*drug therapy/*immunology
MH  - Rubella/blood/*immunology
MH  - Tetanus/blood/*immunology
MH  - Young Adult
OTO - NOTNLM
OT  - Acute lymphoblastic leukemia
OT  - Antibodies
OT  - Chemotherapy
OT  - Humoral immunity
OT  - Immunizations
EDAT- 2016/11/22 06:00
MHDA- 2018/01/30 06:00
CRDT- 2016/11/22 06:00
PHST- 2015/12/13 00:00 [received]
PHST- 2016/07/28 00:00 [accepted]
PHST- 2016/11/22 06:00 [entrez]
PHST- 2016/11/22 06:00 [pubmed]
PHST- 2018/01/30 06:00 [medline]
AID - 10.5546/aap.2016.eng.549 [doi]
PST - ppublish
SO  - Arch Argent Pediatr. 2016 Dec 1;114(6):549-552. doi: 10.5546/aap.2016.eng.549.

PMID- 23218737
OWN - NLM
STAT- MEDLINE
DCOM- 20140205
LR  - 20130218
IS  - 1578-1852 (Electronic)
IS  - 0213-005X (Linking)
VI  - 31
IP  - 2
DP  - 2013 Feb
TI  - [Measles in a 12 weeks pregnant woman].
PG  - 121-2
LID - S0213-005X(12)00251-0 [pii]
LID - 10.1016/j.eimc.2012.07.002 [doi]
FAU - Díaz-Pollán, Beatriz
AU  - Díaz-Pollán B
FAU - Nuñez-Orantos, M José
AU  - Nuñez-Orantos MJ
FAU - Isernia, Valentina
AU  - Isernia V
FAU - Mariano-Lázaro, José Alberto
AU  - Mariano-Lázaro JA
LA  - spa
PT  - Case Reports
PT  - Letter
TT  - Sarampión en gestante de 12 semanas.
DEP - 20121206
PL  - Spain
TA  - Enferm Infecc Microbiol Clin
JT  - Enfermedades infecciosas y microbiologia clinica
JID - 9104081
SB  - IM
MH  - Adult
MH  - Female
MH  - Humans
MH  - *Measles/diagnosis/therapy
MH  - Pregnancy
MH  - *Pregnancy Complications, Infectious/diagnosis/therapy
MH  - Pregnancy Trimester, First
EDAT- 2012/12/12 06:00
MHDA- 2014/02/06 06:00
CRDT- 2012/12/11 06:00
PHST- 2012/05/10 00:00 [received]
PHST- 2012/07/02 00:00 [revised]
PHST- 2012/07/09 00:00 [accepted]
PHST- 2012/12/11 06:00 [entrez]
PHST- 2012/12/12 06:00 [pubmed]
PHST- 2014/02/06 06:00 [medline]
AID - S0213-005X(12)00251-0 [pii]
AID - 10.1016/j.eimc.2012.07.002 [doi]
PST - ppublish
SO  - Enferm Infecc Microbiol Clin. 2013 Feb;31(2):121-2. doi: 10.1016/j.eimc.2012.07.002. 
      Epub 2012 Dec 6.

PMID- 26177432
OWN - NLM
STAT- MEDLINE
DCOM- 20170117
LR  - 20170117
IS  - 2448-5667 (Electronic)
IS  - 0443-5117 (Linking)
VI  - 53
IP  - 4
DP  - 2015 Jul-Aug
TI  - [Epidemiological surveillance of febrile rash illness].
PG  - 444-52
AB  - BACKGROUND: Three imported cases of measles were detected in 2011, so the issue of 
      surveillance with epidemiological alerts intensified. The aim of this article is to 
      describe the phenomenon of intensified surveillance of febrile rash illness before 
      the import of confirmed measles in the country at the Mexican Institute of Social 
      Security cases. METHODS: The cases of epidemiological surveillance system 2011 were 
      obtained was compared with the prior year It was determined t-Student mean 
      difference and Wilson test for proportions, both with an alpha value of 0.05. 
      RESULTS: 2786 cases of febrile rash illness were reported, 51.2 % more cases than 
      the previous year were reported in 2011, the number of reported cases in relation to 
      the expected increase in 29 of the 35 Delegations, an increase in the average number 
      of cases reported from week 26. 67.4 % of reported cases are concentrated in 
      children under 5 years of age. The average days to collect laboratory sample 
      improved after issuing alerts from 3.4 to 2.6 days (p < 0.000000559). CONCLUSIONS: A 
      significant increase in reported cases of febrile rash illness compared with the 
      prior year was appreciated. The Institute has a surveillance system for robust and 
      febrile rash illness, which has identified risks to the population.
FAU - Pérez-Pérez, Gabriela Fidela
AU  - Pérez-Pérez GF
AD  - Coordinación de Vigilancia Epidemiológica, Instituto Mexicano del Seguro Social, 
      Distrito Federal, México. dcpreventiva@gmail.com.
FAU - Rojas-Mendoza, Teresita
AU  - Rojas-Mendoza T
FAU - Cabrera-Gaytán, David Alejandro
AU  - Cabrera-Gaytán DA
FAU - Grajales-Muñiz, Concepción
AU  - Grajales-Muñiz C
FAU - Maldonado-Burgos, Martha Alejandra
AU  - Maldonado-Burgos MA
LA  - spa
PT  - Journal Article
TT  - Vigilancia epidemiológica de la enfermedad febril exantemática por casos importados 
      de sarampión.
PL  - Mexico
TA  - Rev Med Inst Mex Seguro Soc
JT  - Revista medica del Instituto Mexicano del Seguro Social
JID - 101243727
SB  - IM
MH  - Academies and Institutes
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Child
MH  - Child, Preschool
MH  - *Disease Notification
MH  - Exanthema/*etiology
MH  - Female
MH  - Fever/*etiology
MH  - Humans
MH  - Incidence
MH  - Infant
MH  - Infant, Newborn
MH  - Male
MH  - Measles/complications/diagnosis/*epidemiology
MH  - Mexico/epidemiology
MH  - Middle Aged
MH  - *Public Health Surveillance
MH  - Social Security
MH  - Young Adult
OTO - NOTNLM
OT  - Epidemiological surveillance
OT  - Exanthema
OT  - Measles
EDAT- 2015/07/16 06:00
MHDA- 2017/01/18 06:00
CRDT- 2015/07/16 06:00
PHST- 2015/07/16 06:00 [entrez]
PHST- 2015/07/16 06:00 [pubmed]
PHST- 2017/01/18 06:00 [medline]
PST - ppublish
SO  - Rev Med Inst Mex Seguro Soc. 2015 Jul-Aug;53(4):444-52.

PMID- 26230440
OWN - NLM
STAT- MEDLINE
DCOM- 20160303
LR  - 20150803
IS  - 0716-1018 (Print)
IS  - 0716-1018 (Linking)
VI  - 32
IP  - 3
DP  - 2015 Jun
TI  - [Measles outbreaks in developed countries: A lesson for Chile].
PG  - 326-8
LID - S0716-10182015000400011 [pii]
LID - 10.4067/S0716-10182015000400011 [doi]
AB  - The measles vaccine has been used for over 50 years and has proven to be safe, 
      effective and inexpensive, Nevertheless, in 2013 145,700 measles deaths occurred, 
      mostly in countries with low per capita income and weak health infrastructure. The 
      occurrence of measles cases is not restricted to developing countries, but also 
      affects developed countries (Europe and USA), where is associated with a reduction 
      in vaccination coverage, explained by a loss of confidence of some parents in the 
      vaccine. This perspective article addresses the loss of confidence in the vaccine, 
      and the individual and collective consequences of the decision to not vaccinate a 
      child. Various strategies to reverse this phenomenon are presented, most notably the 
      continuing education of health professionals, parents and patients using scientific 
      arguments, given in an understandable and interesting language. Finally, the current 
      situation of Chile (a country with current certification of measles elimination) is 
      presented, emphasizing the importance of maintaining this condition.
FAU - Cerda, Jaime
AU  - Cerda J
FAU - Abarca, Katia
AU  - Abarca K
FAU - Jiménez, Jorge
AU  - Jiménez J
LA  - spa
PT  - English Abstract
PT  - Historical Article
PT  - Journal Article
TT  - Brotes de sarampión en países desarrollados: Una lección para Chile.
PL  - Chile
TA  - Rev Chilena Infectol
JT  - Revista chilena de infectologia : organo oficial de la Sociedad Chilena de 
      Infectologia
JID - 9305754
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Child
MH  - Child, Preschool
MH  - Chile
MH  - Developed Countries/*statistics & numerical data
MH  - Developing Countries
MH  - *Disease Outbreaks
MH  - Female
MH  - History, 20th Century
MH  - History, 21st Century
MH  - Humans
MH  - Measles/*epidemiology/history/prevention & control
MH  - Measles Vaccine/*administration & dosage
EDAT- 2015/08/01 06:00
MHDA- 2016/03/05 06:00
CRDT- 2015/08/01 06:00
PHST- 2015/08/01 06:00 [entrez]
PHST- 2015/08/01 06:00 [pubmed]
PHST- 2016/03/05 06:00 [medline]
AID - S0716-10182015000400011 [pii]
AID - 10.4067/S0716-10182015000400011 [doi]
PST - ppublish
SO  - Rev Chilena Infectol. 2015 Jun;32(3):326-8. doi: 10.4067/S0716-10182015000400011.

PMID- 26580793
OWN - NLM
STAT- MEDLINE
DCOM- 20160628
LR  - 20181202
IS  - 2173-9110 (Electronic)
IS  - 1135-5727 (Linking)
VI  - 89
IP  - 4
DP  - 2015 Jul-Aug
TI  - [Microbiological Surveillance of Measles and Rubella in Spain. Laboratory Network].
PG  - 381-91
LID - S1135-57272015000400006 [pii]
LID - 10.4321/S1135-57272015000400006 [doi]
AB  - The Laboratory is a fundamental component on the surveillance of measles and 
      rubella. Cases need to be properly confirmed to ensure an accurate estimation of the 
      incidence. Strains should be genetically characterized to know the transmission 
      pattern of these viruses and frequently, outbreaks and transmission chains can be 
      totally discriminated only after that. Finally, the susceptibility of the population 
      is estimated on the basis of sero-prevalence surveys. Detection of specific IgM 
      response is the base of the laboratory diagnosis of these diseases. It should be 
      completed with genomic detection by RT-PCR to reach an optimal efficiency, 
      especially when sampling is performed early in the course of the disease. Genotyping 
      is performed by genomic sequencing according to reference protocols of the WHO. 
      Laboratory surveillance of measles and rubella in Spain is organized as a net of 
      regional laboratories with different capabilities. The National Center of 
      Microbiology as National Reference Laboratory (NRL), supports regional laboratories 
      ensuring the availability of all required techniques in the whole country and 
      watching for the quality of the results. The NRL is currently working in the 
      implementation of new molecular techniques based on the analysis of genomic 
      hypervariable regions for the strain characterization at sub-genotypic levels and 
      use them in the surveillance.
FAU - Echevarría, Juan Emilio
AU  - Echevarría JE
FAU - Fernández García, Aurora
AU  - Fernández García A
FAU - de Ory, Fernando
AU  - de Ory F
LA  - spa
PT  - Journal Article
TT  - Vigilancia microbiológica del sarampión y la rubéola en España. Red de laboratorios.
PL  - Spain
TA  - Rev Esp Salud Publica
JT  - Revista espanola de salud publica
JID - 9600212
SB  - IM
MH  - *Clinical Laboratory Techniques
MH  - Disease Outbreaks
MH  - Genotype
MH  - Humans
MH  - Laboratories/*organization & administration
MH  - Measles/diagnosis/epidemiology/transmission
MH  - Measles virus/genetics/isolation & purification
MH  - Rubella/*diagnosis/epidemiology/transmission
MH  - Rubella virus/genetics/isolation & purification
MH  - Seroepidemiologic Studies
MH  - Spain/epidemiology
EDAT- 2015/11/19 06:00
MHDA- 2016/06/29 06:00
CRDT- 2015/11/19 06:00
PHST- 2015/11/19 06:00 [entrez]
PHST- 2015/11/19 06:00 [pubmed]
PHST- 2016/06/29 06:00 [medline]
AID - S1135-57272015000400006 [pii]
AID - 10.4321/S1135-57272015000400006 [doi]
PST - ppublish
SO  - Rev Esp Salud Publica. 2015 Jul-Aug;89(4):381-91. doi: 
      10.4321/S1135-57272015000400006.

PMID- 19664857
OWN - NLM
STAT- MEDLINE
DCOM- 20100721
LR  - 20181201
IS  - 1578-1852 (Electronic)
IS  - 0213-005X (Linking)
VI  - 28
IP  - 2
DP  - 2010 Feb
TI  - [Measles outbreak in Barcelona. Clinical and epidemiological characteristics].
PG  - 82-6
LID - 10.1016/j.eimc.2009.05.006 [doi]
AB  - INTRODUCTION: Measles is an acute, highly contagious illness that affects humans, 
      the only natural host. Although effective attenuated virus vaccines exist for this 
      disease, outbreaks continue to occur in susceptible subgroups. From August 2006 to 
      July 2007, an outbreak of measles occurred in the Barcelona (Spain) area, resulting 
      from an imported case. The aim of this study was to describe the clinical and 
      epidemiological characteristics of children with microbiologically confirmed measles 
      diagnosed at our hospital. METHODS: Retrospective, descriptive study. The clinical 
      histories and emergency records of children diagnosed with measles and evaluated at 
      our hospital during the outbreak were analyzed. RESULTS: Of the 130 children with 
      suspected measles evaluated, 99 cases were confirmed by laboratory tests. Median age 
      at diagnosis was 12.4 months (25th-75th percentile: 9.6-14.4 months; 74.6% 6-15 
      months of age) and 51.4% were boys. Among the total, 23.6% of patients had been 
      vaccinated against measles and 55.3% reported previous contact with a confirmed 
      measles case. The most frequent symptoms/signs were fever (100%; mean evolution 4.3 
      days (standard deviation [SD]: 2.2 days), rash (82.7%), Koplik's spots (60.2%), and 
      red eyes (59.2%). Complementary tests were performed in 35.7% of children. Most 
      common complications were acute otitis media (20.4%) and pneumonia (15.3%). Among 
      the total, 23.5% of patients were hospitalized for a mean duration of 6.6 days (SD: 
      3.6 days). CONCLUSION: Geographical mobility facilitates the reappearance of 
      diseases having a low incidence. Infants 6-15 months of age were the patient group 
      most highly affected by the measles outbreak. Most cases were diagnosed with typical 
      signs and symptoms of the infection, but as the outbreak advanced, patients were 
      diagnosed based on less specific symptoms because of the epidemiological context.
CI  - Copyright (c) 2008 Elsevier España, S.L. All rights reserved.
FAU - Monfort, Laura
AU  - Monfort L
AD  - Sección de Urgencias, Servicio de Pediatría, Hospital Universitari Sant Joan de Déu, 
      Esplugues de Llobregat, Barcelona, Spain.
FAU - Muñoz, David
AU  - Muñoz D
FAU - Trenchs, Victoria
AU  - Trenchs V
FAU - Hernández, Susanna
AU  - Hernández S
FAU - García, Juan José
AU  - García JJ
FAU - Aguilar, Ana Cristina
AU  - Aguilar AC
FAU - Juncosa, María Teresa
AU  - Juncosa MT
FAU - Luaces, Carles
AU  - Luaces C
LA  - spa
PT  - Journal Article
TT  - Brote de sarampión en Barcelona. Características clínicas y epidemiológicas.
DEP - 20090806
PL  - Spain
TA  - Enferm Infecc Microbiol Clin
JT  - Enfermedades infecciosas y microbiologia clinica
JID - 9104081
RN  - 0 (Antibodies, Viral)
RN  - 0 (Immunoglobulin M)
RN  - 0 (Measles Vaccine)
SB  - IM
CIN - Enferm Infecc Microbiol Clin. 2010 Feb;28(2):73-4. PMID: 20096973
MH  - Adolescent
MH  - Antibodies, Viral/blood
MH  - Child
MH  - Child, Preschool
MH  - Disease Notification
MH  - *Disease Outbreaks
MH  - Female
MH  - Hospitalization/statistics & numerical data
MH  - Humans
MH  - Immunoglobulin M/blood
MH  - Infant
MH  - Italy/ethnology
MH  - Male
MH  - Measles/complications/diagnosis/*epidemiology/prevention & 
      control/transmission/urine
MH  - Measles Vaccine
MH  - Measles virus/immunology/isolation & purification
MH  - Otitis Media/etiology/virology
MH  - Pneumonia, Viral/etiology/virology
MH  - Retrospective Studies
MH  - Spain/epidemiology
MH  - Urine/virology
MH  - Vaccination/statistics & numerical data
EDAT- 2009/08/12 09:00
MHDA- 2010/07/22 06:00
CRDT- 2009/08/12 09:00
PHST- 2008/11/21 00:00 [received]
PHST- 2009/05/05 00:00 [revised]
PHST- 2009/05/05 00:00 [accepted]
PHST- 2009/08/12 09:00 [entrez]
PHST- 2009/08/12 09:00 [pubmed]
PHST- 2010/07/22 06:00 [medline]
AID - S0213-005X(09)00347-4 [pii]
AID - 10.1016/j.eimc.2009.05.006 [doi]
PST - ppublish
SO  - Enferm Infecc Microbiol Clin. 2010 Feb;28(2):82-6. doi: 10.1016/j.eimc.2009.05.006. 
      Epub 2009 Aug 6.

PMID- 31967252
OWN - NLM
STAT- MEDLINE
DCOM- 20200724
LR  - 20200724
IS  - 1726-4642 (Electronic)
IS  - 1726-4634 (Linking)
VI  - 36
IP  - 4
DP  - 2019 Oct-Dec
TI  - [Coverage and factors associated with measles vaccination in children aged 12-59 
      months in Peru: estimate based on the 2017 demographic and family health survey].
PG  - 610-619
LID - 10.17843/rpmesp.2019.360.4456 [doi]
AB  - OBJECTIVES: . To estimate coverage and determine factors associated with measles 
      vaccination in Peru. MATERIALS AND METHODS: . We conducted a secondary source study 
      using the 2017 Demographic and Family Health Survey (ENDES). The reporting unit was 
      a woman of childbearing age, 15 to 49 years; the unit of analysis was a child, 12 to 
      59 months (for the first dose), or a child, 18 to 59 months (for the booster dose) 
      who had vaccination information. Coverage data were obtained from the vaccination 
      card. RESULTS: . According to the vaccination card, coverage for the first dose was 
      70.2% (95% CI: 68.8-71.6); for the booster dose, 52% (95% CI: 50.5-53.6). Children 
      aged 24-35 months were more likely to be vaccinated for the first dose (OR 1.59, 95% 
      CI: 1.28-1.97) and booster dose (OR 2.04, 95% CI: 1.62-2.56), compared with children 
      aged 12-23 months and 18-23 months respectively. Children with growth and 
      development check-ups performed in the private sector were less likely to be 
      vaccinated for the first dose (OR 0.30, 95% CI: 0.21-0.43) and booster dose (OR 
      0.26, 95% CI: 0.17-0.40), compared to those being monitored in the public sector. 
      CONCLUSIONS: . According to ENDES 2017, Peru and none of its regions achieved 95.0% 
      coverage for the first and booster doses. Growth and development monitoring in 
      public sector facilities is associated with measles vaccination in terms of first 
      and booster doses.
FAU - Vásquez-Uriarte, Karina
AU  - Vásquez-Uriarte K
AD  - Universidad Nacional de Cajamarca. Cajamarca, Perú.
FAU - Ninatanta Ortiz, Juana Aurelia
AU  - Ninatanta Ortiz JA
AD  - Universidad Nacional de Cajamarca. Cajamarca, Perú.
FAU - Romani, Franco
AU  - Romani F
AD  - Oficina General de Investigación y Transferencia Tecnológica, Instituto Nacional de 
      Salud. Lima, Perú.
FAU - Roque-Henriquez, Joel Christian
AU  - Roque-Henriquez JC
AD  - Oficina General de Investigación y Transferencia Tecnológica, Instituto Nacional de 
      Salud. Lima, Perú.
AD  - Universidad de San Martín de Porres. Lima, Perú.
LA  - spa
PT  - Journal Article
TT  - Cobertura y factores asociados a la vacunación contra el sarampión en niños de 12 a 
      59 meses en Perú: estimación basada en la encuesta demográfica y de salud familiar 
      2017.
DEP - 20200117
PL  - Peru
TA  - Rev Peru Med Exp Salud Publica
JT  - Revista peruana de medicina experimental y salud publica
JID - 101227566
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Child, Preschool
MH  - Family Health
MH  - Female
MH  - Health Surveys
MH  - Humans
MH  - Immunization, Secondary/statistics & numerical data
MH  - Infant
MH  - Measles/*prevention & control
MH  - Measles Vaccine/*administration & dosage
MH  - Middle Aged
MH  - Peru
MH  - Vaccination/*statistics & numerical data
MH  - Vaccination Coverage/*statistics & numerical data
MH  - Young Adult
EDAT- 2020/01/23 06:00
MHDA- 2020/07/25 06:00
CRDT- 2020/01/23 06:00
PHST- 2019/04/11 00:00 [received]
PHST- 2019/10/02 00:00 [accepted]
PHST- 2020/01/23 06:00 [entrez]
PHST- 2020/01/23 06:00 [pubmed]
PHST- 2020/07/25 06:00 [medline]
AID - 10.17843/rpmesp.2019.360.4456 [doi]
PST - ppublish
SO  - Rev Peru Med Exp Salud Publica. 2019 Oct-Dec;36(4):610-619. doi: 
      10.17843/rpmesp.2019.360.4456. Epub 2020 Jan 17.

PMID- 26580795
OWN - NLM
STAT- MEDLINE
DCOM- 20160628
LR  - 20181202
IS  - 2173-9110 (Electronic)
IS  - 1135-5727 (Linking)
VI  - 89
IP  - 4
DP  - 2015 Jul-Aug
TI  - [Surveillance Plan on Recent Outbreak of Measles and Rubella in Catalonia, Spain].
PG  - 397-406
LID - S1135-57272015000400008 [pii]
LID - 10.4321/S1135-57272015000400008 [doi]
AB  - Measles and rubella are two immuno-preventive illnesses. In Catalonia, since 1988 
      all children are given two doses of measles and rubella vaccine with high levels of 
      vaccination coverage. The measles elimination programme has been carried out since 
      1990 in Catalonia. This programme includes achieving and keeping high immunization 
      levels among population with high vaccination coverage, intense epidemiological 
      surveillance and an immediate response to the appearance of a case or outbreak. In 
      2014, the measles incidence rate was 1.9 cases/ 100,000 inhabitants. There were 4 
      recent outbreaks in 2006, 2011, 2013 and 2014 that affected 381, 289, 31 and 124 
      people respectively. All outbreaks were triggered by an imported case. In 2011 and 
      2014 measles outbreaks, 6% and 5.5% of affected people were health care workers. All 
      outbreaks presented a great variety of measles genotypes. Concerning rubella 
      elimination programme, since 2002, 68 cases of postnatal rubella and 5 cases of 
      congenital rubella were confirmed. Regarding measles and rubella surveillance and 
      control, in addition to strengthen vaccination coverage, it is essential immediate 
      notification, within the first 24 hours since suspicion and laboratory confirmation. 
      In addition there is a need to enforce vaccination among health care workers as well 
      as in other susceptible and unvaccinated people. It is recommended to vaccinate all 
      people who were born after 1966 and who have not been vaccinated with two doses of 
      trivalent measles-mumps-rubella vaccine. Furthermore, we have to emphasize that the 
      progress concerning genotypes study allows identifying various imported cases from 
      other European countries with active outbreaks, aspect that makes easier the 
      surveillance of these illnesses.
FAU - Jané, Mireia
AU  - Jané M
FAU - Torner, Nuria
AU  - Torner N
FAU - Vidal, Ma José
AU  - Vidal MJ
LA  - spa
PT  - Journal Article
TT  - Plan de vigilancia de brotes epidémicos recientes de sarampión y rubeola en 
      Cataluña.
PL  - Spain
TA  - Rev Esp Salud Publica
JT  - Revista espanola de salud publica
JID - 9600212
RN  - 0 (Measles Vaccine)
RN  - 0 (Measles-Mumps-Rubella Vaccine)
SB  - IM
MH  - Child
MH  - Disease Outbreaks/prevention & control
MH  - *Epidemiological Monitoring
MH  - Europe
MH  - Female
MH  - Genotype
MH  - Health Personnel/statistics & numerical data
MH  - Humans
MH  - Male
MH  - Measles/epidemiology/*prevention & control
MH  - Measles Vaccine/*administration & dosage
MH  - Measles-Mumps-Rubella Vaccine/*administration & dosage
MH  - Rubella/epidemiology/*prevention & control
MH  - Spain/epidemiology
MH  - Vaccination
EDAT- 2015/11/19 06:00
MHDA- 2016/06/29 06:00
CRDT- 2015/11/19 06:00
PHST- 2015/11/19 06:00 [entrez]
PHST- 2015/11/19 06:00 [pubmed]
PHST- 2016/06/29 06:00 [medline]
AID - S1135-57272015000400008 [pii]
AID - 10.4321/S1135-57272015000400008 [doi]
PST - ppublish
SO  - Rev Esp Salud Publica. 2015 Jul-Aug;89(4):397-406. doi: 
      10.4321/S1135-57272015000400008.

PMID- 23892677
OWN - NLM
STAT- MEDLINE
DCOM- 20140312
LR  - 20181202
IS  - 2173-9110 (Electronic)
IS  - 1135-5727 (Linking)
VI  - 87
IP  - 3
DP  - 2013 May-Jun
TI  - [Measles outbreak in a socially deprived area of the province of Seville, Spain].
PG  - 257-66
LID - S1135-57272013000300005 [pii]
LID - 10.4321/S1135-57272013000300005 [doi]
AB  - BACKGROUND: In 2011 in Seville (Spain), measles outbreak affected 1759 people. It 
      began in the neighbourhood of Santa Isabel (city San Juan de Aznalfarache), where 
      Roma community resides. We described the outbreak epidemiologically and calculated 
      the risk of disease in the population. METHOD: Descriptive study of outbreak and 
      cohort study. Exposed population was considered to Barriada resident and not exposed 
      to the rest of the municipality. The data sources were: the Institute of Statistics 
      of Andalusia, the social services of San Juan´s town and the Epidemiological 
      Surveillance System of Andalusia. We described the outbreak and incidences were 
      calculated and Relative Risk. The cases were confirmed by clinical, laboratory 
      and/or epidemiological. RESULTS: In the neighbourhood the cases were concentrated 
      among the group between 2 and 19 years, while in the rest of the town occurred in 
      children under 2 and over 19 years. The overall incidence of the outbreak was 0,98 
      per 1.000 inhabitants, 4,94 in San Juan; from 23,15 in the exposed, 2,1 in the 
      unexposed and in the group of 2-19 years 89,58 in the neighbourhood and 5,33 in the 
      rest on the town. CONCLUSIONS: The outbreak affected more children under 20 years 
      old, unvaccinated and residents in the neighborhood Santa Isabel. The risk of 
      falling ill with measles in the neighbourhood was 11 and 17 in the group between 2 
      and 19 years. We need to develop strategies to reduce health inequalities that 
      accompany some outbreaks.
FAU - Luna Sánchez, Antonio
AU  - Luna Sánchez A
AD  - Servicio de Epidemiología, Distrito Sanitario Aljarafe-Sevilla Norte, Servicio 
      Andaluz de Salud, Sevilla, España. antonio.luna.sanchez.sspa@juntadeandalucia.es
FAU - Rodríguez Benjumeda, Luis Miguel
AU  - Rodríguez Benjumeda LM
FAU - Ortega Sánchez, Paula Cristina
AU  - Ortega Sánchez PC
LA  - spa
PT  - Journal Article
TT  - Análisis de un brote de sarampión en una barriada de la provincia de Sevilla, 
      España.
PL  - Spain
TA  - Rev Esp Salud Publica
JT  - Revista espanola de salud publica
JID - 9600212
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Age Distribution
MH  - Child
MH  - Child, Preschool
MH  - Cohort Studies
MH  - Disease Outbreaks/prevention & control/*statistics & numerical data
MH  - Humans
MH  - Incidence
MH  - Infant
MH  - Male
MH  - Measles/*epidemiology/prevention & control
MH  - Measles Vaccine/administration & dosage
MH  - Poverty Areas
MH  - Risk Factors
MH  - Roma
MH  - Socioeconomic Factors
MH  - Spain/epidemiology
MH  - Young Adult
EDAT- 2013/07/31 06:00
MHDA- 2014/03/13 06:00
CRDT- 2013/07/30 06:00
PHST- 2013/07/30 06:00 [entrez]
PHST- 2013/07/31 06:00 [pubmed]
PHST- 2014/03/13 06:00 [medline]
AID - S1135-57272013000300005 [pii]
AID - 10.4321/S1135-57272013000300005 [doi]
PST - ppublish
SO  - Rev Esp Salud Publica. 2013 May-Jun;87(3):257-66. doi: 
      10.4321/S1135-57272013000300005.

PMID- 9883077
OWN - NLM
STAT- MEDLINE
DCOM- 19990127
LR  - 20190607
IS  - 1020-4989 (Print)
IS  - 1020-4989 (Linking)
VI  - 4
IP  - 5
DP  - 1998 Nov
TI  - [Strategies for minimizing nosocomial transmission of measles].
PG  - 350-7
AB  - Because of the highly contagious nature of measles before the onset of rash, 
      nosocomial transmission will remain a threat until the disease is eradicated. 
      However, a number of strategies can minimize its nosocomial spread. It is therefore 
      vital to maximize awareness among health care staff that an individual with measles 
      can enter a health facility at any time and that a continual risk of the nosocomial 
      transmission of measles exists. The present review makes two groups of 
      recommendations: those which are generally applicable to all countries, and certain 
      additional recommendations which may be suitable only for industrialized countries.
FAU - Biellik, R J
AU  - Biellik RJ
AD  - Organización Mundial de la Salud, Harare, Zimbabwe.
FAU - Clements, C J
AU  - Clements CJ
LA  - spa
PT  - English Abstract
PT  - Journal Article
PT  - Review
TT  - Estrategias para reducir a un mínimo la transmisión nosocomial del sarampión.
PL  - United States
TA  - Rev Panam Salud Publica
JT  - Revista panamericana de salud publica = Pan American journal of public health
JID - 9705400
SB  - IM
MH  - Child
MH  - Female
MH  - Humans
MH  - *International Cooperation
MH  - Male
MH  - Measles/epidemiology/prevention & control/*transmission
MH  - World Health Organization
RF  - 62
EDAT- 1999/01/12 00:00
MHDA- 1999/01/12 00:01
CRDT- 1999/01/12 00:00
PHST- 1999/01/12 00:00 [pubmed]
PHST- 1999/01/12 00:01 [medline]
PHST- 1999/01/12 00:00 [entrez]
AID - S1020-49891998001100009 [pii]
AID - 10.1590/s1020-49891998001100009 [doi]
PST - ppublish
SO  - Rev Panam Salud Publica. 1998 Nov;4(5):350-7. doi: 10.1590/s1020-49891998001100009.

PMID- 22285495
OWN - NLM
STAT- MEDLINE
DCOM- 20130412
LR  - 20121022
IS  - 1578-8989 (Electronic)
IS  - 0025-7753 (Linking)
VI  - 139
IP  - 12
DP  - 2012 Nov 17
TI  - [Koplik spots as a diagnostic clue in a case of measles].
PG  - 560
LID - S0025-7753(11)01182-1 [pii]
LID - 10.1016/j.medcli.2011.12.005 [doi]
FAU - Jiménez Gómez, Natalia
AU  - Jiménez Gómez N
AD  - Servicio de Dermatología, Hospital Universitario Ramón y Cajal, Madrid, España. 
      natjgomez@gmail.com
FAU - Ballester Martínez, María Asunción
AU  - Ballester Martínez MA
FAU - Alcántara González, Javier
AU  - Alcántara González J
FAU - Jaén Olasolo, Pedro
AU  - Jaén Olasolo P
LA  - spa
PT  - Case Reports
PT  - Journal Article
TT  - Manchas de Koplik como clave diagnóstica en un caso de sarampión.
DEP - 20120127
PL  - Spain
TA  - Med Clin (Barc)
JT  - Medicina clinica
JID - 0376377
SB  - IM
MH  - Adult
MH  - Female
MH  - Humans
MH  - Measles/*diagnosis/pathology
MH  - Mouth Mucosa/*pathology
EDAT- 2012/01/31 06:00
MHDA- 2013/04/13 06:00
CRDT- 2012/01/31 06:00
PHST- 2011/11/30 00:00 [received]
PHST- 2011/12/06 00:00 [accepted]
PHST- 2012/01/31 06:00 [entrez]
PHST- 2012/01/31 06:00 [pubmed]
PHST- 2013/04/13 06:00 [medline]
AID - S0025-7753(11)01182-1 [pii]
AID - 10.1016/j.medcli.2011.12.005 [doi]
PST - ppublish
SO  - Med Clin (Barc). 2012 Nov 17;139(12):560. doi: 10.1016/j.medcli.2011.12.005. Epub 
      2012 Jan 27.

PMID- 21676666
OWN - NLM
STAT- MEDLINE
DCOM- 20120123
LR  - 20181201
IS  - 1695-9531 (Electronic)
IS  - 1695-4033 (Linking)
VI  - 75
IP  - 3
DP  - 2011 Sep
TI  - [Why don't parents vaccinate their children? Reflections on a measles outbreak in a 
      neighbourhood of Granada].
PG  - 209-10
LID - 10.1016/j.anpedi.2011.04.002 [doi]
FAU - Martínez Romero, M
AU  - Martínez Romero M
FAU - Martínez Diz, S
AU  - Martínez Diz S
FAU - García Iglesias, F
AU  - García Iglesias F
LA  - spa
PT  - Letter
TT  - ¿Por qué los padres no vacunan a sus hijos? Reflexiones tras un brote de sarampión 
      en un barrio de Granada.
DEP - 20110614
PL  - Spain
TA  - An Pediatr (Barc)
JT  - Anales de pediatria (Barcelona, Spain : 2003)
JID - 101162596
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Child
MH  - *Disease Outbreaks
MH  - Humans
MH  - Measles/*epidemiology/*prevention & control
MH  - *Measles Vaccine
MH  - *Parents
MH  - Spain/epidemiology
MH  - Vaccination/*statistics & numerical data
EDAT- 2011/06/17 06:00
MHDA- 2012/01/24 06:00
CRDT- 2011/06/17 06:00
PHST- 2011/02/25 00:00 [received]
PHST- 2011/04/02 00:00 [revised]
PHST- 2011/04/08 00:00 [accepted]
PHST- 2011/06/17 06:00 [entrez]
PHST- 2011/06/17 06:00 [pubmed]
PHST- 2012/01/24 06:00 [medline]
AID - S1695-4033(11)00254-2 [pii]
AID - 10.1016/j.anpedi.2011.04.002 [doi]
PST - ppublish
SO  - An Pediatr (Barc). 2011 Sep;75(3):209-10. doi: 10.1016/j.anpedi.2011.04.002. Epub 
      2011 Jun 14.

PMID- 10650757
OWN - NLM
STAT- MEDLINE
DCOM- 20000210
LR  - 20061115
IS  - 1135-5727 (Print)
IS  - 1135-5727 (Linking)
VI  - 73
IP  - 5
DP  - 1999 Sep-Oct
TI  - [Eradication of measles. Synthesis outline].
PG  - 639-43
FAU - Amela, C
AU  - Amela C
AD  - Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Ministerio de 
      Sanidad y Consumo.
LA  - spa
PT  - Comparative Study
PT  - Journal Article
TT  - Eliminación del sarampión. Planteamiento de síntesis.
PL  - Spain
TA  - Rev Esp Salud Publica
JT  - Revista espanola de salud publica
JID - 9600212
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Child
MH  - Child, Preschool
MH  - Female
MH  - Humans
MH  - Male
MH  - Measles/epidemiology/*prevention & control
MH  - Measles Vaccine/administration & dosage
MH  - Population Surveillance
MH  - Spain/epidemiology
MH  - Vaccination
EDAT- 2000/01/29 00:00
MHDA- 2000/01/29 00:01
CRDT- 2000/01/29 00:00
PHST- 2000/01/29 00:00 [pubmed]
PHST- 2000/01/29 00:01 [medline]
PHST- 2000/01/29 00:00 [entrez]
PST - ppublish
SO  - Rev Esp Salud Publica. 1999 Sep-Oct;73(5):639-43.

PMID- 10650753
OWN - NLM
STAT- MEDLINE
DCOM- 20000210
LR  - 20061115
IS  - 1135-5727 (Print)
IS  - 1135-5727 (Linking)
VI  - 73
IP  - 5
DP  - 1999 Sep-Oct
TI  - [Eradication of measles. Vaccination coverage in Spain].
PG  - 617-8
FAU - de la Torre Misiego, J L
AU  - de la Torre Misiego JL
LA  - spa
PT  - Comparative Study
PT  - Journal Article
TT  - Eliminación del sarampión. Cobertura vacunal en España.
PL  - Spain
TA  - Rev Esp Salud Publica
JT  - Revista espanola de salud publica
JID - 9600212
RN  - 0 (Diphtheria-Tetanus-Pertussis Vaccine)
RN  - 0 (Hepatitis B Vaccines)
RN  - 0 (Measles Vaccine)
RN  - 0 (Mumps Vaccine)
SB  - IM
MH  - Adolescent
MH  - Age Factors
MH  - Child
MH  - Diphtheria-Tetanus-Pertussis Vaccine/administration & dosage
MH  - Hepatitis B Vaccines/administration & dosage
MH  - Humans
MH  - Infant
MH  - Measles Vaccine/administration & dosage
MH  - Mumps Vaccine/administration & dosage
MH  - Spain
MH  - *Vaccination/statistics & numerical data
EDAT- 2000/01/29 00:00
MHDA- 2000/01/29 00:01
CRDT- 2000/01/29 00:00
PHST- 2000/01/29 00:00 [pubmed]
PHST- 2000/01/29 00:01 [medline]
PHST- 2000/01/29 00:00 [entrez]
PST - ppublish
SO  - Rev Esp Salud Publica. 1999 Sep-Oct;73(5):617-8.

PMID- 23006334
OWN - NLM
STAT- MEDLINE
DCOM- 20140207
LR  - 20220129
IS  - 1365-3156 (Electronic)
IS  - 1360-2276 (Linking)
VI  - 17
IP  - 12
DP  - 2012 Dec
TI  - Non-specific effects of diphtheria-tetanus-pertussis and measles vaccinations? An 
      analysis of surveillance data from Navrongo, Ghana.
PG  - 1492-505
LID - 10.1111/j.1365-3156.2012.03093.x [doi]
AB  - OBJECTIVES: Studies from low-income countries have suggested that routine 
      vaccinations may have non-specific effects on child mortality; measles vaccine (MV) 
      is associated with lower mortality and diphtheria-tetanus-pertussis (DTP) with 
      relatively higher mortality. We used data from Navrongo, Ghana, to examine the 
      impact of vaccinations on child mortality. METHODS: Vaccination status was assessed 
      at the initiation of a trial of vitamin A supplementation and after 12 and 24 months 
      of follow-up. Within the placebo group, we compared the mortality over the first 4 
      months and the full 2 years of follow-up for different vaccination status groups 
      with different likelihoods of additional vaccinations during follow-up. The 
      frequency of additional vaccinations was assessed among children whose vaccination 
      card was seen at 12 and 24 months of follow-up. RESULTS: Among children with a 
      vaccination card, more than 75% received missing DTP or MV during the first 12 
      months of follow-up, whereas only 25% received these vaccines among children with no 
      vaccination card at enrollment. Children without a card at enrollment had a 
      significant threefold higher mortality over the 2-year follow-up period than those 
      fully vaccinated. The small group of children with DTP3-4 but no MV at enrollment 
      had lower mortality than children without a card and had the same mortality as fully 
      vaccinated children. In contrast, children with 1-2 DTP doses but no MV had a higher 
      mortality during the first 4 months than children without a card [MRR = 1.65 (0.95, 
      2.87)]; compared with the fully vaccinated children, they had significantly higher 
      mortality after 4 months [MRR = 2.38 (1.07, 5.30)] and after 2 years [MRR = 2.41 
      (1.41, 4.15)]. Children with 0-2 DTP doses at enrollment had higher mortality after 
      4 months (MRR = 1.67 (0.82, 3.43) and after 2 years [MRR = 1.85 (1.16, 2.95)] than 
      children who had all three doses of DTP at enrollment. CONCLUSIONS: As hypothesised, 
      DTP vaccination was associated with higher child mortality than measles vaccination. 
      To optimise vaccination policies, routine vaccinations need to be evaluated in 
      randomised trials measuring the impact on survival.
CI  - © 2012 Blackwell Publishing Ltd.
FAU - Welaga, Paul
AU  - Welaga P
AD  - Navrongo Health Research Centre, Navrongo, Ghana  Bandim Health Project, Statens 
      Serum Institut, Copenhagen, Denmark  London School of Hygiene and Tropical Medicine, 
      London, UK  Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau.
FAU - Nielsen, Jens
AU  - Nielsen J
FAU - Adjuik, Martin
AU  - Adjuik M
FAU - Debpuur, Cornelius
AU  - Debpuur C
FAU - Ross, David A
AU  - Ross DA
FAU - Ravn, Henrik
AU  - Ravn H
FAU - Benn, Christine S
AU  - Benn CS
FAU - Aaby, Peter
AU  - Aaby P
LA  - eng
GR  - 243149/ERC_/European Research Council/International
PT  - Journal Article
PT  - Observational Study
PT  - Research Support, Non-U.S. Gov't
DEP - 20120924
PL  - England
TA  - Trop Med Int Health
JT  - Tropical medicine & international health : TM & IH
JID - 9610576
RN  - 0 (Diphtheria-Tetanus-Pertussis Vaccine)
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Case-Control Studies
MH  - *Child Mortality
MH  - Child, Preschool
MH  - Developing Countries
MH  - Diphtheria-Tetanus-Pertussis Vaccine/*pharmacology
MH  - Follow-Up Studies
MH  - Ghana/epidemiology
MH  - Humans
MH  - Infant
MH  - Measles Vaccine/*pharmacology
MH  - Proportional Hazards Models
MH  - Survival Analysis
OTO - NOTNLM
OT  - difteria‐tétano‐pertusis
OT  - diphtheria‐tetanus‐pertussis
OT  - diphtérie‐tétanos‐coqueluche
OT  - efectos no específicos
OT  - effets non spécifiques
OT  - measles
OT  - mortalidad
OT  - mortality
OT  - mortalité
OT  - non‐specific effects
OT  - rougeole
OT  - sarampión
OT  - vaccines
OT  - vaccins
OT  - vacunas
EDAT- 2012/09/26 06:00
MHDA- 2014/02/08 06:00
CRDT- 2012/09/26 06:00
PHST- 2012/09/26 06:00 [entrez]
PHST- 2012/09/26 06:00 [pubmed]
PHST- 2014/02/08 06:00 [medline]
AID - 10.1111/j.1365-3156.2012.03093.x [doi]
PST - ppublish
SO  - Trop Med Int Health. 2012 Dec;17(12):1492-505. doi: 
      10.1111/j.1365-3156.2012.03093.x. Epub 2012 Sep 24.

PMID- 24766425
OWN - NLM
STAT- MEDLINE
DCOM- 20140811
LR  - 20191210
IS  - 1365-3156 (Electronic)
IS  - 1360-2276 (Linking)
VI  - 19
IP  - 7
DP  - 2014 Jul
TI  - Socio-economic determinants and inequities in coverage and timeliness of early 
      childhood immunisation in rural Ghana.
PG  - 802-11
LID - 10.1111/tmi.12324 [doi]
AB  - OBJECTIVES: To assess the extent of socio-economic inequity in coverage and 
      timeliness of key childhood immunisations in Ghana. METHODS: Secondary analysis of 
      vaccination card data collected from babies born between January 2008 and January 
      2010 who were registered in the surveillance system supporting the ObaapaVita and 
      Newhints Trials was carried out. 20 251 babies had 6 weeks' follow-up, 16 652 had 26 
      weeks' follow-up, and 5568 had 1 year's follow-up. We performed a descriptive 
      analysis of coverage and timeliness of vaccinations by indicators for urban/rural 
      status, wealth and educational attainment. The association of coverage with 
      socio-economic indicators was tested using a chi-square-test and the association 
      with timeliness using Cox regression. RESULTS: Overall coverage at 1 year of age was 
      high (>95%) for Bacillus Calmette-Guérin (BCG), all three pentavalent 
      diphtheria-pertussis-tetanus-haemophilus influenzae B-hepatitis B (DPTHH) doses and 
      all polio doses except polio at birth (63%). Coverage against measles and yellow 
      fever was 85%. Median delay for BCG was 1.7 weeks. For polio at birth, the median 
      delay was 5 days; all other vaccine doses had median delays of 2-4 weeks. We found 
      substantial health inequity across all socio-economic indicators for all vaccines in 
      terms of timeliness, but not coverage at 1 year. For example, for the last DPTHH 
      dose, the proportion of children delayed more than 8 weeks were 27% for urban 
      children and 31% for rural children (P < 0.001), 21% in the wealthiest quintile and 
      41% in the poorest quintile (P < 0.001), and 9% in the most educated group and 39% 
      in the least educated group (P < 0.001). However, 1-year coverage of the same dose 
      remained above 90% for all levels of all socio-economic indicators. CONCLUSIONS: 
      Ghana has substantial health inequity across urban/rural, socio-economic and 
      educational divides. While overall coverage was high, most vaccines suffered from 
      poor timeliness. We suggest that countries achieving high coverage should include 
      timeliness indicators in their surveillance systems.
CI  - © 2014 John Wiley & Sons Ltd.
FAU - Gram, Lu
AU  - Gram L
AD  - London School of Hygiene and Tropical Medicine, London, UK; Institute Of Child 
      Health, University College London, London, UK.
FAU - Soremekun, Seyi
AU  - Soremekun S
FAU - ten Asbroek, Augustinus
AU  - ten Asbroek A
FAU - Manu, Alexander
AU  - Manu A
FAU - O'Leary, Maureen
AU  - O'Leary M
FAU - Hill, Zelee
AU  - Hill Z
FAU - Danso, Samuel
AU  - Danso S
FAU - Amenga-Etego, Seeba
AU  - Amenga-Etego S
FAU - Owusu-Agyei, Seth
AU  - Owusu-Agyei S
FAU - Kirkwood, Betty R
AU  - Kirkwood BR
LA  - eng
PT  - Journal Article
DEP - 20140428
PL  - England
TA  - Trop Med Int Health
JT  - Tropical medicine & international health : TM & IH
JID - 9610576
RN  - 0 (Bacterial Vaccines)
RN  - 0 (Viral Vaccines)
SB  - IM
MH  - Bacterial Vaccines/administration & dosage
MH  - Child Health Services/organization & administration/*statistics & numerical data
MH  - Female
MH  - Ghana/epidemiology
MH  - Healthcare Disparities/*statistics & numerical data
MH  - Humans
MH  - Immunization Programs/*statistics & numerical data
MH  - *Immunization Schedule
MH  - Infant
MH  - Infant, Newborn
MH  - Longitudinal Studies
MH  - Male
MH  - Medical Records/statistics & numerical data
MH  - Outcome Assessment, Health Care/statistics & numerical data
MH  - Principal Component Analysis
MH  - Public Health Surveillance
MH  - Rural Population/statistics & numerical data
MH  - Social Class
MH  - Social Determinants of Health/*statistics & numerical data
MH  - Time Factors
MH  - Urban Population/statistics & numerical data
MH  - Vaccination/*statistics & numerical data
MH  - Viral Vaccines/administration & dosage
MH  - World Health Organization
OTO - NOTNLM
OT  - BCG
OT  - Bacillus Calmette-Guérin
OT  - Ghana
OT  - calendrier des vaccinations
OT  - childhood immunisation
OT  - cobertura vacunal
OT  - coqueluche
OT  - couverture vaccinale
OT  - difteria
OT  - diphtheria
OT  - diphtérie
OT  - fiebre amarilla
OT  - fièvre jaune
OT  - health inequity
OT  - indicadores
OT  - indicateurs socioéconomiques
OT  - inequidad sanitaria
OT  - inmunización infantil
OT  - inégalité dans la santé
OT  - measles
OT  - pertussis
OT  - polio
OT  - poliomyélite
OT  - rougeole
OT  - sarampión
OT  - socio-economic indicators
OT  - socioeconómicos
OT  - temporalidad vacunal
OT  - tetanus
OT  - tétanos
OT  - vaccination coverage
OT  - vaccination des enfants
OT  - vaccination timeliness
OT  - yellow fever
EDAT- 2014/04/29 06:00
MHDA- 2014/08/12 06:00
CRDT- 2014/04/29 06:00
PHST- 2014/04/29 06:00 [entrez]
PHST- 2014/04/29 06:00 [pubmed]
PHST- 2014/08/12 06:00 [medline]
AID - 10.1111/tmi.12324 [doi]
PST - ppublish
SO  - Trop Med Int Health. 2014 Jul;19(7):802-11. doi: 10.1111/tmi.12324. Epub 2014 Apr 
      28.

PMID- 25327273
OWN - NLM
STAT- MEDLINE
DCOM- 20150408
LR  - 20181202
IS  - 2173-9110 (Electronic)
IS  - 1135-5727 (Linking)
VI  - 88
IP  - 5
DP  - 2014 Oct
TI  - [Serological survey of measles, rubella and mumps immunity among pediatric and 
      resident physicians, Valencia, Spain].
PG  - 653-9
LID - S1135-57272014000500009 [pii]
LID - 10.4321/S1135-57272014000500009 [doi]
AB  - BACKGROUND: Health workers are exposed to vaccine-preventable diseases. Therefore, 
      vaccination programs are essential for preventing sanitary environment-acquired 
      infections and avoiding additional damage to patients. The objectives were to 
      estimate the prevalence of antibodies against measles, rubella and mumps among 
      physicians of the Clinical Area of Children Diseases of the La Fe University 
      Hospital (Valencia) and to study its relationship with history of disease, 
      vaccination and professional status. METHODS: Observational, cross-sectional and 
      analytical study. All subjects underwent a serological test for detection of 
      specific antibodies against measles, rubella and mumps. Some of them also completed 
      a questionnaire about the history of disease and vaccination. A descriptive and 
      relation analysis was performed to each disease. RESULTS: 97 physicians participated 
      in the study. 75 participants (77,3%) had positive serology to measles, 85 (87,6%) 
      to rubella and 68 (70,1%) to mumps. The logistic regression model showed a 
      significant effect of age (OR 1,22) in the prevalence of antibodies against measles 
      and a significant effect of sex (OR 5,16) in the prevalence of antibodies against 
      rubella. CONCLUSION: Given the high prevalence of seronegative young physicians and 
      taking into account their professional activity, vaccination in this group would be 
      recommended. Therefore it would be desirable to design strategies to achieve the 
      accession of physicians to the vaccination program.
FAU - Andani Cervera, Joaquín
AU  - Andani Cervera J
FAU - Castañeda Gordillo, Patricia
AU  - Castañeda Gordillo P
FAU - Fuente Goig, M Teresa
AU  - Fuente Goig MT
FAU - Giménez Martí, M José
AU  - Giménez Martí MJ
FAU - Alcaraz Soriano, M Jesús
AU  - Alcaraz Soriano MJ
FAU - Gómez Pajares, Fernando
AU  - Gómez Pajares F
FAU - Diez Domingo, Javier
AU  - Diez Domingo J
FAU - Boitos, Cristina
AU  - Boitos C
LA  - spa
PT  - Journal Article
PT  - Observational Study
TT  - Seroprevalencia frente a sarampión, rubeola y parotiditis en personal facultativo 
      del servicio de pediatría del Hospital Universitario y Politécnico La Fe de 
      Valencia.
PL  - Spain
TA  - Rev Esp Salud Publica
JT  - Revista espanola de salud publica
JID - 9600212
SB  - IM
MH  - Adult
MH  - Cross-Sectional Studies
MH  - Female
MH  - Health Personnel/statistics & numerical data
MH  - Humans
MH  - Immunization Programs
MH  - *Internship and Residency/statistics & numerical data
MH  - Male
MH  - Measles/epidemiology/*immunology
MH  - Mumps/epidemiology/*immunology
MH  - *Pediatrics/education/statistics & numerical data
MH  - Rubella/epidemiology/*immunology
MH  - Seroepidemiologic Studies
MH  - Spain/epidemiology
MH  - Surveys and Questionnaires
MH  - Vaccination/statistics & numerical data
EDAT- 2014/10/21 06:00
MHDA- 2015/04/09 06:00
CRDT- 2014/10/21 06:00
PHST- 2014/10/21 06:00 [entrez]
PHST- 2014/10/21 06:00 [pubmed]
PHST- 2015/04/09 06:00 [medline]
AID - S1135-57272014000500009 [pii]
AID - 10.4321/S1135-57272014000500009 [doi]
PST - ppublish
SO  - Rev Esp Salud Publica. 2014 Oct;88(5):653-9. doi: 10.4321/S1135-57272014000500009.

PMID- 22265376
OWN - NLM
STAT- MEDLINE
DCOM- 20121001
LR  - 20120604
IS  - 1695-9531 (Electronic)
IS  - 1695-4033 (Linking)
VI  - 76
IP  - 6
DP  - 2012 Jun
TI  - [Outbreak of measles in the population of Spanish origin in North Madrid].
PG  - 350-4
LID - 10.1016/j.anpedi.2011.11.017 [doi]
AB  - After being virtually eradicated in Europe, thousands of cases of measles in the 
      population of Spanish origin have appeared in the last 3 years. We describe the 
      cases diagnosed in the north of Madrid between January and June 2011. A total of 22 
      cases are reported, 18 of them grouped in 2 outbreaks (2 nurseries). The primary 
      attack rate was 29% in the main outbreak. All cases were in unvaccinated patients 
      (median = 14 months). Genotype D4 was predominant (95%). There was a 45% 
      complication rate and 45% were admitted to hospitals. The Public Health Service 
      recommended isolating cases and vaccinating susceptible contacts in advance. Health 
      Centres established a specific protocol to respond to suspected cases. The Measles 
      vaccination has been brought forward from 15 to 12 months in Madrid. Measles is a 
      re-emerging disease in Europe. The coordinated management between public health and 
      health facilities is essential to limiting outbreaks.
CI  - Copyright © 2011 Asociación Española de Pediatría. Published by Elsevier Espana. All 
      rights reserved.
FAU - Tagarro García, A
AU  - Tagarro García A
AD  - Servicio de Pediatría, Hospital Universitario Infanta Sofía, San Sebastián de los 
      Reyes, Madrid, Spain. alfredotagarro@hotmail.com
FAU - Jiménez Bueno, S
AU  - Jiménez Bueno S
FAU - Herreros Fernández, M L
AU  - Herreros Fernández ML
FAU - Santiago García, B
AU  - Santiago García B
FAU - González Gil, I
AU  - González Gil I
FAU - Baquero-Artigao, F
AU  - Baquero-Artigao F
FAU - Piñeiro Pérez, R
AU  - Piñeiro Pérez R
FAU - Agúndez Reigosa, B
AU  - Agúndez Reigosa B
FAU - Cilleruelo Ortega, M J
AU  - Cilleruelo Ortega MJ
FAU - Pérez Cid, L
AU  - Pérez Cid L
FAU - Sanz, J C
AU  - Sanz JC
FAU - Martín Rodrigo, D
AU  - Martín Rodrigo D
FAU - Mosquera, M M
AU  - Mosquera MM
FAU - Cañete Díaz, A
AU  - Cañete Díaz A
LA  - spa
PT  - English Abstract
PT  - Journal Article
PT  - Multicenter Study
TT  - Brote de 22 casos de sarampión autóctono en la zona norte de Madrid.
DEP - 20120120
PL  - Spain
TA  - An Pediatr (Barc)
JT  - Anales de pediatria (Barcelona, Spain : 2003)
JID - 101162596
SB  - IM
MH  - *Disease Outbreaks
MH  - Humans
MH  - Infant
MH  - Measles/*epidemiology
MH  - Prospective Studies
MH  - Retrospective Studies
MH  - Spain/epidemiology
MH  - Urban Health
EDAT- 2012/01/24 06:00
MHDA- 2012/10/02 06:00
CRDT- 2012/01/24 06:00
PHST- 2011/09/16 00:00 [received]
PHST- 2011/11/18 00:00 [revised]
PHST- 2011/11/21 00:00 [accepted]
PHST- 2012/01/24 06:00 [entrez]
PHST- 2012/01/24 06:00 [pubmed]
PHST- 2012/10/02 06:00 [medline]
AID - S1695-4033(11)00585-6 [pii]
AID - 10.1016/j.anpedi.2011.11.017 [doi]
PST - ppublish
SO  - An Pediatr (Barc). 2012 Jun;76(6):350-4. doi: 10.1016/j.anpedi.2011.11.017. Epub 
      2012 Jan 20.

PMID- 24630583
OWN - NLM
STAT- MEDLINE
DCOM- 20150608
LR  - 20170418
IS  - 1578-1852 (Electronic)
IS  - 0213-005X (Linking)
VI  - 32 Suppl 1
DP  - 2014 Feb
TI  - [Reemergence of measles. Epidemic situation in the Valencian Community during the 
      years 2011 and 2012].
PG  - 43-50
LID - S0213-005X(14)70149-1 [pii]
LID - 10.1016/S0213-005X(14)70149-1 [doi]
AB  - Measles incidence declined until becomes a sporadic reporting and infrequent 
      notification in the last decade. The reemergence of the disease reached 744 cases in 
      2012, a rate of 14.50×10(5) inhabitants. A classic design in Public Health 
      Surveillance was performed: retrospective analysis of cumulative incidence and 
      characteristics of the affected subjects. Those dates were in record linkage with 
      Valencia Microbiology Network (RedMIVA). Finally, 976 cases of measles were 
      confirmed in 2011-2012 epidemic period. Time-line distribution shows three waves 
      with amplitude length on 12-15 weeks. Proportion of unvaccinated or unknown subjects 
      came up to 85% of cases. 25 outbreaks were reported, 499 cases associated. In 7 of 
      the 10 community outbreaks early cases were from Roma population unvaccinated. In 
      the city of Valencia was applied post-exposure prophylaxis in 32 schools and was 
      observed low coverage: between 63% and 77% in 8 schools and less than 50% in 4. 
      Serum negative rate was 12.4% and we highlight the rate under 16 months: 44.8%. 
      Cohorts of 20-59 years had negative rates between 13.5 to 5.9%. The origin of the 
      epidemic was the importation of cases to a territory with inadequate immune 
      protection against measles. Its impact and development was conditioned by previous 
      immunization coverage, the social and ethnic pattern of different areas or quarters 
      and the extensive application of post-exposure prophylaxis at school and family 
      contacts of cases.
CI  - Copyright © 2014 Elsevier España, S.L. All rights reserved.
FAU - Rodrigo, Silvia Guiral
AU  - Rodrigo SG
AD  - Dirección General de Salud Pública de la Comunidad Valenciana, Servicio de 
      Vigilancia y Control Epidemiológico. Electronic address: guiral_sil@gva.es.
FAU - Calatrava, Rosana Guaita
AU  - Calatrava RG
AD  - Sección de Epidemiología, Centro de Salud Pública de Valencia, Valencia, España.
FAU - Vicenta Rigo Medrano, M
AU  - Vicenta Rigo Medrano M
AD  - Sección de Epidemiología de Alicante, Alicante, España.
FAU - Vidal, Miquel Amat
AU  - Vidal MA
AD  - Unidad de Epidemiología de Elx, Elx, Alicante, España.
FAU - Martín-Sierra Balibrea, Miguel
AU  - Martín-Sierra Balibrea M
AD  - Dirección General de Salud Pública de la Comunidad Valenciana, Servicio de 
      Vigilancia y Control Epidemiológico.
FAU - Zarco, Isabel Huertas
AU  - Zarco IH
AD  - Dirección General de Salud Pública de la Comunidad Valenciana, Servicio de 
      Vigilancia y Control Epidemiológico.
FAU - Ramón, Jorge Roda
AU  - Ramón JR
AD  - Sección de Epidemiología de Alicante, Alicante, España.
FAU - Cifre, Antonio Salazar
AU  - Cifre AS
AD  - Sección de Epidemiología, Centro de Salud Pública de Valencia, Valencia, España.
FAU - Morán, Francisco González
AU  - Morán FG
AD  - Dirección General de Salud Pública de la Comunidad Valenciana, Servicio de 
      Vigilancia y Control Epidemiológico.
CN  - Red de Vigilancia Epidemiológica de la Comunidad Valenciana
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Reemergencia del sarampión. Situación epidémica en la Comunidad Valenciana durante 
      los años 2011 y 2012.
PL  - Spain
TA  - Enferm Infecc Microbiol Clin
JT  - Enfermedades infecciosas y microbiologia clinica
JID - 9104081
SB  - IM
CIN - Enferm Infecc Microbiol Clin. 2015 Jun-Jul;33(6):432. PMID: 25728852
MH  - Adolescent
MH  - Adult
MH  - Child
MH  - Child, Preschool
MH  - *Disease Outbreaks
MH  - Humans
MH  - Incidence
MH  - Infant
MH  - Infant, Newborn
MH  - Measles/*epidemiology
MH  - Retrospective Studies
MH  - Spain/epidemiology
MH  - Time Factors
MH  - Young Adult
OTO - NOTNLM
OT  - Brote de sarampión
OT  - Epidemia
OT  - Epidemics
OT  - Intervención y control
OT  - Intervention and control
OT  - Measles
OT  - Measles outbreak
OT  - Sarampión
OT  - Surveillance
OT  - Vaccination
OT  - Vacunación
OT  - Vigilancia
FIR - Blasco, D
IR  - Blasco D
FIR - Arnedo, A
IR  - Arnedo A
FIR - Bellido, J
IR  - Bellido J
FIR - Romeo, A
IR  - Romeo A
FIR - Giner, E
IR  - Giner E
FIR - Borrás, M J
IR  - Borrás MJ
FIR - Chover, J L
IR  - Chover JL
FIR - Bayo, J
IR  - Bayo J
FIR - Sarrión, A
IR  - Sarrión A
FIR - Guardiola, S
IR  - Guardiola S
FIR - Tabernero, T
IR  - Tabernero T
FIR - Fernández, C
IR  - Fernández C
FIR - Llacer, I
IR  - Llacer I
FIR - Peñuelas, J A
IR  - Peñuelas JA
FIR - Morera, V
IR  - Morera V
FIR - Silvestre, A
IR  - Silvestre A
FIR - García, M V
IR  - García MV
FIR - Rolando, H
IR  - Rolando H
FIR - Carratalá, E
IR  - Carratalá E
FIR - Martín-Aragón, E
IR  - Martín-Aragón E
FIR - Marco, R
IR  - Marco R
FIR - Noguera, E
IR  - Noguera E
EDAT- 2014/03/19 06:00
MHDA- 2015/06/09 06:00
CRDT- 2014/03/18 06:00
PHST- 2014/03/18 06:00 [entrez]
PHST- 2014/03/19 06:00 [pubmed]
PHST- 2015/06/09 06:00 [medline]
AID - S0213-005X(14)70149-1 [pii]
AID - 10.1016/S0213-005X(14)70149-1 [doi]
PST - ppublish
SO  - Enferm Infecc Microbiol Clin. 2014 Feb;32 Suppl 1:43-50. doi: 
      10.1016/S0213-005X(14)70149-1.

PMID- 24940889
OWN - NLM
STAT- MEDLINE
DCOM- 20150528
LR  - 20140619
IS  - 1988-9518 (Electronic)
IS  - 0214-3429 (Linking)
VI  - 27
IP  - 2
DP  - 2014 Jun
TI  - [Seroprevalence of measles, rubella, mumps and varicella in health workers in the 
      Community of Madrid].
PG  - 98-101
AB  - BACKGROUND: The vaccination of health workers has a large repercussion on the health 
      of the workers, the patients and the population in general. Due to this, we proposed 
      to discover the serological status for varicella, rubella, mumps and measles in the 
      workers of a tertiary hospital in Madrid. METHODS: We have conducted a retrospective 
      epidemiological study of 1060 health workers, obtaining information such as age, 
      sex, service area, employment status, pre-exposure vaccination and post-vaccination 
      serology and vaccination status. RESULTS: In the population studied, 90.1% were 
      protected against varicella, 65.6% against mumps, 95.6% against rubella and 92.9% 
      against measles. There is no better protection against these illnesses for workers 
      who treat patients directly, workers who treat immunosuppressed patients or for 
      workers in services or units with a higher risk of infection. CONCLUSION: There is 
      no better protection against varicella, rubella, mumps and measles for the workers 
      who have higher risk of infection at work; and the workers who treat patients, that 
      if they suffer these diseases, this could put their health at risk.
FAU - Rodríguez, Ma Luisa
AU  - Rodríguez ML
AD  - Maria Luisa Rodríguez de la Pinta. Servicio de Prevención de Riesgos Laborales. 
      Hospital Universitario Puerta de Hierro Majadahonda, Calle Joaquín Rodrigo Nº 2, 
      28220 Majadahonda, Madrid, Spain. mrpinta@salud.madrid.org.
FAU - Martínez, David
AU  - Martínez D
FAU - Santos-Sancho, Juana Maria
AU  - Santos-Sancho JM
FAU - Borda, Jenry Ricardo
AU  - Borda JR
FAU - Orero, Ana
AU  - Orero A
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Seroprevalencia de sarampión, rubéola, paperas y varicela en los trabajadores de un 
      área sanitaria de la Comunidad de Madrid.
PL  - Spain
TA  - Rev Esp Quimioter
JT  - Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de 
      Quimioterapia
JID - 9108821
RN  - 0 (Antibodies, Viral)
RN  - 0 (Chickenpox Vaccine)
RN  - 0 (Measles-Mumps-Rubella Vaccine)
SB  - IM
MH  - Adult
MH  - Antibodies, Viral/blood
MH  - Chickenpox/*epidemiology/prevention & control
MH  - Chickenpox Vaccine
MH  - Female
MH  - Health Personnel/*statistics & numerical data
MH  - Hospital Departments
MH  - Humans
MH  - Male
MH  - Measles/*epidemiology/prevention & control
MH  - Measles-Mumps-Rubella Vaccine
MH  - Middle Aged
MH  - Mumps/*epidemiology/prevention & control
MH  - Occupational Exposure
MH  - Retrospective Studies
MH  - Rubella/*epidemiology/prevention & control
MH  - Seroepidemiologic Studies
MH  - Spain/epidemiology
MH  - Tertiary Care Centers
MH  - Vaccination/statistics & numerical data
EDAT- 2014/06/19 06:00
MHDA- 2015/05/29 06:00
CRDT- 2014/06/19 06:00
PHST- 2014/06/19 06:00 [entrez]
PHST- 2014/06/19 06:00 [pubmed]
PHST- 2015/05/29 06:00 [medline]
AID - rodriguez [pii]
PST - ppublish
SO  - Rev Esp Quimioter. 2014 Jun;27(2):98-101.

PMID- 22137370
OWN - NLM
STAT- MEDLINE
DCOM- 20120724
LR  - 20120327
IS  - 1578-1852 (Electronic)
IS  - 0213-005X (Linking)
VI  - 30
IP  - 4
DP  - 2012 Apr
TI  - [Susceptibility to measles and varicella in healthcare workers in a tertiary 
      hospital in Catalonia].
PG  - 184-8
LID - 10.1016/j.eimc.2011.10.002 [doi]
AB  - INTRODUCTION: To estimate the susceptibility to measles and varicella (chickenpox) 
      in healthcare workers in a public tertiary level teaching hospital, in Catalonia. 
      METHODS: A prevalence study was conducted from January 2006 to December 2008 on 
      2,752 workers who had serology performed for the determination of measles or 
      varicella by ELISA test during a health examination. Data were analysed by, sex, 
      age, professional category and work unit. RESULTS: A total of 153 healthcare workers 
      were susceptible to measles and 187 to varicella. The susceptibility of healthcare 
      workers to measles was 6.04% (95% CI: 5.78 to 6.30), and to varicella it was 7.45% 
      (95% CI: 7.14 to 7.75). The highest susceptibility to measles was in resident 
      physicians with 14% (95% CI: 10.8 to 18.5). In high-risk services, where highly 
      immunocompromised patients are attended, the susceptibility of workers was slightly 
      higher than the rest to measles (6.32% vs 5.93%) and varicella (8.34% vs 7.09%). 
      Healthcare workers born after 1980 were 20 times (95% CI: 11.0 to 37.2) more likely 
      to be susceptible to measles, and 2 times (95% CI: 1.2 to 3.2) more likely to be 
      susceptible to varicella than those those born before 1965. CONCLUSIONS: The 
      susceptibility to measles in healthcare workers in our centre is higher in younger 
      cohorts, with values higher than expected in a community with high vaccination 
      coverage against measles, mumps, rubella vaccine (MMR) in the paediatric population 
      for many years.
CI  - Copyright © 2011 Elsevier España, S.L. All rights reserved.
FAU - Fernández-Cano, María Isabel
AU  - Fernández-Cano MI
AD  - Departamento de Enfermería, Universitat Autònoma de Barcelona (UAB), Bellaterra, 
      Cerdanyola del Vallès, Spain. MariaIsabel.FernandezC@uab.cat
FAU - Armadans, Lluís
AU  - Armadans L
FAU - Sulleiro, Elena
AU  - Sulleiro E
FAU - Espuga, Meritxell
AU  - Espuga M
FAU - Ferrer, Esther
AU  - Ferrer E
FAU - Martínez-Gómez, Xavi
AU  - Martínez-Gómez X
FAU - Vaqué, Josep
AU  - Vaqué J
FAU - Campins, Magda
AU  - Campins M
LA  - spa
PT  - Comparative Study
PT  - English Abstract
PT  - Journal Article
TT  - Susceptibilidad frente a sarampión y varicela en el personal sanitario de un 
      hospital de tercer nivel en Cataluña.
DEP - 20111201
PL  - Spain
TA  - Enferm Infecc Microbiol Clin
JT  - Enfermedades infecciosas y microbiologia clinica
JID - 9104081
RN  - 0 (Antibodies, Viral)
RN  - 0 (Immunoglobulin G)
SB  - IM
MH  - Adult
MH  - Age Factors
MH  - Aged
MH  - Antibodies, Viral/*blood
MH  - Chickenpox/*epidemiology
MH  - Disease Susceptibility
MH  - Female
MH  - Herpesvirus 3, Human/immunology
MH  - Hospitals, University/*statistics & numerical data
MH  - Humans
MH  - Immunocompromised Host
MH  - Immunoglobulin G/blood
MH  - Infectious Disease Transmission, Patient-to-Professional/prevention & control
MH  - Male
MH  - Measles/*epidemiology
MH  - Measles virus/immunology
MH  - Middle Aged
MH  - Occupational Exposure
MH  - Personnel, Hospital/*statistics & numerical data
MH  - Risk
MH  - Seroepidemiologic Studies
MH  - Spain/epidemiology
MH  - Young Adult
EDAT- 2011/12/06 06:00
MHDA- 2012/07/25 06:00
CRDT- 2011/12/06 06:00
PHST- 2011/06/19 00:00 [received]
PHST- 2011/09/15 00:00 [revised]
PHST- 2011/10/02 00:00 [accepted]
PHST- 2011/12/06 06:00 [entrez]
PHST- 2011/12/06 06:00 [pubmed]
PHST- 2012/07/25 06:00 [medline]
AID - S0213-005X(11)00319-3 [pii]
AID - 10.1016/j.eimc.2011.10.002 [doi]
PST - ppublish
SO  - Enferm Infecc Microbiol Clin. 2012 Apr;30(4):184-8. doi: 10.1016/j.eimc.2011.10.002. 
      Epub 2011 Dec 1.

PMID- 15023323
OWN - NLM
STAT- MEDLINE
DCOM- 20040712
LR  - 20201121
IS  - 0212-6567 (Print)
IS  - 1578-1275 (Electronic)
IS  - 0212-6567 (Linking)
VI  - 33
IP  - 4
DP  - 2004 Mar 15
TI  - [Measles in Spain: its move into the adult population].
PG  - 200-2
FAU - Peña-Rey Lorenzo, I
AU  - Peña-Rey Lorenzo I
AD  - Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, España. 
      sabela@iscii.es
FAU - Santa-Olalla Peralta, P
AU  - Santa-Olalla Peralta P
FAU - Amela Heras, C
AU  - Amela Heras C
LA  - spa
PT  - Journal Article
TT  - Sarampión en España, desplazamiento a población adulta.
TA  - Aten Primaria
JT  - Atencion primaria
JID - 9111075
SB  - IM
MH  - Adult
MH  - Humans
MH  - Measles/*epidemiology
MH  - Spain/epidemiology
PMC - PMC7668919
EDAT- 2004/03/17 05:00
MHDA- 2004/07/13 05:00
CRDT- 2004/03/17 05:00
PHST- 2004/03/17 05:00 [pubmed]
PHST- 2004/07/13 05:00 [medline]
PHST- 2004/03/17 05:00 [entrez]
AID - 13058765 [pii]
AID - 10.1016/s0212-6567(04)79394-4 [doi]
PST - ppublish
SO  - Aten Primaria. 2004 Mar 15;33(4):200-2. doi: 10.1016/s0212-6567(04)79394-4.

PMID- 23250311
OWN - NLM
STAT- MEDLINE
DCOM- 20131206
LR  - 20191210
IS  - 0124-0064 (Print)
IS  - 0124-0064 (Linking)
VI  - 14
IP  - 1
DP  - 2012 Jan-Feb
TI  - [Epidemiological surveillance of measles and Germán measles (rubella) within the 
      context of the elimination plan: Colombia, 1995-2009].
PG  - 1-14
LID - S0124-00642012000100001 [pii]
AB  - OBJECTIVE: Describing the behavior of epidemiologic surveillance regarding measles 
      and German measles (rubella) to provide evidence about the interruption of the 
      endemic circulation of tríese viruses in Colombia. METHODS: This was a retrospective 
      descriptive study of epidemiological surveillance for measles and German measles in 
      Colombia from 1995 to 2009 by reviewing available notification information from the 
      measles elimination surveillance system (MESS), the Colombian Public Health 
      Surveillance System (SIVIGILA) and the Colombian Statistics Department (DANE) for 
      population projections. Surveillance quality was evaluated by using the indicators 
      proposed for integrated measles and German measles surveillance. RESULTS: 28,732 
      suspicious cases were notified during the study period (66.15 % concerned measles 
      and 33.8 % German measles). The greatest number of notified cases occurred in 2002 
      (22.4 %); this was detected in the 6-11 month and 2-4 year-old groups. Confirmed 
      measles cases amounted to 495 (1995-2002) and German measles to 946 (for the whole 
      period). The cumulative average for indicators was as follows: timely research had a 
      pattern below 80.5 %, weekly notification was above 80 %, suitable sampling was 93.7 
      % on average and sample reception was 65.2 % for 1995-2006 and 83.3 % for 2007-2009. 
      CONCLUSIONS: According to the information compiled regarding epidemiological 
      surveillance, Colombia complied with 4 of the 7 proposed indicators for quality 
      evaluation; these showed active surveillance having suitable indicator performance 
      regarding laboratory and notification rate. They demonstrated interrupted endemic 
      circulation of measles and German measles in Colombia.
FAU - Morón-Duarte, Lina S
AU  - Morón-Duarte LS
AD  - Escuela de Medicina y Ciencias de la Salud, Centro de Investigaciones Ciencias de la 
      Salud,, Universidad del Rosario, Bogotá, Colombia. sofismodu@yahoo.com
FAU - Castillo-Pabón, José O
AU  - Castillo-Pabón JO
LA  - spa
PT  - Evaluation Study
PT  - Journal Article
TT  - La vigilancia epidemiológica de sarampión y rubéola en el marco del plan de 
      eliminación: Colombia 1995-2009.
PL  - Colombia
TA  - Rev Salud Publica (Bogota)
JT  - Revista de salud publica (Bogota, Colombia)
JID - 100936348
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Child
MH  - Child, Preschool
MH  - Colombia/epidemiology
MH  - Cross-Sectional Studies
MH  - *Disease Eradication
MH  - Disease Notification/statistics & numerical data
MH  - Female
MH  - Humans
MH  - Infant
MH  - Male
MH  - Measles/*epidemiology/prevention & control
MH  - *Public Health Surveillance
MH  - Retrospective Studies
MH  - Rubella/*epidemiology/prevention & control
MH  - Young Adult
EDAT- 2012/12/20 06:00
MHDA- 2013/12/16 06:00
CRDT- 2012/12/20 06:00
PHST- 2011/04/07 00:00 [received]
PHST- 2011/12/28 00:00 [accepted]
PHST- 2012/12/20 06:00 [entrez]
PHST- 2012/12/20 06:00 [pubmed]
PHST- 2013/12/16 06:00 [medline]
AID - S0124-00642012000100001 [pii]
AID - 10.1590/s0124-00642012000100001 [doi]
PST - ppublish
SO  - Rev Salud Publica (Bogota). 2012 Jan-Feb;14(1):1-14. doi: 
      10.1590/s0124-00642012000100001.

PMID- 20628704
OWN - NLM
STAT- MEDLINE
DCOM- 20101105
LR  - 20191111
IS  - 0124-0064 (Print)
IS  - 0124-0064 (Linking)
VI  - 12
IP  - 1
DP  - 2010 Feb
TI  - [Simulating measles and rubella elimination levels according to social 
      stratification and interaction].
PG  - 103-15
LID - S0124-00642010000100010 [pii]
AB  - OBJECTIVE: The study was aimed at comparing measles and rubella disease elimination 
      levels in a homogeneous and heterogeneous population according to socioeconomic 
      status with interactions amongst low- and high-income individuals and diversity in 
      the average number of contacts amongst them. METHODS: Effective reproductive rate 
      simulations were deduced from a susceptibleinfected- recovered (SIR) mathematical 
      model according to different immunisation rates using measles (1980 and 2005) and 
      rubella (1998 and 2005) incidence data from Latin-America and the Caribbean. Low- 
      and high-income individuals' social interaction and their average number of contacts 
      were analysed by bipartite random network analysis. MAPLE 12 (Maplesoft Inc, Ontario 
      Canada) software was used for making the simulations. RESULTS: The progress made in 
      eliminating both diseases between both periods of time was reproduced in the 
      socially-homogeneous population. Measles (2005) would be eliminated in high- and 
      low-income groups; however, it would only be achieved in rubella (2005) if there 
      were a high immunity rate amongst the low-income group. If the average number of 
      contacts were varied, then rubella would not be eliminated, even with a 95 % 
      immunity rate. CONCLUSION: Monitoring the elimination level in diseases like measles 
      and rubella requires that socio-economic status be considered as well as the 
      population's interaction pattern. Special attention should be paid to communities 
      having diversity in their average number of contacts occurring in confined spaces 
      such as displaced communities, prisons, educational establishments, or hospitals.
FAU - Hincapié-Palacio, Doracelly
AU  - Hincapié-Palacio D
AD  - Facultad Nacional de Salud Pública, Universidad de Antioquia, Medellín, Colombia. 
      doracely@guajiros.udea.edu.co
FAU - Ospina-Giraldo, Juan
AU  - Ospina-Giraldo J
FAU - Gómez-Arias, Rubén D
AU  - Gómez-Arias RD
FAU - Uyi-Afuwape, Anthony
AU  - Uyi-Afuwape A
FAU - Chowell-Puente, Gerardo
AU  - Chowell-Puente G
LA  - spa
PT  - Comparative Study
PT  - English Abstract
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
TT  - Simulación del nivel de eliminación de sarampión y rubéola según la estratificación 
      e interacción social.
PL  - Colombia
TA  - Rev Salud Publica (Bogota)
JT  - Revista de salud publica (Bogota, Colombia)
JID - 100936348
RN  - 0 (Measles Vaccine)
RN  - 0 (Rubella Vaccine)
SB  - IM
MH  - Caribbean Region/epidemiology
MH  - *Computer Simulation
MH  - Confined Spaces
MH  - Contact Tracing/statistics & numerical data
MH  - Cultural Diversity
MH  - Humans
MH  - *Income/statistics & numerical data
MH  - *Interpersonal Relations
MH  - Latin America/epidemiology
MH  - Measles/epidemiology/*prevention & control/transmission
MH  - Measles Vaccine
MH  - *Models, Theoretical
MH  - Residence Characteristics
MH  - Rubella/epidemiology/*prevention & control/transmission
MH  - Rubella Vaccine
MH  - Socioeconomic Factors
MH  - Vaccination/statistics & numerical data
MH  - Vulnerable Populations
EDAT- 2010/07/16 06:00
MHDA- 2010/11/06 06:00
CRDT- 2010/07/15 06:00
PHST- 2009/06/06 00:00 [received]
PHST- 2010/02/02 00:00 [accepted]
PHST- 2010/07/15 06:00 [entrez]
PHST- 2010/07/16 06:00 [pubmed]
PHST- 2010/11/06 06:00 [medline]
AID - S0124-00642010000100010 [pii]
AID - 10.1590/s0124-00642010000100010 [doi]
PST - ppublish
SO  - Rev Salud Publica (Bogota). 2010 Feb;12(1):103-15. doi: 
      10.1590/s0124-00642010000100010.

PMID- 28453157
OWN - NLM
STAT- MEDLINE
DCOM- 20180215
LR  - 20181202
IS  - 0124-0064 (Print)
IS  - 0124-0064 (Linking)
VI  - 18
IP  - 1
DP  - 2016 Feb
TI  - [Seroprevalence of antibodies to measles, rubella, mumps, hepatitis B viruses and 
      all three poliovirus serotypes among children in Quindío, Colombia].
PG  - 95-103
LID - S0124-00642016000100009 [pii]
LID - 10.15446/rsap.v18n1.44514 [doi]
AB  - Objective The main goal of this research was to assess the seroprevalence of 
      antibodies against measles, rubella, mumps, hepatitis B and all three poliovirus 
      serotypes among children in the Quindío Department, Colombia. Methods Blood samples 
      were obtained from 170 healthy children aged 5-9 years from nine municipalities in 
      Quindío. The presence of serum IgG antibodies against measles, rubella, mumps and 
      Hepatitis B were determined using commercial indirect ELISA kits. Immunity to 
      poliomyelitis was assessed through the presence of neutralizing antibodies following 
      the method recommended by the World Health Organization. Results Among the 170 
      children enrolled, 169 (99.41%), 170 (100 %), and 167 (98.2 %) were seropositive to 
      poliovirus 1, poliovirus 2, and poliovirus 3, respectively. The average reciprocal 
      antibody titers were 178 for poliovirus type 1, 120 for type 2 and 56 for type 3. Of 
      the 170 children, 96.47 % were protected against mumps and rubella, and 86.47 % 
      against measles. Only 106 (62.35 %) of the studied subjects were proved to be 
      seropositive to hepatitis B. Conclusion The immunization program in Quindío has 
      provided seroprotection against all three poliomyelitis serotypes, rubella and 
      mumps. However, the child population is not fully protected against measles and 
      hepatitis B virus infections.
FAU - González, María M
AU  - González MM
AD  - Facultad Ciencias de la Salud, Universidad del Quindío, Armenia, Colombia.
FAU - Sarmiento, Luis
AU  - Sarmiento L
AD  - Department of Clinical Sciences, Skåne University Hospital, Malmo, Sweden.
FAU - Giraldo, Alejandra M
AU  - Giraldo AM
AD  - Facultad Ciencias de la Salud, Universidad del Quindío, Armenia, Colombia.
FAU - Padilla, Leonardo
AU  - Padilla L
AD  - Facultad Ciencias de la Salud, Universidad del Quindío, Armenia, Colombia.
FAU - Rey-Benito, Gloria
AU  - Rey-Benito G
AD  - Organización Panamericana de la Salud, Colombia.
FAU - Castaño, Jhon C
AU  - Castaño JC
AD  - Facultad Ciencias de la Salud, Universidad del Quindío, Armenia, Colombia.
LA  - spa
PT  - Journal Article
TT  - Seroprevalencia de anticuerpos a virus del sarampión, rubeola, parotiditis, 
      hepatitis B y los tres serotipos de poliovirus, en niños de Quindío, Colombia.
PL  - Colombia
TA  - Rev Salud Publica (Bogota)
JT  - Revista de salud publica (Bogota, Colombia)
JID - 100936348
RN  - 0 (Antibodies, Viral)
RN  - 0 (Immunoglobulin G)
SB  - IM
MH  - Antibodies, Viral/*blood
MH  - Child
MH  - Child, Preschool
MH  - Colombia
MH  - Cross-Sectional Studies
MH  - Hepatitis B virus/*immunology
MH  - Humans
MH  - Immunoglobulin G/blood
MH  - Measles/*immunology
MH  - Mumps/*immunology
MH  - Poliovirus/*immunology
MH  - Rubella/*immunology
MH  - Seroepidemiologic Studies
EDAT- 2016/02/01 00:00
MHDA- 2018/02/16 06:00
CRDT- 2017/04/29 06:00
PHST- 2014/07/21 00:00 [received]
PHST- 2015/09/09 00:00 [accepted]
PHST- 2017/04/29 06:00 [entrez]
PHST- 2016/02/01 00:00 [pubmed]
PHST- 2018/02/16 06:00 [medline]
AID - S0124-00642016000100009 [pii]
AID - 10.15446/rsap.v18n1.44514 [doi]
PST - ppublish
SO  - Rev Salud Publica (Bogota). 2016 Feb;18(1):95-103. doi: 10.15446/rsap.v18n1.44514.

PMID- 11602147
OWN - NLM
STAT- MEDLINE
DCOM- 20020115
LR  - 20191210
IS  - 0213-005X (Print)
IS  - 0213-005X (Linking)
VI  - 19
IP  - 8
DP  - 2001 Oct
TI  - [Evaluation of a capture enzyme-immunoassay (ELISA) for the diagnosis of measles 
      virus infection].
PG  - 409-11
FAU - de Ory, F
AU  - de Ory F
LA  - spa
PT  - Evaluation Study
PT  - Letter
PT  - Research Support, Non-U.S. Gov't
TT  - Evaluación de un ensayo de enzimoinmunoanálisis (ELISA) de captura para el 
      diagnóstico de la infección por virus del sarampión.
PL  - Spain
TA  - Enferm Infecc Microbiol Clin
JT  - Enfermedades infecciosas y microbiologia clinica
JID - 9104081
RN  - 0 (Antibodies, Viral)
RN  - 0 (Biomarkers)
RN  - 0 (Immunoglobulin M)
SB  - IM
MH  - Antibodies, Viral/*blood
MH  - Biomarkers/blood
MH  - Enzyme-Linked Immunosorbent Assay/*methods
MH  - Humans
MH  - Immunoglobulin M/*blood
MH  - Measles/*diagnosis
EDAT- 2001/10/17 10:00
MHDA- 2002/01/16 10:01
CRDT- 2001/10/17 10:00
PHST- 2001/10/17 10:00 [pubmed]
PHST- 2002/01/16 10:01 [medline]
PHST- 2001/10/17 10:00 [entrez]
AID - S0213-005X(01)72678-X [pii]
AID - 10.1016/s0213-005x(01)72678-x [doi]
PST - ppublish
SO  - Enferm Infecc Microbiol Clin. 2001 Oct;19(8):409-11. doi: 
      10.1016/s0213-005x(01)72678-x.

PMID- 31363357
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20200225
IS  - 1680-5348 (Electronic)
IS  - 1020-4989 (Print)
IS  - 1020-4989 (Linking)
VI  - 41
DP  - 2017
TI  - [Risk matrix for estimating imported outbreaks of measles or rubella in ChileMatriz 
      de risco para estimar surtos importados de sarampo ou rubéola aplicada ao Chile].
PG  - e47
LID - 10.26633/RPSP.2017.47 [doi]
LID - e47
AB  - OBJECTIVE: Develop a risk matrix to evaluate the ongoing risk of measles and rubella 
      outbreaks associated with imported cases in Chile. METHODS: The risk assessment 
      tools were developed in the following stages: preparation and approval of 
      biological, programmatic, and demographic variables; weighting of the selected 
      variables by a panel of experts; calculation of the risk index; specialization; and 
      knowledge transfer. RESULTS: Of the 346 Chilean communes analyzed, 34% were in the 
      high-risk interval for experiencing a measles and rubella outbreak with the 
      introduction of the virus, 59%, in the average-risk interval, and 3%, in the 
      low-risk interval. The remaining percentage corresponded to communes lacking data in 
      at least one of the 13 variables required for calculating the risk index. 
      CONCLUSION: Use of this tool will enable subnational teams to use their own data to 
      evaluate the risk of outbreaks in their area and take corrective action for a rapid 
      response to any importation of these viruses in the post-elimination phase.
FAU - Gallegos, Doris
AU  - Gallegos D
AD  - Departamento de Epidemiología, División de Planificación Sanitaria Subsecretaría de 
      Salud Pública, Ministerio de Salud Santiago Chile Departamento de Epidemiología, 
      División de Planificación Sanitaria, Subsecretaría de Salud Pública, Ministerio de 
      Salud, Santiago, Chile.
FAU - Vergara, Natalia
AU  - Vergara N
AD  - Departamento de Epidemiología, División de Planificación Sanitaria Subsecretaría de 
      Salud Pública, Ministerio de Salud Santiago Chile Departamento de Epidemiología, 
      División de Planificación Sanitaria, Subsecretaría de Salud Pública, Ministerio de 
      Salud, Santiago, Chile.
FAU - Gatica, Luz
AU  - Gatica L
AD  - Geógrafos Asesores técnicos del estudio Comuna de Santiago Chile Geógrafos, Asesores 
      técnicos del estudio, Comuna de Santiago, Chile.
FAU - Castillo, Carlos
AU  - Castillo C
AD  - Organización Panamericana de la Salud Washington, DC Estados Unidos de América 
      Organización Panamericana de la Salud, Washington, DC, Estados Unidos de América.
FAU - Basaldúa, Andrea
AU  - Basaldúa A
AD  - Geógrafos Asesores técnicos del estudio Comuna de Santiago Chile Geógrafos, Asesores 
      técnicos del estudio, Comuna de Santiago, Chile.
FAU - Guerrero, Rodrigo
AU  - Guerrero R
AD  - Geógrafos Asesores técnicos del estudio Comuna de Santiago Chile Geógrafos, Asesores 
      técnicos del estudio, Comuna de Santiago, Chile.
FAU - Bravo-Alcántara, Pamela
AU  - Bravo-Alcántara P
AD  - Organización Panamericana de la Salud Washington, DC Estados Unidos de América 
      Organización Panamericana de la Salud, Washington, DC, Estados Unidos de América.
FAU - Del Aguila, Roberto
AU  - Del Aguila R
AD  - Organización Panamericana de la Salud Washington, DC Estados Unidos de América 
      Organización Panamericana de la Salud, Washington, DC, Estados Unidos de América.
FAU - Loayza, Sergio
AU  - Loayza S
AD  - Departamento de Epidemiología, División de Planificación Sanitaria Subsecretaría de 
      Salud Pública, Ministerio de Salud Santiago Chile Departamento de Epidemiología, 
      División de Planificación Sanitaria, Subsecretaría de Salud Pública, Ministerio de 
      Salud, Santiago, Chile.
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Matriz de riesgo para estimar brotes importados de sarampión o rubéola aplicada a 
      Chile.
DEP - 20171117
TA  - Rev Panam Salud Publica
JT  - Revista panamericana de salud publica = Pan American journal of public health
JID - 9705400
PMC - PMC6612727
OAB - Publisher: Abstract available from the publisher.
OABL- spa
OTO - NOTNLM
OT  - Chile
OT  - Public health
OT  - geographic information systems
OT  - geography
OT  - medical
OT  - risk management
COIS- Conflictos de interés Los autores declaran no tener conflictos de interés.
EDAT- 2017/11/17 00:00
MHDA- 2017/11/17 00:01
CRDT- 2019/08/01 06:00
PHST- 2016/12/21 00:00 [received]
PHST- 2017/03/31 00:00 [accepted]
PHST- 2019/08/01 06:00 [entrez]
PHST- 2017/11/17 00:00 [pubmed]
PHST- 2017/11/17 00:01 [medline]
AID - RPSP.2017.47 [pii]
AID - 10.26633/RPSP.2017.47 [doi]
PST - epublish
SO  - Rev Panam Salud Publica. 2017 Nov 17;41:e47. doi: 10.26633/RPSP.2017.47. eCollection 
      2017.

PMID- 25041586
OWN - NLM
STAT- MEDLINE
DCOM- 20140929
LR  - 20211021
IS  - 1365-3156 (Electronic)
IS  - 1360-2276 (Print)
IS  - 1360-2276 (Linking)
VI  - 19
IP  - 9
DP  - 2014 Sep
TI  - Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying 
      and challenges to maintaining measles and rubella elimination.
PG  - 1105-15
LID - 10.1111/tmi.12335 [doi]
AB  - OBJECTIVES: We conducted a nationwide survey to assess measles containing vaccine 
      (MCV) coverage among children aged 1-9 years in Haiti and identify factors 
      associated with vaccination before and during the 2012 nationwide supplementary 
      immunisation activities (SIA). METHODS: Haiti was stratified into five geographic 
      regions (Metropolitan Port-au-Prince, North, Centre, South and West), 40 clusters 
      were randomly selected in each region, and 35 households were selected per cluster. 
      RESULTS: Among the 7000 visited households, 75.8% had at least one child aged 1-9 
      years; of these, 5279 (99.5%) households consented to participate in the survey. Of 
      9883 children enrolled, 91% received MCV before and/or during the SIA; 31% received 
      MR for the first time during the SIA, and 50.7% received two doses of MCV (one 
      before and one during the 2012 SIA). Among the 1685 unvaccinated children during the 
      SIA, the primary reason of non-vaccination was caregivers not being aware of the SIA 
      (31.0%). Children aged 1-4 years had significantly lower MR SIA coverage than those 
      aged 5-9 years (79.5% vs. 84.8%) (P < 0.0001). A higher proportion of children 
      living in the West (12.3%) and Centre (11.2%) regions had never been vaccinated than 
      in other regions (4.8-9.1%). Awareness, educational level of the mother and region 
      were significantly associated with MR vaccination during and before the SIA (P < 
      0.001). CONCLUSIONS: The 2012 SIA successfully increased MR coverage; however, to 
      maintain measles and rubella elimination, coverage needs to be further increased 
      among children aged 1-4 years and in regions with lower coverage.
CI  - © 2014 John Wiley & Sons Ltd.
FAU - Tohme, Rania A
AU  - Tohme RA
AD  - Global Immunization Division, US Centers for Disease Control and Prevention, 
      Atlanta, GA, USA.
FAU - François, Jeannot
AU  - François J
FAU - Wannemuehler, Kathleen
AU  - Wannemuehler K
FAU - Magloire, Roc
AU  - Magloire R
FAU - Danovaro-Holliday, M Carolina
AU  - Danovaro-Holliday MC
FAU - Flannery, Brendan
AU  - Flannery B
FAU - Cavallaro, Kathleen F
AU  - Cavallaro KF
FAU - Fitter, David L
AU  - Fitter DL
FAU - Purcell, Nora
AU  - Purcell N
FAU - Dismer, Amber
AU  - Dismer A
FAU - Tappero, Jordan W
AU  - Tappero JW
FAU - Vertefeuille, John F
AU  - Vertefeuille JF
FAU - Hyde, Terri B
AU  - Hyde TB
LA  - eng
GR  - CC999999/Intramural CDC HHS/United States
PT  - Journal Article
DEP - 20140716
TA  - Trop Med Int Health
JT  - Tropical medicine & international health : TM & IH
JID - 9610576
RN  - 0 (Measles Vaccine)
RN  - 0 (Rubella Vaccine)
SB  - IM
MH  - Child
MH  - Child, Preschool
MH  - Family Characteristics
MH  - Female
MH  - Haiti
MH  - Health Care Surveys
MH  - Humans
MH  - Immunization Programs/*statistics & numerical data
MH  - Infant
MH  - Male
MH  - Measles/*prevention & control
MH  - *Measles Vaccine
MH  - Rubella/*prevention & control
MH  - *Rubella Vaccine
MH  - Vaccination/*statistics & numerical data
PMC - PMC4608013
MID - NIHMS729533
OID - NLM: HHSPA729533
OTO - NOTNLM
OT  - Estudio de cobertura
OT  - Haiti
OT  - Haití
OT  - Haïti
OT  - Rubeola
OT  - actividades suplementarias de inmunización
OT  - activité de vaccination supplémentaire
OT  - coverage survey
OT  - measles
OT  - rougeole
OT  - rubella
OT  - rubéole
OT  - sarampión
OT  - supplementary immunisation activity
OT  - surveillance de la couverture
EDAT- 2014/07/22 06:00
MHDA- 2014/09/30 06:00
CRDT- 2014/07/22 06:00
PHST- 2014/07/22 06:00 [entrez]
PHST- 2014/07/22 06:00 [pubmed]
PHST- 2014/09/30 06:00 [medline]
AID - 10.1111/tmi.12335 [doi]
PST - ppublish
SO  - Trop Med Int Health. 2014 Sep;19(9):1105-15. doi: 10.1111/tmi.12335. Epub 2014 Jul 
      16.

PMID- 15228897
OWN - NLM
STAT- MEDLINE
DCOM- 20041005
LR  - 20191210
IS  - 0213-005X (Print)
IS  - 0213-005X (Linking)
VI  - 22
IP  - 6
DP  - 2004 Jun-Jul
TI  - [Comparison of serological procedures used for the diagnosis of viral exanthema in 
      laboratories participating in the measles elimination plan].
PG  - 319-22
AB  - OBJECTIVE: The comparison of serological methods used by the laboratories 
      participating in the Network for the Elimination of Measles to diagnose measles 
      virus infection as well as differential diagnosis with other exanthematic diseases 
      are compared. MATERIALS AND METHODS: One panel of 20 serum samples including measles 
      (12), rubella (4), parvovirus B19 (2) and dengue (2) infections was established. All 
      cases were diagnosed by detection of specific IgM. The panel was sent to the 
      laboratories of the Network. The results were compared with those obtained at the 
      reference laboratory. RESULTS AND DISCUSSION: Regarding measles, IgM response from 
      20 laboratories (19 by ELISA and 1 by indirect immunofluorescence) was obtained, 
      with an agreement of 91.5%. Related to rubella IgM, replay from 6 laboratories, 
      using ELISA, was received, with an agreement of 98.7%. With respect to parvovirus 
      B19 IgM, response from 10 laboratories (8 by ELISA and 2 by indirect 
      immunofluorescence) was obtained, with an agreement of 94.6%. Results about dengue 
      virus were not reported by any laboratory. CONCLUSION: Some laboratories from the 
      network should review the methods used for the diagnosis of measles and other 
      exanthematic diseases. The results reassert the need for a reference laboratory to 
      support confirmation of the results.
FAU - de Ory, Fernando
AU  - de Ory F
AD  - Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain. 
      fory@isciii.es
FAU - Sanz, Juan Carlos
AU  - Sanz JC
FAU - Echevarría, Juan Emilio
AU  - Echevarría JE
FAU - Mosquera, María del Mar
AU  - Mosquera Mdel M
FAU - Guisasola, María Eulalia
AU  - Guisasola ME
CN  - Red de Laboratorios Autonómicos para el Plan de Eliminación del Sarampión
LA  - spa
PT  - Comparative Study
PT  - Evaluation Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
TT  - Comparación de los procedimientos serológicos de los laboratorios del Plan para la 
      Eliminación del Sarampión en el diagnóstico de exantemas víricos.
PL  - Spain
TA  - Enferm Infecc Microbiol Clin
JT  - Enfermedades infecciosas y microbiologia clinica
JID - 9104081
RN  - 0 (Antibodies, Viral)
RN  - 0 (Immunoglobulin M)
SB  - IM
MH  - Antibodies, Viral/*blood
MH  - Dengue/blood/diagnosis
MH  - Dengue Virus/immunology
MH  - Diagnosis, Differential
MH  - Enzyme-Linked Immunosorbent Assay
MH  - Exanthema/blood/*diagnosis/virology
MH  - Exanthema Subitum/blood/diagnosis
MH  - Fluorescent Antibody Technique, Indirect
MH  - Humans
MH  - Immunoglobulin M/*blood
MH  - Infection Control/organization & administration
MH  - Laboratories/statistics & numerical data
MH  - Measles/blood/*diagnosis/prevention & control
MH  - Measles virus/immunology
MH  - Parvovirus B19, Human/immunology
MH  - Predictive Value of Tests
MH  - Rubella/blood/diagnosis
MH  - Rubella virus/immunology
MH  - Serologic Tests/*methods
MH  - Spain
EDAT- 2004/07/02 05:00
MHDA- 2004/10/06 09:00
CRDT- 2004/07/02 05:00
PHST- 2004/07/02 05:00 [pubmed]
PHST- 2004/10/06 09:00 [medline]
PHST- 2004/07/02 05:00 [entrez]
AID - 13063042 [pii]
AID - 10.1016/s0213-005x(04)73102-x [doi]
PST - ppublish
SO  - Enferm Infecc Microbiol Clin. 2004 Jun-Jul;22(6):319-22. doi: 
      10.1016/s0213-005x(04)73102-x.

PMID- 15871835
OWN - NLM
STAT- MEDLINE
DCOM- 20050901
LR  - 20190917
IS  - 1695-4033 (Print)
IS  - 1695-4033 (Linking)
VI  - 62
IP  - 5
DP  - 2005 May
TI  - [Sudden bilateral deafness after measles, mumps and rubella vaccination].
PG  - 482-3
FAU - García Callejo, F J
AU  - García Callejo FJ
FAU - Costa Alcácer, I
AU  - Costa Alcácer I
FAU - de Paula Vernetta, C
AU  - de Paula Vernetta C
FAU - Marco Algarra, J
AU  - Marco Algarra J
LA  - spa
PT  - Case Reports
PT  - Letter
TT  - Sordera súbita bilateral tras vacunación del sarampión, rubéola y parotiditis.
PL  - Spain
TA  - An Pediatr (Barc)
JT  - Anales de pediatria (Barcelona, Spain : 2003)
JID - 101162596
RN  - 0 (Measles-Mumps-Rubella Vaccine)
SB  - IM
MH  - Audiometry, Pure-Tone
MH  - Child
MH  - Hearing Loss, Bilateral/*diagnosis/*etiology
MH  - Hearing Loss, Sudden/*diagnosis/*etiology
MH  - Humans
MH  - Male
MH  - Measles-Mumps-Rubella Vaccine/*adverse effects
MH  - Severity of Illness Index
EDAT- 2005/05/06 09:00
MHDA- 2005/09/02 09:00
CRDT- 2005/05/06 09:00
PHST- 2005/05/06 09:00 [pubmed]
PHST- 2005/09/02 09:00 [medline]
PHST- 2005/05/06 09:00 [entrez]
AID - 13074627 [pii]
AID - 10.1157/13074627 [doi]
PST - ppublish
SO  - An Pediatr (Barc). 2005 May;62(5):482-3. doi: 10.1157/13074627.

PMID- 20571720
OWN - NLM
STAT- MEDLINE
DCOM- 20100803
LR  - 20191111
IS  - 1135-5727 (Print)
IS  - 1135-5727 (Linking)
VI  - 84
IP  - 2
DP  - 2010 Mar-Apr
TI  - [Measles outbreak in Campo de Gibraltar, Cádiz, Spain, during the Period 
      February-July 2008].
PG  - 203-14
LID - S1135-57272010000200007 [pii]
AB  - BACKGROUND: On the 4th of February 2008, 2 cases of measles, epidemiologically 
      linked (2 members of the crew of the Fast-Ferry Jaime I from the company Balearia, 
      which performs the route Algeciras-Tangier), were notified to the Epidemiological 
      Surveillance Network in Andalusia (SVEA). The aim of this paper is to 
      epidemiologically characterize this population level outbreak detected in the area 
      of Campo de Gibraltar, the vaccine effectiveness and the control measures 
      implemented. METHODS: Descriptive observational study of reported cases. We have 
      analysed the following variables: age, sex, municipality of residence, onset date, 
      virus genotype, groups involved, previous immunization status, interventions, 
      vaccine effectiveness. Information sources are SVEA records, vaccination program and 
      individual digital story (Diraya). Rates 10(5) were calculated according to age 
      group and frequency measurements. To compare vaccine effectiveness, the Chi(2) test 
      was used. RESULTS: We confirmed 155 cases of measles, 88.4% by laboratory 
      techniques. Most affected age groups under 2 years (19%) and from 21 to 40 (51%). 
      The 54.2% male. The 72,14% were not vaccinated. Virus was isolated from imported 
      measles genotype D4. The vaccine efficacy was greater than 99%. CONCLUSIONS: The 
      outbreak of the imported measles virus was confirmed. More than half of the cases 
      were not vaccinated. The decrease in the incidence in vaccinated individuals 
      recommends the necessity of carrying out Catch-Up campaigns to increase the coverage 
      therefore avoiding the appearance of these outbreaks.
FAU - Nieto Vera, Juan
AU  - Nieto Vera J
AD  - Unidad de Prevención, Promoción y Vigilancia en Salud Pública, Distrito Sanitario 
      Bahía de Cádiz-La Janda, Servicio Andaluz de Salud. 
      juan.nieto.sspa@juntadeandalucia.es
FAU - Rodríguez Benjumeda, Luís Miguel
AU  - Rodríguez Benjumeda LM
FAU - Mosquera Gutiérrez, María Del Mar
AU  - Mosquera Gutiérrez Mdel M
FAU - Mayoral Cortes, José María
AU  - Mayoral Cortes JM
FAU - Masa Calles, Josefa
AU  - Masa Calles J
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Brote de sarampión en Campo de Gibraltar, Cádiz, durante el período febrero-julio 
      2008.
PL  - Spain
TA  - Rev Esp Salud Publica
JT  - Revista espanola de salud publica
JID - 9600212
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Child
MH  - Child, Preschool
MH  - *Disease Outbreaks
MH  - Female
MH  - Humans
MH  - Infant
MH  - Male
MH  - Measles/*epidemiology/prevention & control
MH  - Spain/epidemiology
MH  - Time Factors
MH  - Young Adult
EDAT- 2010/06/24 06:00
MHDA- 2010/08/04 06:00
CRDT- 2010/06/24 06:00
PHST- 2010/06/24 06:00 [entrez]
PHST- 2010/06/24 06:00 [pubmed]
PHST- 2010/08/04 06:00 [medline]
AID - S1135-57272010000200007 [pii]
AID - 10.1590/s1135-57272010000200007 [doi]
PST - ppublish
SO  - Rev Esp Salud Publica. 2010 Mar-Apr;84(2):203-14. doi: 
      10.1590/s1135-57272010000200007.

PMID- 24210738
OWN - NLM
STAT- MEDLINE
DCOM- 20160411
LR  - 20140929
IS  - 1578-1852 (Electronic)
IS  - 0213-005X (Linking)
VI  - 32
IP  - 8
DP  - 2014 Oct
TI  - [Re-emergence of measles in the province of Guadalajara, Spain. Is it time to 
      establish new strategies for its elimination?].
PG  - 486-90
LID - S0213-005X(13)00293-0 [pii]
LID - 10.1016/j.eimc.2013.08.005 [doi]
AB  - BACKGROUND: Measles is a viral infection that was almost eradicated, but it is 
      re-emerging in Spain and Europe in recent years. The aim of this study was to 
      describe the microbiological, clinical and epidemiological characteristics of a 
      measles outbreak that occurred in Guadalajara (Spain) from June to August 2012. 
      METHODS: A descriptive and retrospective study was conducted. A total of 117 samples 
      (including serum, urine and pharyngeal swabs) from 52 patients were analyzed for 
      measles. RESULTS: Measles was diagnosed in 50 patients, 41 of them by 
      microbiological diagnosis, and 9 by epidemiological link. The patients were grouped 
      in four community outbreaks. No imported cases were observed. Positive IgM and 
      positive CRP were detected in 25 patients, positive CRP only in 11 and positive IgM 
      only in 5. The genotype D4 was identified in 13 patients and the genotype A in a 
      post-vaccine case. The age groups most affected were adults between 20-34 years of 
      age (38%) and younger than 15 months (26%). The large majority (86%) of patients 
      were unvaccinated (44% Roma population, 27% younger than 15 months, 11% ideological 
      reasons), 6% had one vaccine dose. The signs/symptoms were: rash and fever, 100%, 
      cough, 82%, and conjunctivitis 50%. Almost one-third (32%) of patients were 
      hospitalized, and 28% had complications. CONCLUSIONS: It is very important to 
      intensify the epidemiological surveillance of infections in the elimination phase. 
      The increased incidence of measles was associated to unvaccinated pockets, 
      presenting a challenge for Public Health Centers. These agencies should prepare 
      strategies to obtain a higher vaccine coverage for the eradication of measles.
CI  - Copyright © 2013 Elsevier España, S.L.U. y Sociedad Española de Enfermedades 
      Infecciosas y Microbiología Clínica. All rights reserved.
FAU - Martínez-Ramírez, Mariela
AU  - Martínez-Ramírez M
AD  - Sección de Microbiología, Hospital Universitario de Guadalajara, Guadalajara, 
      España.
FAU - González-Praetorius, Alejandro
AU  - González-Praetorius A
AD  - Sección de Microbiología, Hospital Universitario de Guadalajara, Guadalajara, 
      España. Electronic address: agonzalezp@sescam.jccm.es.
FAU - Ory-Manchón, Fernando de
AU  - Ory-Manchón Fd
AD  - Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 
      Madrid, España.
FAU - Martínez-Benito, Yolanda
AU  - Martínez-Benito Y
AD  - Servicio de Epidemiología, Dirección General de Salud Pública de Castilla-La Mancha, 
      Toledo, España.
FAU - García-Rivera, M Victoria
AU  - García-Rivera MV
AD  - Servicio de Epidemiología, Dirección General de Salud Pública de Castilla-La Mancha, 
      Toledo, España.
FAU - Hübschen, Judith
AU  - Hübschen J
AD  - Laboratorio Europeo de Referencia de Sarampión de la OMS para el sur de Europa, 
      Centre de Recherche Public de la Santé, Luxemburgo, Luxemburgo.
FAU - Echevarría-Mayo, Juan Emilio
AU  - Echevarría-Mayo JE
AD  - Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 
      Madrid, España.
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Reemergencia de sarampión en la provincia de Guadalajara. ¿Es el momento de 
      establecer nuevas estrategias para su eliminación?
DEP - 20131107
PL  - Spain
TA  - Enferm Infecc Microbiol Clin
JT  - Enfermedades infecciosas y microbiologia clinica
JID - 9104081
RN  - 0 (Antibodies, Viral)
RN  - 0 (Measles Vaccine)
RN  - 9007-41-4 (C-Reactive Protein)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Antibodies, Viral/blood
MH  - C-Reactive Protein/analysis
MH  - Child
MH  - Child, Preschool
MH  - Genotype
MH  - Hospitalization/statistics & numerical data
MH  - Humans
MH  - Infant
MH  - Measles/*epidemiology/prevention & control
MH  - Measles Vaccine
MH  - Measles virus/classification/genetics/immunology/isolation & purification
MH  - Morbidity/trends
MH  - Pharynx/virology
MH  - Retrospective Studies
MH  - Spain/epidemiology
MH  - Urine/virology
MH  - Vaccination/statistics & numerical data
MH  - Viremia/epidemiology
MH  - Young Adult
OTO - NOTNLM
OT  - Brote
OT  - Epidemiological surveillance
OT  - España
OT  - Measles
OT  - No vacunados
OT  - Outbreak
OT  - Sarampión
OT  - Spain
OT  - Unvaccinated
OT  - Vigilancia epidemiológica
EDAT- 2013/11/12 06:00
MHDA- 2016/04/12 06:00
CRDT- 2013/11/12 06:00
PHST- 2013/03/18 00:00 [received]
PHST- 2013/07/27 00:00 [revised]
PHST- 2013/08/09 00:00 [accepted]
PHST- 2013/11/12 06:00 [entrez]
PHST- 2013/11/12 06:00 [pubmed]
PHST- 2016/04/12 06:00 [medline]
AID - S0213-005X(13)00293-0 [pii]
AID - 10.1016/j.eimc.2013.08.005 [doi]
PST - ppublish
SO  - Enferm Infecc Microbiol Clin. 2014 Oct;32(8):486-90. doi: 
      10.1016/j.eimc.2013.08.005. Epub 2013 Nov 7.

PMID- 11412417
OWN - NLM
STAT- MEDLINE
DCOM- 20011227
LR  - 20060328
IS  - 0302-4342 (Print)
IS  - 0302-4342 (Linking)
VI  - 54
IP  - 6
DP  - 2001 Jun
TI  - [Seroepidemiological study of the measles virus].
PG  - 608-9
FAU - Eiros Bouza, J
AU  - Eiros Bouza J
FAU - Bachiller Luque, M
AU  - Bachiller Luque M
FAU - Ortiz De Lejarazu, R
AU  - Ortiz De Lejarazu R
FAU - Rodríguez Torres, A
AU  - Rodríguez Torres A
LA  - spa
PT  - Letter
TT  - Estudio seroepidemiológico frente al virus del sarampión.
PL  - Spain
TA  - An Esp Pediatr
JT  - Anales espanoles de pediatria
JID - 0420463
RN  - 0 (Antibodies, Viral)
SB  - IM
MH  - Adolescent
MH  - Antibodies, Viral/*blood
MH  - Child
MH  - Cross-Sectional Studies
MH  - Humans
MH  - Measles/blood/epidemiology
MH  - Measles virus/*immunology
MH  - Seroepidemiologic Studies
MH  - Spain
EDAT- 2001/06/20 10:00
MHDA- 2002/01/05 10:01
CRDT- 2001/06/20 10:00
PHST- 2001/06/20 10:00 [pubmed]
PHST- 2002/01/05 10:01 [medline]
PHST- 2001/06/20 10:00 [entrez]
PST - ppublish
SO  - An Esp Pediatr. 2001 Jun;54(6):608-9.

PMID- 23338627
OWN - NLM
STAT- MEDLINE
DCOM- 20140121
LR  - 20191112
IS  - 1726-4642 (Electronic)
IS  - 1726-4634 (Linking)
VI  - 29
IP  - 4
DP  - 2012 Oct-Dec
TI  - [Evaluation of the seroprotection against measles, rubella and hepatitis B in 
      children under 5 years of age in Peru, 2011].
PG  - 437-43
LID - S1726-46342012000400004 [pii]
AB  - OBJECTIVES: To estimate the prevalence of antibodies against measles, rubella and 
      hepatitis B in children aged between 1 and 4 years in Peru. MATERIALS AND METHODS: A 
      national survey was conducted based on a questionnaire and capillary blood sample 
      taken on filter paper in order to study antibodies against measles, rubella and 
      hepatitis B in children from 1 to 4 years of age. A stratified, multistage, 
      probability sampling design was used to be representative at the national level and 
      at level of seven ambits, including the Metropolitan Lima Area, the rest of the 
      urban coast, the rural coast, the urban highlands, the rural highlands, the urban 
      jungle and the rural jungle. The capillary blood samples were processed according to 
      the standardized protocols for detection of antibodies using the ELISA technique and 
      commercial reagents. RESULTS: The survey showed a national prevalence of antibodies 
      against measles, rubella and hepatitis B of 91.6% (CI 95%: 90.6%; 92.7%), 91.3% (CI 
      95%: 90.3%; 92.4%) and 95.9% (CI 95%: 95.0%; 96.8%) respectively. There was no 
      evidence of significant differences in the prevalence among the ambits of study or 
      among the socioeconomic strata of the conglomerates for any of the three types of 
      antibodies. CONCLUSIONS: In children from 1 to 4 years of age, the national 
      prevalence of antibodies against measles and Rubella was between 90-93%, while the 
      prevalence of antibodies against Hepatitis B (anti-HBsAg) was between 95-97%.
FAU - Fiestas Solórzano, Víctor
AU  - Fiestas Solórzano V
AD  - Unidad de Análisis y Generación de Evidencias en Salud Pública, Instituto nacional 
      de salud, Lima, Perú. vicfiso@yahoo.es
FAU - Gonzáles Noriega, Marco
AU  - Gonzáles Noriega M
FAU - Fiestas, Fabián
AU  - Fiestas F
FAU - Cabezudo, Edwin
AU  - Cabezudo E
FAU - Suárez, Magna
AU  - Suárez M
FAU - Suárez, Víctor
AU  - Suárez V
LA  - spa
PT  - English Abstract
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
TT  - Evaluación de la seroprotección contra sarampión, rubéola y hepatitis B en niños 
      menores de cinco años del Perú, 2011.
PL  - Peru
TA  - Rev Peru Med Exp Salud Publica
JT  - Revista peruana de medicina experimental y salud publica
JID - 101227566
RN  - 0 (Antibodies, Viral)
RN  - 0 (Hepatitis B Surface Antigens)
RN  - 0 (Hepatitis B Vaccines)
RN  - 0 (Immunoglobulin G)
RN  - 0 (Measles Vaccine)
RN  - 0 (Rubella Vaccine)
SB  - IM
MH  - Antibodies, Viral/*blood
MH  - Child, Preschool
MH  - Cross-Sectional Studies
MH  - Female
MH  - Hepatitis B Surface Antigens/*immunology
MH  - Hepatitis B Vaccines/*immunology
MH  - Hepatitis B virus/*immunology
MH  - Humans
MH  - Immunoglobulin G/*blood
MH  - Infant
MH  - Male
MH  - Measles Vaccine/*immunology
MH  - Measles virus/*immunology
MH  - Peru
MH  - Rubella Vaccine/*immunology
MH  - Rubella virus/*immunology
EDAT- 2013/01/23 06:00
MHDA- 2014/01/22 06:00
CRDT- 2013/01/23 06:00
PHST- 2012/07/30 00:00 [received]
PHST- 2012/10/17 00:00 [accepted]
PHST- 2013/01/23 06:00 [entrez]
PHST- 2013/01/23 06:00 [pubmed]
PHST- 2014/01/22 06:00 [medline]
AID - S1726-46342012000400004 [pii]
AID - 10.1590/s1726-46342012000400004 [doi]
PST - ppublish
SO  - Rev Peru Med Exp Salud Publica. 2012 Oct-Dec;29(4):437-43. doi: 
      10.1590/s1726-46342012000400004.

PMID- 12152486
OWN - NLM
STAT- MEDLINE
DCOM- 20021104
LR  - 20041117
IS  - 0120-4157 (Print)
IS  - 0120-4157 (Linking)
VI  - 22
IP  - 2
DP  - 2002 Jun
TI  - [Measles outbreaks in Colombia, February-March 2002].
PG  - 219-9
FAU - Castillo, Orlando
AU  - Castillo O
AD  - Instituto Nacional de Salud, Bogotá, D.C., Colombia.
FAU - Rey, Gloria
AU  - Rey G
FAU - Pastor, Desirée
AU  - Pastor D
FAU - Quintero, Juliana
AU  - Quintero J
FAU - Suárez, Luis
AU  - Suárez L
FAU - Eguis, Elsy
AU  - Eguis E
FAU - Eslait, Elsa
AU  - Eslait E
FAU - Donado, Marco
AU  - Donado M
FAU - Carreño, Xiomara
AU  - Carreño X
FAU - Ortiz, Nancy
AU  - Ortiz N
FAU - Hernández, Priscilla
AU  - Hernández P
FAU - Sanabria, Bernarda
AU  - Sanabria B
FAU - Peñaloza, Sixta
AU  - Peñaloza S
FAU - Pretelt, Elvira
AU  - Pretelt E
FAU - Cutha, Matilde
AU  - Cutha M
FAU - Pérez, Neguit
AU  - Pérez N
FAU - Cabas, Marina
AU  - Cabas M
FAU - Oliveros, Horacio
AU  - Oliveros H
FAU - Pertuz, Hilda
AU  - Pertuz H
FAU - Bruzón, Leslie
AU  - Bruzón L
LA  - spa
PT  - Case Reports
PT  - Journal Article
TT  - Brotes de sarampión en Colombia, febrero-marzo de 2002.
PL  - Colombia
TA  - Biomedica
JT  - Biomedica : revista del Instituto Nacional de Salud
JID - 8205605
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Child
MH  - Colombia/epidemiology
MH  - Disease Notification
MH  - *Disease Outbreaks
MH  - Female
MH  - Humans
MH  - Infant
MH  - Male
MH  - Measles/*epidemiology/transmission
MH  - Transportation
MH  - Travel
MH  - Venezuela/epidemiology
EDAT- 2002/08/03 10:00
MHDA- 2002/11/26 04:00
CRDT- 2002/08/03 10:00
PHST- 2002/08/03 10:00 [pubmed]
PHST- 2002/11/26 04:00 [medline]
PHST- 2002/08/03 10:00 [entrez]
PST - ppublish
SO  - Biomedica. 2002 Jun;22(2):219-9.

PMID- 20111811
OWN - NLM
STAT- MEDLINE
DCOM- 20100329
LR  - 20100129
IS  - 1135-5727 (Print)
IS  - 1135-5727 (Linking)
VI  - 83
IP  - 5
DP  - 2009 Sep-Oct
TI  - [Evolution of measles, rubella and mumps from the third seroepidemiological survey 
      in the autonomous region of Madrid, Spain].
PG  - 625-37
LID - S1135-57272009000500004 [pii]
AB  - In this study results against measles, rubella and mumps obtained in the III 
      Sero-epidemiological Survey of the Autonomous Region of Madrid, performed in 
      1999-2000, were related to the posterior evolution of these diseases in this Region. 
      The prevalence of antibodies against measles, rubella and mumps was >90%, >95% and 
      <90 %, respectively. Despite of the good results obtained for rubella and measles, 
      in 2005 and 2006 two important outbreaks of these diseases occurred in Madrid. The 
      rubella outbreak in 2005 (450 cases) affected especially to immigrants of both sexes 
      (mainly from Central and South America) and Spanish adults males. The 2006 measles 
      outbreak (174 cases) was imported, a high proportion of cases were adults and most 
      of the patients were unvaccinated. No differences according to sex were observed. In 
      Madrid mumps virus circulation has continued from 1999 to present. Two epidemic 
      waves in the periods 2000-2001 and 2006-2007 have been detected. During 2006-2007, 
      an important proportion of cases showed antecedents of vaccination. Each one of 
      these three diseases has typical characteristics. However, the three has in common 
      the change in the age of apparition, with a growing frequency of cases among young 
      adults.
FAU - Sanz Moreno, Juan Carlos
AU  - Sanz Moreno JC
AD  - Laboratorio Regional de Salud Pública, Comunidad de Madrid, Madrid, España. 
      juan.sanz@salud.madrid.org
FAU - García Comas, Luis
AU  - García Comas L
FAU - Ramírez Fernández, Rosa
AU  - Ramírez Fernández R
FAU - Ramos Blázquez, Belén
AU  - Ramos Blázquez B
FAU - Ordobás Gavín, María
AU  - Ordobás Gavín M
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Evolución del sarampión, rubeola y parotiditis desde la III Encuesta de 
      serovigilancia de la Comunidad de Madrid 1999-2000 (III ESVCM).
PL  - Spain
TA  - Rev Esp Salud Publica
JT  - Revista espanola de salud publica
JID - 9600212
RN  - 0 (Antibodies, Viral)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Antibodies, Viral/*blood
MH  - Child
MH  - Child, Preschool
MH  - Female
MH  - Health Surveys
MH  - Humans
MH  - Male
MH  - Measles/*blood/*epidemiology
MH  - Mumps/*blood/*epidemiology
MH  - Rubella/*blood/*epidemiology
MH  - Seroepidemiologic Studies
MH  - Spain
MH  - Urban Health
MH  - Young Adult
EDAT- 2010/01/30 06:00
MHDA- 2010/03/30 06:00
CRDT- 2010/01/30 06:00
PHST- 2010/01/30 06:00 [entrez]
PHST- 2010/01/30 06:00 [pubmed]
PHST- 2010/03/30 06:00 [medline]
AID - S1135-57272009000500004 [pii]
PST - ppublish
SO  - Rev Esp Salud Publica. 2009 Sep-Oct;83(5):625-37.

PMID- 10650754
OWN - NLM
STAT- MEDLINE
DCOM- 20000210
LR  - 20071115
IS  - 1135-5727 (Print)
IS  - 1135-5727 (Linking)
VI  - 73
IP  - 5
DP  - 1999 Sep-Oct
TI  - [Eradication of measles. Strategies in the Autonomous Community of Catalonia].
PG  - 619-27
FAU - Salleras Sanmartí, L
AU  - Salleras Sanmartí L
AD  - Departamento de Sanidad y Seguridad Social, Generalidad de Cataluña, Barcelona.
FAU - Domínguez García, A
AU  - Domínguez García A
FAU - Batalla Clavell, J
AU  - Batalla Clavell J
FAU - Coll, R P
AU  - Coll RP
LA  - spa
PT  - Comparative Study
PT  - Journal Article
TT  - Eliminación del sarampión. Estrategias en la Comunidad Autónoma de Cataluña.
PL  - Spain
TA  - Rev Esp Salud Publica
JT  - Revista espanola de salud publica
JID - 9600212
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Child
MH  - Child, Preschool
MH  - Cohort Studies
MH  - Evaluation Studies as Topic
MH  - Humans
MH  - Infant
MH  - Infant, Newborn
MH  - Measles/epidemiology/*prevention & control
MH  - Measles Vaccine/administration & dosage
MH  - Measles virus/immunology
MH  - Population Surveillance
MH  - Seroepidemiologic Studies
MH  - Spain/epidemiology
MH  - Vaccination
EDAT- 2000/01/29 00:00
MHDA- 2000/01/29 00:01
CRDT- 2000/01/29 00:00
PHST- 2000/01/29 00:00 [pubmed]
PHST- 2000/01/29 00:01 [medline]
PHST- 2000/01/29 00:00 [entrez]
PST - ppublish
SO  - Rev Esp Salud Publica. 1999 Sep-Oct;73(5):619-27.

PMID- 11833255
OWN - NLM
STAT- MEDLINE
DCOM- 20020405
LR  - 20181130
IS  - 0325-7541 (Print)
IS  - 0325-7541 (Linking)
VI  - 33
IP  - 4
DP  - 2001 Oct-Dec
TI  - [Resurgence of measles in the province of Cordoba, Argentina, in 2000].
PG  - 229-34
AB  - Since 1993, ministers of health of countries of America established as a goal the 
      eradication of measles by the year 2000. As a consequence of measles eradication 
      vaccination strategy there has been a reduction in the incidence of reported cases. 
      Despite that, measles has continued occurring in epidemic outbreaks in many 
      Argentinian provinces. This paper describes and analyzes the outbreak which occurred 
      at Córdoba province, in 2000. Out of 46 serum samples analyzed from suspected cases, 
      6 (13.3%) were confirmed as measles by indirect immunofluorescence and enzyme 
      immunoassays. All of them were detected in Cordoba city among both without 
      vaccination data and unvaccinated individuals. The epidemiological links among the 
      measles cases could be established although the geographic source of measles 
      importation as well as the primary infection source remain unknown. The highest 
      measles incidence was observed in the group > or = 20 year old (50%), followed by 
      the pre-school age group (< or = 4 year old, 33.3%). The active vaccination data 
      directed against the suspected case contacts along with a high measles population 
      immunity probably contributed to restrict the 2000 outbreak.
FAU - Isa, M B
AU  - Isa MB
AD  - Instituto de Virologia Dr. J. M. Vanella, Facultad de Ciencias Médicas, Universidad 
      Nacional de Córdoba, Agencia 4, Ciudad Universitaria, 5000 Córdoba, Argentina.
FAU - Martinez, L C
AU  - Martinez LC
FAU - Giordano, M O
AU  - Giordano MO
FAU - Ferreyra, L J
AU  - Ferreyra LJ
FAU - Gonzalez, M
AU  - Gonzalez M
FAU - Glatstein, N
AU  - Glatstein N
FAU - Passeggi, C
AU  - Passeggi C
FAU - De Wolff, M C
AU  - De Wolff MC
FAU - Nates, S V
AU  - Nates SV
LA  - spa
PT  - Journal Article
TT  - Resurgimiento de sarampión en ia provincia de Córdoba, Argentina, en 2000.
PL  - Argentina
TA  - Rev Argent Microbiol
JT  - Revista Argentina de microbiologia
JID - 8002834
RN  - 0 (Antibodies, Viral)
RN  - 0 (Immunoglobulin M)
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Antibodies, Viral/blood
MH  - Argentina/epidemiology
MH  - Child
MH  - Child, Preschool
MH  - Contact Tracing
MH  - *Disease Outbreaks
MH  - Enzyme-Linked Immunosorbent Assay
MH  - Female
MH  - Fluorescent Antibody Technique, Indirect
MH  - Humans
MH  - Immunoglobulin M/blood
MH  - Incidence
MH  - Infant
MH  - Male
MH  - Measles/*epidemiology/transmission
MH  - Measles Vaccine
MH  - Measles virus/immunology
MH  - Middle Aged
MH  - National Health Programs
MH  - Seroepidemiologic Studies
MH  - Vaccination/statistics & numerical data
EDAT- 2002/02/09 10:00
MHDA- 2002/04/06 10:01
CRDT- 2002/02/09 10:00
PHST- 2002/02/09 10:00 [pubmed]
PHST- 2002/04/06 10:01 [medline]
PHST- 2002/02/09 10:00 [entrez]
PST - ppublish
SO  - Rev Argent Microbiol. 2001 Oct-Dec;33(4):229-34.

PMID- 10650750
OWN - NLM
STAT- MEDLINE
DCOM- 20000210
LR  - 20061115
IS  - 1135-5727 (Print)
IS  - 1135-5727 (Linking)
VI  - 73
IP  - 5
DP  - 1999 Sep-Oct
TI  - [Strategies of measles eradication in the world].
PG  - 597-603
FAU - Olivé, J M
AU  - Olivé JM
LA  - spa
PT  - Comparative Study
PT  - Journal Article
TT  - Estrategias de eliminación del sarampión en el mundo.
PL  - Spain
TA  - Rev Esp Salud Publica
JT  - Revista espanola de salud publica
JID - 9600212
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Adolescent
MH  - Africa
MH  - Asia
MH  - Australia
MH  - Child
MH  - Child, Preschool
MH  - Europe
MH  - Humans
MH  - Infant
MH  - Japan
MH  - Latin America
MH  - Measles/complications/*prevention & control
MH  - Measles Vaccine/administration & dosage
MH  - United States
MH  - Vaccination
MH  - World Health Organization
EDAT- 2000/01/29 00:00
MHDA- 2000/01/29 00:01
CRDT- 2000/01/29 00:00
PHST- 2000/01/29 00:00 [pubmed]
PHST- 2000/01/29 00:01 [medline]
PHST- 2000/01/29 00:00 [entrez]
PST - ppublish
SO  - Rev Esp Salud Publica. 1999 Sep-Oct;73(5):597-603.

PMID- 10650749
OWN - NLM
STAT- MEDLINE
DCOM- 20000210
LR  - 20061115
IS  - 1135-5727 (Print)
IS  - 1135-5727 (Linking)
VI  - 73
IP  - 5
DP  - 1999 Sep-Oct
TI  - [Endeavors to eradicate measles in the Americas].
PG  - 589-96
FAU - de Quadros, C A
AU  - de Quadros CA
LA  - spa
PT  - Comparative Study
PT  - Journal Article
TT  - Actividades de la eliminación del sarampión en las Américas.
PL  - Spain
TA  - Rev Esp Salud Publica
JT  - Revista espanola de salud publica
JID - 9600212
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Adolescent
MH  - Age Factors
MH  - Child
MH  - Child, Preschool
MH  - Humans
MH  - Infant
MH  - Latin America
MH  - Measles/epidemiology/*prevention & control
MH  - Measles Vaccine/administration & dosage
MH  - Pan American Health Organization
MH  - United States
MH  - Vaccination
MH  - World Health Organization
EDAT- 2000/01/29 00:00
MHDA- 2000/01/29 00:01
CRDT- 2000/01/29 00:00
PHST- 2000/01/29 00:00 [pubmed]
PHST- 2000/01/29 00:01 [medline]
PHST- 2000/01/29 00:00 [entrez]
PST - ppublish
SO  - Rev Esp Salud Publica. 1999 Sep-Oct;73(5):589-96.

PMID- 12590379
OWN - NLM
STAT- MEDLINE
DCOM- 20030925
LR  - 20061115
IS  - 0213-4853 (Print)
IS  - 0213-4853 (Linking)
VI  - 18
IP  - 1
DP  - 2003 Jan-Feb
TI  - [Movement disorders in adult-onset measles encephalitis].
PG  - 30-3
AB  - There are three different neurological complications of measles infections in the 
      brain: acute postinfectious encephalitis, acute progressive infectious encephalitis, 
      and subacute sclerosing panencephalitis. The diagnosis of measles encephalitis (ME) 
      is established when supported by the clinical picture, mainly of juvenile onset, and 
      confirmed by the presence of cerebrospinal measles antibodies. Although ME is 
      clinically characterized by progressive behavioral and mental deterioration 
      associated with myoclonus, prior reports have suggested that adult-onset may have 
      atypical features. We describe a 28 year-old immunocompetent man, admitted into the 
      hospital due to a rapid motor and cognitive decline after an episode of fever and 
      gastroenteritis. His neurological examination was significant for cognitive 
      impairment, cervical dystonia, spontaneous and action induced myoclonus, choreiform 
      movements, parkinsonism and ataxic gait. He was diagnosed of acute postinfectious ME 
      based on the presence of elevated intrathecal synthesis of measles antibodies in his 
      CSF, and a lymphocytic infiltrate of perivascular distribution without viral 
      inclusions, with PCR negative for measles from brain biopsy. The patient continued 
      to deteriorate to an akinetic mutism state, dying a few weeks later. Adult-onset ME 
      is an entity rarely seen in the Western world. Although myoclonus is the most common 
      movement disorder related to juvenile-onset ME, ataxia and other dyskinesias such as 
      chorea, dystonia, and parkinsonism, can result from this infection when presenting 
      in adult life.
FAU - Cubo, E
AU  - Cubo E
AD  - Rush-Prebyterian-St. Luke's Medical Center, Neurology Department, Movement Disorders 
      Unit, Chicago, IL, USA. cubox01@yahoo.com
LA  - spa
PT  - Case Reports
PT  - English Abstract
PT  - Journal Article
TT  - Trastornos del movimiento secundarios a encefalitis por sarampión en paciente 
      adulto.
PL  - Spain
TA  - Neurologia
JT  - Neurologia (Barcelona, Spain)
JID - 9005460
RN  - 0 (Antibodies)
SB  - IM
MH  - Adult
MH  - Age of Onset
MH  - Antibodies/cerebrospinal fluid
MH  - Encephalitis, Viral/*etiology/pathology
MH  - Frontal Lobe/pathology
MH  - Humans
MH  - Male
MH  - Measles/*complications/immunology
MH  - Movement Disorders/*etiology
EDAT- 2003/02/19 04:00
MHDA- 2003/09/26 05:00
CRDT- 2003/02/19 04:00
PHST- 2003/02/19 04:00 [pubmed]
PHST- 2003/09/26 05:00 [medline]
PHST- 2003/02/19 04:00 [entrez]
AID - 3109116 [pii]
PST - ppublish
SO  - Neurologia. 2003 Jan-Feb;18(1):30-3.

PMID- 16381498
OWN - NLM
STAT- MEDLINE
DCOM- 20060502
LR  - 20091111
IS  - 0016-3813 (Print)
IS  - 0016-3813 (Linking)
VI  - 141
IP  - 6
DP  - 2005 Nov-Dec
TI  - [Antibody development and frequency of events temporarily associated with measles 
      and rubella vaccines among university health personnel in Jalisco].
PG  - 455-9
AB  - OBJECTIVE: To evaluate the seroprevalence, seroconversion, anamnesic response and 
      events temporally associated with immune status pre and post immunization with 
      measles and rubella vaccine in health personnel from a public University in 
      Guadalajara, Mexico. MATERIAL AND METHODS: We carried out a prospective, 
      longitudinal and comparative study from May to June 2000 among 120 healthy 
      volunteers. Informed consent was obtained from all participants. We administered 
      measles (Schwarz) and rubella (RA 27/3) vaccines. Weekly phone calls during six 
      weeks were recorded from each volunteer to assess local and systemic events 
      temporally associated with immunization non attributable to any other disease. Serum 
      samples were obtained before and after vaccination in 75 volunteers. Antibodies 
      against measles and rubella were measured by an enzyme immunoassay kit (Behring) 
      with cut-off points of 300mUI/mL 8UI/mL respectively. Statistical analysis included 
      mean, standard deviation and paired Student's t-test (P < 0.05). RESULTS: 105/120 
      participants (87.5%) were followed during 6 weeks. 87.4% were health personnel and 
      44.6% were males. The age range was 17-71 years (median = 21). We found a prior 
      history of measles in 57.1%. Local events included pain, heat, redness and 
      induration and were reported by 4/105. Systemic events such as fever, exanthema, 
      pain in joints and arthritis was reported by 9/105. The proportion of study subjects 
      with protective antibodies against measles and rubella prior to vaccination was 90.7 
      and 94.7% respectively. Both groups reached 100% after vaccination. CONCLUSIONS: The 
      proportion of non-immune health personnel was low and similar to other reports. 
      However, the potential spread of measles and rubella virus from a non-immunized 
      infected health care provider could be amplified by the number of patients seen 
      daily during the peak period of 3-5 days. The vaccination of health personnel should 
      be encouraged.
FAU - Villaseñor-Sierra, Alberto
AU  - Villaseñor-Sierra A
AD  - Hospital de Pediatría Centro Medico Nacional Occidente, Instituto Mexicano del 
      Seguro Social, Guadalajara, Jal., México. avillase@prodigy.net.mx
FAU - Santos-Preciado, José Ignacio
AU  - Santos-Preciado JI
FAU - Alvarez-y-Muñoz, María Teresa
AU  - Alvarez-y-Muñoz MT
FAU - Rivas-García, María Elena
AU  - Rivas-García ME
FAU - Martínez-Sandoval, Francisco
AU  - Martínez-Sandoval F
FAU - Falcón-Franco, Marco Antonio
AU  - Falcón-Franco MA
LA  - spa
PT  - Comparative Study
PT  - English Abstract
PT  - Journal Article
TT  - Desarrollo de anticuerpos y frecuencia de eventos temporalmente asociados a las 
      vacunas contra el sarampión y rubéola en personal de salud universitario de Jalisco.
PL  - Mexico
TA  - Gac Med Mex
JT  - Gaceta medica de Mexico
JID - 0010333
RN  - 0 (Antibodies)
RN  - 0 (Measles Vaccine)
RN  - 0 (Rubella Vaccine)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Antibodies/immunology
MH  - Female
MH  - Health Personnel
MH  - Humans
MH  - Longitudinal Studies
MH  - Male
MH  - Measles Vaccine/*adverse effects/*immunology
MH  - Middle Aged
MH  - Prospective Studies
MH  - Rubella Vaccine/*adverse effects/*immunology
MH  - Time Factors
EDAT- 2005/12/31 09:00
MHDA- 2006/05/04 09:00
CRDT- 2005/12/31 09:00
PHST- 2005/12/31 09:00 [pubmed]
PHST- 2006/05/04 09:00 [medline]
PHST- 2005/12/31 09:00 [entrez]
PST - ppublish
SO  - Gac Med Mex. 2005 Nov-Dec;141(6):455-9.

PMID- 10650756
OWN - NLM
STAT- MEDLINE
DCOM- 20000210
LR  - 20041117
IS  - 1135-5727 (Print)
IS  - 1135-5727 (Linking)
VI  - 73
IP  - 5
DP  - 1999 Sep-Oct
TI  - [Eradication of measles. Diagnostic strategies in Spain].
PG  - 635-8
FAU - Echevarría Mayo, J E
AU  - Echevarría Mayo JE
AD  - Centro Nacional de Microbiología, Instituto de Salud Carlos III.
LA  - spa
PT  - Journal Article
TT  - Eliminación del sarampión. Estrategias de diagnóstico en España.
PL  - Spain
TA  - Rev Esp Salud Publica
JT  - Revista espanola de salud publica
JID - 9600212
RN  - 0 (Antibodies, Viral)
RN  - 0 (Antigens, Viral)
RN  - 0 (RNA, Viral)
SB  - IM
MH  - Antibodies, Viral/analysis
MH  - Antigens, Viral/analysis
MH  - Humans
MH  - Immunoenzyme Techniques
MH  - Measles/*diagnosis/prevention & control
MH  - Measles virus/genetics/isolation & purification
MH  - Polymerase Chain Reaction
MH  - RNA, Viral/analysis
MH  - Spain
EDAT- 2000/01/29 00:00
MHDA- 2000/01/29 00:01
CRDT- 2000/01/29 00:00
PHST- 2000/01/29 00:00 [pubmed]
PHST- 2000/01/29 00:01 [medline]
PHST- 2000/01/29 00:00 [entrez]
PST - ppublish
SO  - Rev Esp Salud Publica. 1999 Sep-Oct;73(5):635-8.

PMID- 9542240
OWN - NLM
STAT- MEDLINE
DCOM- 19980513
LR  - 20060328
IS  - 0302-4342 (Print)
IS  - 0302-4342 (Linking)
VI  - 48
IP  - 1
DP  - 1998 Jan
TI  - [Measles. A disease of childhood that is shifting to adolescence].
PG  - 104-5
FAU - Chiclana Hoyos, B
AU  - Chiclana Hoyos B
FAU - Garrido Colino, C
AU  - Garrido Colino C
FAU - Arconada Martín, M J
AU  - Arconada Martín MJ
FAU - Jimeno Díez, I
AU  - Jimeno Díez I
LA  - spa
PT  - Letter
TT  - El sarampión. Una enfermedad de la infancia que se desplaza a la adolescencia.
PL  - Spain
TA  - An Esp Pediatr
JT  - Anales espanoles de pediatria
JID - 0420463
SB  - IM
MH  - Adolescent
MH  - Age Distribution
MH  - Child
MH  - Disease Outbreaks/statistics & numerical data
MH  - Humans
MH  - Measles/*epidemiology
MH  - Spain/epidemiology
EDAT- 1998/05/16 00:00
MHDA- 1998/05/16 00:01
CRDT- 1998/05/16 00:00
PHST- 1998/05/16 00:00 [pubmed]
PHST- 1998/05/16 00:01 [medline]
PHST- 1998/05/16 00:00 [entrez]
PST - ppublish
SO  - An Esp Pediatr. 1998 Jan;48(1):104-5.

PMID- 9780432
OWN - NLM
STAT- MEDLINE
DCOM- 19981110
LR  - 20041117
IS  - 0212-7199 (Print)
IS  - 0212-7199 (Linking)
VI  - 15
IP  - 8
DP  - 1998 Aug
TI  - [Rhabdomyolysis associated with measles in a young adult].
PG  - 451-2
FAU - Alamillo, A
AU  - Alamillo A
FAU - Fernández-Fúnez, A
AU  - Fernández-Fúnez A
FAU - Segura, J C
AU  - Segura JC
FAU - Tirado, R
AU  - Tirado R
LA  - spa
PT  - Case Reports
PT  - Letter
TT  - Rabdomiolisis asociada a sarampión en un adulto joven.
PL  - Spain
TA  - An Med Interna
JT  - Anales de medicina interna (Madrid, Spain : 1984)
JID - 9112183
SB  - IM
MH  - Adolescent
MH  - Humans
MH  - Male
MH  - Measles/*complications
MH  - Rhabdomyolysis/*complications
EDAT- 1998/10/22 00:00
MHDA- 1998/10/22 00:01
CRDT- 1998/10/22 00:00
PHST- 1998/10/22 00:00 [pubmed]
PHST- 1998/10/22 00:01 [medline]
PHST- 1998/10/22 00:00 [entrez]
PST - ppublish
SO  - An Med Interna. 1998 Aug;15(8):451-2.

PMID- 9629761
OWN - NLM
STAT- MEDLINE
DCOM- 19980813
LR  - 20061115
IS  - 0034-9887 (Print)
IS  - 0034-9887 (Linking)
VI  - 126
IP  - 1
DP  - 1998 Jan
TI  - [Laboratory surveillance of measles. Chile, 1992-1995].
PG  - 107-14
AB  - BACKGROUND: The first massive national measles vaccination campaign in Chile was 
      done in 1992. Since then a laboratory surveillance of the disease has been 
      undertaken at the Instituto de Salud Pública. AIM: To report the results of 
      laboratory surveillance of measles between 1992 and 1995. MATERIAL AND METHODS: 
      Paired serum samples from suspected cases of measles were received at the Institute. 
      Measles specific IgG was determined with indirect immunofluorescence methods. IgG 
      and IgM immunoenzymatic methods were used as complementary techniques, and rubella 
      infections were ruled out by hemmaglutination inhibition tests. RESULTS: Sera from 
      1087 presumptive cases (489 in 1992, 196 in 1993, 180 in 1994 and 222 in 1995) were 
      analyzed. Only two cases of wild imported measles were confirmed, one in Arica in 
      1992 and the other in Santiago in 1993. Five additional post vaccine cases were 
      detected. Eighty eight percent of samples in 1992 and 75% in 1994 were seropositive. 
      A high percentage of cases were confirmed as rubella (55% in 1992 and 19% in 1994). 
      CONCLUSIONS: Absence of wild measles virus circulation in Chile from 1992 to 1995 
      emphasizes the importance of laboratory surveillance of the disease.
FAU - Vicente, M
AU  - Vicente M
AD  - Departamento Laboratorios de Salud, Instituto de Salud Pública de Chile.
FAU - Yung, V
AU  - Yung V
FAU - Fasce, R
AU  - Fasce R
FAU - Lezano, V
AU  - Lezano V
FAU - Vera, L
AU  - Vera L
FAU - Villagra, E
AU  - Villagra E
FAU - Espiñeira, E
AU  - Espiñeira E
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Vigilancia de laboratorio en sarampión. Chile, 1992-1995.
PL  - Chile
TA  - Rev Med Chil
JT  - Revista medica de Chile
JID - 0404312
RN  - 0 (Immunoglobulin G)
RN  - 0 (Immunoglobulin M)
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Child
MH  - Child, Preschool
MH  - Chile
MH  - Humans
MH  - Immunoglobulin G/analysis
MH  - Immunoglobulin M/analysis
MH  - Infant
MH  - Measles/*diagnosis/immunology/prevention & control
MH  - *Measles Vaccine
EDAT- 1998/06/18 00:00
MHDA- 1998/06/18 00:01
CRDT- 1998/06/18 00:00
PHST- 1998/06/18 00:00 [pubmed]
PHST- 1998/06/18 00:01 [medline]
PHST- 1998/06/18 00:00 [entrez]
PST - ppublish
SO  - Rev Med Chil. 1998 Jan;126(1):107-14.

PMID- 15633573
OWN - NLM
STAT- MEDLINE
DCOM- 20050324
LR  - 20091111
IS  - 0016-3813 (Print)
IS  - 0016-3813 (Linking)
VI  - 140
IP  - 6
DP  - 2004 Nov-Dec
TI  - [Thirtieth anniversary of the National Measles Vaccination Program in Mexico. The 
      great benefits and potential risks].
PG  - 639-41
FAU - Valdespino-Gómez, José Luis
AU  - Valdespino-Gómez JL
AD  - Académico Numerario, Investigador en Ciencias Médicas F del Instituto Nacional de 
      Salud Pública. jvaldep@insp.mx
FAU - García-García, María de Lourdes
AU  - García-García Mde L
LA  - spa
PT  - Historical Article
PT  - Journal Article
TT  - 30 aniversario del Programa Nacional de Vacunación contra Sarampión en México. Los 
      grandes beneficios y los riesgos potenciales.
PL  - Mexico
TA  - Gac Med Mex
JT  - Gaceta medica de Mexico
JID - 0010333
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - History, 20th Century
MH  - Measles Vaccine/adverse effects/*history
MH  - Mexico
MH  - Risk Factors
MH  - Vaccination/*history
EDAT- 2005/01/07 09:00
MHDA- 2005/03/25 09:00
CRDT- 2005/01/07 09:00
PHST- 2005/01/07 09:00 [pubmed]
PHST- 2005/03/25 09:00 [medline]
PHST- 2005/01/07 09:00 [entrez]
PST - ppublish
SO  - Gac Med Mex. 2004 Nov-Dec;140(6):639-41.

PMID- 10349427
OWN - NLM
STAT- MEDLINE
DCOM- 19990616
LR  - 20091111
IS  - 0375-0760 (Print)
IS  - 0375-0760 (Linking)
VI  - 50
IP  - 2
DP  - 1998
TI  - [The immunoassay of IgM antibodies in samples clinically suspected of measles].
PG  - 105-9
AB  - 60 matched sera clinically suspicious of measles that were received at the 
      Diagnostic Laboratory of the "Pedro Kourí" Tropical Medicine Institute between 
      January and May, 1996, coming from the seroepidemiological surveillance of the MPR 
      vaccine were studied. The detection of measles and rubella hemagglutinant 
      antibodies, as well as of IgM, was carried out with the Clark Laboratories INC. 
      Measles IgM ELISA diagnostic kit. The positive cases were confirmed by the 
      IgM-indirect immunofluorescence and neutralization. 3 positive cases to measles and 
      rubella, which were negative to measles IgM, were obtained by hemagglutination 
      inhibition. Antibodies against Epstein Barr, cytomegalovirus and herpes simplex 
      virus were also determined by indirect immunofluorescence (IIF) due to the capacity 
      of these viruses to induces polyclonal responses. 6 positive cases, which were 
      negative by IIF, were detected by means of the above mentioned diagnostic kit.
FAU - Ribas Antúnez, M A
AU  - Ribas Antúnez MA
AD  - Instituto de Medicina Tropical Pedro Kourí, Ciudad de La Habana, Cuba.
FAU - Arocha Rosete, Y
AU  - Arocha Rosete Y
FAU - Toraño Canto, I
AU  - Toraño Canto I
FAU - Rodríguez Valdés, C
AU  - Rodríguez Valdés C
LA  - spa
PT  - Comparative Study
PT  - English Abstract
PT  - Journal Article
TT  - Inmunovaloración de anticuerpos IgM en muestras sospechosas de sarampión 
      clínicamente.
PL  - Cuba
TA  - Rev Cubana Med Trop
JT  - Revista cubana de medicina tropical
JID - 0074364
RN  - 0 (Antibodies, Viral)
RN  - 0 (Immunoglobulin G)
RN  - 0 (Immunoglobulin M)
SB  - IM
MH  - Antibodies, Viral/*blood
MH  - Cytomegalovirus/immunology
MH  - Enzyme-Linked Immunosorbent Assay/methods
MH  - Fluorescent Antibody Technique, Indirect
MH  - Hemagglutination Inhibition Tests
MH  - Herpesvirus 4, Human/immunology
MH  - Humans
MH  - Immunoglobulin G/blood
MH  - Immunoglobulin M/*blood
MH  - Measles virus/*immunology
MH  - Rubella virus/immunology
MH  - Simplexvirus/immunology
EDAT- 1999/06/01 00:00
MHDA- 1999/06/01 00:01
CRDT- 1999/06/01 00:00
PHST- 1999/06/01 00:00 [pubmed]
PHST- 1999/06/01 00:01 [medline]
PHST- 1999/06/01 00:00 [entrez]
PST - ppublish
SO  - Rev Cubana Med Trop. 1998;50(2):105-9.

PMID- 10425666
OWN - NLM
STAT- MEDLINE
DCOM- 19991007
LR  - 20061115
IS  - 0325-7541 (Print)
IS  - 0325-7541 (Linking)
VI  - 31
IP  - 2
DP  - 1999 Apr-Jun
TI  - [Measles outbreak in the province of Córdoba, Argentina, in 1998].
PG  - 90-5
AB  - The World Health Organization had the global target of reducing reported measles 
      incidence from pre-vaccination era in American countries by 1995, to later eliminate 
      indigenous measles transmission. The countries that have given priority to measles 
      control have substantially reduced morbidity and mortality. Despite that, measles 
      has continued occurring in epidemic outbreaks. This paper describes and analyses the 
      outbreak occurred in Cordoba province, Argentina, in 1998. Out of 195 serum samples 
      analysed from suspected cases, 28 (14.4%) were confirmed as measles by laboratory 
      diagnosis. Of them, 25.0% occurred among vaccinated persons, 39.3% among 
      unvaccinated ones, and 35.7% in individuals without reported vaccine status. The 
      highest measles incidence was in the group aged 20-29 years old (60.7%), followed by 
      the pre-school age group (1-4 years old) (21.4%), the infants under one year of age 
      (14.3%) and finally 3.5% in the group older than 30 years old. These findings 
      suggest a change in measles epidemiology with respect to the pre-vaccine era. The 
      ability to prevent the next epidemic outbreaks will depend on the efficacy to 
      prevent the accumulation of susceptible individuals and the maintenance of high 
      measles vaccine coverage levels.
FAU - Isa, M B
AU  - Isa MB
AD  - Instituto de Virología Dr. J. M. Vanella, Facultad de Ciencias Médicas, Universidad 
      Nacional de Córdoba.
FAU - González, M
AU  - González M
FAU - Martínez, L C
AU  - Martínez LC
FAU - Giordano, M O
AU  - Giordano MO
FAU - López De Neira, M J
AU  - López De Neira MJ
FAU - Passeggi, C
AU  - Passeggi C
FAU - De Wolff, M C
AU  - De Wolff MC
FAU - Nates, S V
AU  - Nates SV
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Brote de sarampión en la provincia de Córdoba, Argentina, en 1998.
PL  - Argentina
TA  - Rev Argent Microbiol
JT  - Revista Argentina de microbiologia
JID - 8002834
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Argentina/epidemiology
MH  - Child
MH  - Child, Preschool
MH  - *Disease Outbreaks
MH  - Female
MH  - Humans
MH  - Incidence
MH  - Infant
MH  - Male
MH  - Measles/*epidemiology
MH  - Measles Vaccine
MH  - Middle Aged
MH  - Morbidity/trends
MH  - Retrospective Studies
EDAT- 1999/07/30 00:00
MHDA- 1999/07/30 00:01
CRDT- 1999/07/30 00:00
PHST- 1999/07/30 00:00 [pubmed]
PHST- 1999/07/30 00:01 [medline]
PHST- 1999/07/30 00:00 [entrez]
PST - ppublish
SO  - Rev Argent Microbiol. 1999 Apr-Jun;31(2):90-5.

PMID- 12920993
OWN - NLM
STAT- MEDLINE
DCOM- 20031027
LR  - 20061115
IS  - 0325-7541 (Print)
IS  - 0325-7541 (Linking)
VI  - 35
IP  - 2
DP  - 2003 Apr-Jun
TI  - [Age-related loss of maternal antibodies against measles in children in La Plata].
PG  - 102-5
AB  - Measles outbreaks every 3-4 years have occurred in Argentina. The vaccine was 
      introduced in 1978 as part of a regular program, and the age for the first 
      vaccination was changed to one year old. The optimal age for first measles 
      vaccination is defined as that age with the highest proportion of infants responding 
      to the vaccine. It is dependent on the presence of maternal antibodies against 
      measles virus and the maturation of the immune system. This paper reports the loss 
      of maternal antibodies in infants from vaccinated mothers, attending at the Hospital 
      I.A.E.P. Superiora Sor María Ludovica, La Piata, Argentina. To determine the IgG 
      antibodies against measles virus, an ELISA test was used in a longitudinal follow up 
      of 48 patients (4, 6 and 9 month-old infants). Only 18.7% of 4 month-old infants 
      showed detectable levels of IgG antibodies against measles virus; this value 
      declined to 4.2% in 6 month-old infants (p < 0.01) and measles virus antibodies were 
      undetectable in 9 month-old infants. The extension of this study to a broader 
      population is suggested, in order to reconsider the optimal age of the first measles 
      vaccination.
FAU - del Buono, M B
AU  - del Buono MB
AD  - Hospital Interzonal de Agudos Especializado en Pediatría Superiora Sor María 
      Ludovica, Calle 14 entre 65 y 66, 1900 La Plata, Provincia de Buenos Aires, 
      Argentina. mbeatriz@hotmail.com
FAU - Vaschetti, P
AU  - Vaschetti P
FAU - Iannicelli, J
AU  - Iannicelli J
FAU - Silber, R
AU  - Silber R
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Pérdida con la edad de los anticuerpos maternos contra el sarampión en niños de la 
      ciudad de La Plata.
PL  - Argentina
TA  - Rev Argent Microbiol
JT  - Revista Argentina de microbiologia
JID - 8002834
RN  - 0 (Antibodies, Viral)
RN  - 0 (Immunoglobulin G)
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Adult
MH  - Aging/*immunology
MH  - Antibodies, Viral/*blood
MH  - Argentina
MH  - Female
MH  - Humans
MH  - *Immunity, Maternally-Acquired
MH  - *Immunization Schedule
MH  - Immunoglobulin G/blood
MH  - Infant
MH  - Measles Vaccine/administration & dosage
MH  - Measles virus/*immunology
MH  - Pregnancy
MH  - Vaccination
EDAT- 2003/08/19 05:00
MHDA- 2003/10/28 05:00
CRDT- 2003/08/19 05:00
PHST- 2003/08/19 05:00 [pubmed]
PHST- 2003/10/28 05:00 [medline]
PHST- 2003/08/19 05:00 [entrez]
PST - ppublish
SO  - Rev Argent Microbiol. 2003 Apr-Jun;35(2):102-5.

PMID- 10650755
OWN - NLM
STAT- MEDLINE
DCOM- 20000210
LR  - 20061115
IS  - 1135-5727 (Print)
IS  - 1135-5727 (Linking)
VI  - 73
IP  - 5
DP  - 1999 Sep-Oct
TI  - [Eradication of measles. Strategies of the Autonomous Community of Galicia].
PG  - 629-33
FAU - Farjas Abadía, P
AU  - Farjas Abadía P
LA  - spa
PT  - Comparative Study
PT  - Journal Article
TT  - Eliminación del sarampión. Estrategias en la Comunidad Autónoma de Galicia.
PL  - Spain
TA  - Rev Esp Salud Publica
JT  - Revista espanola de salud publica
JID - 9600212
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Child
MH  - Child, Preschool
MH  - Humans
MH  - Infant
MH  - Infant, Newborn
MH  - Measles/epidemiology/*prevention & control
MH  - Measles Vaccine/administration & dosage
MH  - Population Surveillance
MH  - Spain/epidemiology
MH  - Vaccination
EDAT- 2000/01/29 00:00
MHDA- 2000/01/29 00:01
CRDT- 2000/01/29 00:00
PHST- 2000/01/29 00:00 [pubmed]
PHST- 2000/01/29 00:01 [medline]
PHST- 2000/01/29 00:00 [entrez]
PST - ppublish
SO  - Rev Esp Salud Publica. 1999 Sep-Oct;73(5):629-33.

PMID- 16238940
OWN - NLM
STAT- MEDLINE
DCOM- 20051222
LR  - 20201128
IS  - 0212-6567 (Print)
IS  - 1578-1275 (Electronic)
IS  - 0212-6567 (Linking)
VI  - 36
IP  - 6
DP  - 2005 Oct 15
TI  - [Elimination of measles plan in the Valencia community: epidemiological surveillance 
      in 2003].
PG  - 306-11
AB  - AIMS: Describing the clinical and epidemiological characteristics of the suspicions 
      of measles notified in the CV during the year 2003 and evaluating the system of 
      surveillance. DESIGN: Cross-sectional, descriptive study. SETTING: Community of 
      Valencia (CV), Spain. PARTICIPANTS: Cases of suspected measles notified in 2003. 
      MAIN MEASUREMENTS: Description of the data collected in the questionnaires 
      (including names) of the Plan to Eliminate Measles of the CV, and obtaining of 
      quality indicators for this plan and those proposed in the national action plan. 
      RESULTS: From 43 notified suspicions, 11 (25.6%) were confirmed, 29 (67.4%) 
      discarded, and 3 (7%) compatible. The rate of effect was 0.33 of 105. From 11 
      confirmed cases, 10 belonged to two outbreaks (one familiar and an other one 
      communitary) and one was an isolated and imported case. 80% of areas of health were 
      declared. The majority of the suspicions and all the cases were given in the first 
      half of the year. Five cases were given in cohorts of age not submitted to the 
      program of vaccination (minors of 15 months and major of 20 years), and 2 cases 
      might have been avoidable in agreement with the program (6 and 12-year-old children 
      not vaccinated). 40 samples of whey and 33 of urine were collect within the 
      recommended periods. The majority of quality indicators were over the recommended 
      ones (80%). CONCLUSIONS: In year 2003 no case of measles has taken place from 
      autochthonous virus in the CV.
FAU - Huertas Zarco, I
AU  - Huertas Zarco I
AD  - Vigilancia y Control Epidemiológicos, Dirección General de Salud Pública, Valencia, 
      Spain. huertas_isa@gva.es
FAU - González Morán, F
AU  - González Morán F
FAU - Pérez Pérez, E
AU  - Pérez Pérez E
FAU - Castellanos Martínez, T
AU  - Castellanos Martínez T
FAU - Martín Sierra, M
AU  - Martín Sierra M
FAU - Vanaclocha Luna, H
AU  - Vanaclocha Luna H
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Plan de eliminación del sarampión en la Comunidad Valenciana: vigilancia 
      epidemiológica en el año 2003.
TA  - Aten Primaria
JT  - Atencion primaria
JID - 9111075
SB  - IM
MH  - Humans
MH  - Measles/*epidemiology/prevention & control
MH  - Population Surveillance
MH  - Spain/epidemiology
PMC - PMC7681828
OAB - Publisher: Abstract available from the publisher.
OABL- spa
EDAT- 2005/10/22 09:00
MHDA- 2005/12/24 09:00
CRDT- 2005/10/22 09:00
PHST- 2005/10/22 09:00 [pubmed]
PHST- 2005/12/24 09:00 [medline]
PHST- 2005/10/22 09:00 [entrez]
AID - 13079864 [pii]
AID - 10.1157/13079864 [doi]
PST - ppublish
SO  - Aten Primaria. 2005 Oct 15;36(6):306-11. doi: 10.1157/13079864.

PMID- 10436723
OWN - NLM
STAT- MEDLINE
DCOM- 19991012
LR  - 20061115
IS  - 0034-9887 (Print)
IS  - 0034-9887 (Linking)
VI  - 127
IP  - 3
DP  - 1999 Mar
TI  - [Immune status against measles and rubella among 4 Chilean groups of different 
      ages].
PG  - 359-65
AB  - BACKGROUND: Results of clinical and epidemiological studies confirm that no cases of 
      measles have occurred in Chile since 1993. However, since covering of vaccination 
      programs do not exceed 95%, an immunological surveillance for this disease is 
      warranted. AIM: To know the immune status against measles and rubella in the Chilean 
      population. MATERIAL AND METHODS: A serological census of a representative sample of 
      communities with high (90% or more) or low immunization coverings was performed. 
      Four sub samples along the country were selected: 122 children aged 18 months of age 
      (stratum A), 1,276 children attending the first years of basic school (stratum B), 
      899 teenagers in their last high school year (stratum C) and 399 women attending a 
      family planning clinic (stratum D). IgG antibodies against measles and rubella were 
      measured using ELISA and hemagglutination inhibition techniques, respectively. 
      RESULTS: Antibodies against measles and rubella were found in 96% and 94% of study 
      subjects. No differences in these titres were found between different strata or 
      communities with high or low vaccination covering. There is a high percentage of 
      positive antibodies against measles among children of 18 months of age and a high 
      percentage of antibodies against rubella among teenagers and women in family 
      planning. Only 3% of the sample had not received any vaccine at the moment of the 
      study. CONCLUSIONS: The high prevalence of antibodies against rubella allows to 
      conclude that it is not necessary to consider this antigen in the next vaccination 
      campaign. Due to the high prevalence of antibodies against measles, only the 
      population older than 20 years old should be affected by the disease if this virus 
      enters the country.
FAU - Valenzuela, M T
AU  - Valenzuela MT
AD  - Organización Panamericana de la Salud, Instituto de Salud Pública, Santiago de 
      Chile, Chile.
FAU - Vega, J
AU  - Vega J
FAU - Leal, I
AU  - Leal I
FAU - Vicente, M
AU  - Vicente M
FAU - Young, V
AU  - Young V
FAU - Vera, L
AU  - Vera L
FAU - Fasce, R
AU  - Fasce R
FAU - Ramírez, E
AU  - Ramírez E
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Estado inmunitario de 4 grupos de edad de población chilena contra sarampión y 
      rubeola.
PL  - Chile
TA  - Rev Med Chil
JT  - Revista medica de Chile
JID - 0404312
RN  - 0 (Antibodies, Viral)
RN  - 0 (Measles Vaccine)
RN  - 0 (Rubella Vaccine)
SB  - IM
MH  - Adolescent
MH  - Antibodies, Viral/*blood
MH  - Child
MH  - Chile
MH  - Female
MH  - Humans
MH  - Infant
MH  - Male
MH  - Measles/*immunology
MH  - Measles Vaccine/immunology
MH  - Measles virus/*immunology
MH  - Rubella/*immunology
MH  - Rubella Vaccine/immunology
MH  - Rubella virus/immunology
MH  - Seroepidemiologic Studies
EDAT- 1999/08/07 00:00
MHDA- 1999/08/07 00:01
CRDT- 1999/08/07 00:00
PHST- 1999/08/07 00:00 [pubmed]
PHST- 1999/08/07 00:01 [medline]
PHST- 1999/08/07 00:00 [entrez]
PST - ppublish
SO  - Rev Med Chil. 1999 Mar;127(3):359-65.

PMID- 10394183
OWN - NLM
STAT- MEDLINE
DCOM- 19991021
LR  - 20061115
IS  - 0302-4342 (Print)
IS  - 0302-4342 (Linking)
VI  - 50
IP  - 5
DP  - 1999 May
TI  - [Seroprevalence of antibodies against measles, rubella, mumps and varicella among 
      school children in Madrid].
PG  - 459-62
AB  - OBJECTIVE: The aim of this study was to assess the seroprevalence of antibodies 
      against MMR and varicella in a population of children between 6 and 7 years of age 
      vaccinated against measles, mumps and rubella at 15 months of age. PATIENTS AND 
      METHODS: This cross-sectional study was carried out in a group of healthy children 
      (6-7 years of age) of the Autonomous Community of Madrid, Spain. Vaccination against 
      MMR at 15 months of age was documented for all children included in the study. Blood 
      samples were drawn from all participants and sera were stored at -20C until they 
      were tested at the end of the study. Measles, mumps, rubella and varicella antibody 
      levels were measured by means of the enzyme linked immunosorbent assay (ELISA) 
      method (IgG Genzyme Virotech GmbH). Positive values were defined as optical density 
      values of > or = 0.20 for measles, > or = 0.30 for mumps, > or = 0.40 for rubella 
      and > or = 0.36 for varicella. Prevalence (and the corresponding 95% confidence 
      limits) assessed by the presence of anti-measles, anti-mumps, anti-rubella and 
      anti-VZV antibodies on the study population were calculated. The Chi-squared test 
      was used to evaluate differences in prevalence between sexes. The Chi-squared test 
      was used to evaluate differences in prevalence between the sexes. RESULTS: A total 
      of 174 children were recruited between October and November 1997. The mean age (SD) 
      and male/female ratio were 6.4 (0.5) years and 0.8 (45.6%/54.5%), respectively. 
      Prevalence of antibodies against measles, rubella, mumps and varicella were 92% 
      (88-96%), 95% (92-98%), 81% (76-86%) and 85% (90-90%), respectively. There were no 
      significant differences between the sexes in relationship to the prevalence of 
      measles, mumps, rubella or varicella antibodies. CONCLUSIONS: Approximately 20% of 
      these 6 to 7 year old children vaccinated at 15 months of age were unprotected 
      against the mumps. Eight percent and 5% were sero-negative for measles and rubella, 
      respectively. Administration of the second dose of MMR vaccine at 4 to 6 years of 
      age instead of at 11 years would contribute to avoid the accumulation of non-immune 
      children. Eighty-five percent of the study population was sero-positive for VZV. 
      These data suggest that, in Spain, VZV infections commonly affect children younger 
      than 5 years of age.
FAU - Gil Miguel, A
AU  - Gil Miguel A
AD  - Departamento de Medicina Preventiva y Salud Pública, Facultad de Medicina, 
      Universidad Complutense de Madrid.
FAU - Astasio Arbiza, P
AU  - Astasio Arbiza P
FAU - Ortega Molina, P
AU  - Ortega Molina P
FAU - Domínguez Rojas, V
AU  - Domínguez Rojas V
FAU - González López, A
AU  - González López A
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Seroprevalencia de anticuerpos frente a sarampión, rubéola, parotiditis y varicela 
      en escolares madrileños.
PL  - Spain
TA  - An Esp Pediatr
JT  - Anales espanoles de pediatria
JID - 0420463
RN  - 0 (Antibodies, Viral)
SB  - IM
MH  - Antibodies, Viral/*blood/*immunology
MH  - Chickenpox/*blood/epidemiology/*immunology
MH  - Child
MH  - Cross-Sectional Studies
MH  - Female
MH  - Humans
MH  - Male
MH  - Measles/*blood/epidemiology/*immunology
MH  - Mumps/*blood/epidemiology/*immunology
MH  - Retrospective Studies
MH  - Rubella/*blood/epidemiology/*immunology
MH  - Seroepidemiologic Studies
MH  - Spain/epidemiology
EDAT- 1999/07/08 00:00
MHDA- 1999/07/08 00:01
CRDT- 1999/07/08 00:00
PHST- 1999/07/08 00:00 [pubmed]
PHST- 1999/07/08 00:01 [medline]
PHST- 1999/07/08 00:00 [entrez]
PST - ppublish
SO  - An Esp Pediatr. 1999 May;50(5):459-62.

PMID- 10365512
OWN - NLM
STAT- MEDLINE
DCOM- 19990629
LR  - 20061115
IS  - 0213-005X (Print)
IS  - 0213-005X (Linking)
VI  - 17
IP  - 4
DP  - 1999 Apr
TI  - [Validity of the notifications of red measles based on clinical diagnosis in 
      Cataluna, Spain].
PG  - 180-3
AB  - OBJECTIVE: To compare the characteristics of clinical cases of measles with 
      confirmed cases of measles registered in Cataluña during a period of four months. 
      PATIENTS AND METHODS: An epidemiological survey was carried out on 171 cases of 
      measles detected by a specific system of surveillance. The survey included data on 
      age, sex, clinical symptoms, laboratory confirmation, immunization status and 
      probable site of transmission. The relationship between the variable case (with or 
      without laboratory confirmation) and the rest of variables was determined by the 
      adjusted odds ratio, using a model of logistic regression. RESULTS: The 
      epidemiological survey showed that 30.4% (52/171) had laboratory confirmation, 12.9% 
      (22/171) had epidemiological confirmation and the rest, 56.7% (97/171) only complied 
      with the clinical definition. The rash had a longer duration in confirmed cases (5.9 
      days) than in non confirmed cases (5.2 days). The lack of laboratory confirmation 
      was associated with age younger than 5 years (ORa = 0.1; 95% CI 0.1-0.8), but there 
      were no differences in sex, immunization status or others clinical symptoms. 
      CONCLUSION: In clinical cases of measles the duration of the rash was lower than 
      confirmed cases. The proportion of cases with laboratory confirmation was low 
      (30.4%) and should be increased in the future. History of previous immunization 
      ought not to rule out diagnosis of measles.
FAU - Godoy, P
AU  - Godoy P
AD  - Departamento de Sanidad, Ayuntamiento de Barcelona. godoy@slle.scs.es
FAU - Domínguez, A
AU  - Domínguez A
FAU - Camps, N
AU  - Camps N
FAU - Jansà, J M
AU  - Jansà JM
FAU - Orcau, A
AU  - Orcau A
FAU - Artigues, A
AU  - Artigues A
FAU - Salleras, L
AU  - Salleras L
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Validez de las notificaciones de sarampión basadas en el diagnóstico clínico en 
      Cataluña.
PL  - Spain
TA  - Enferm Infecc Microbiol Clin
JT  - Enfermedades infecciosas y microbiologia clinica
JID - 9104081
SB  - IM
MH  - Adolescent
MH  - Child
MH  - Child, Preschool
MH  - Disease Notification
MH  - Female
MH  - Humans
MH  - Logistic Models
MH  - Male
MH  - Measles/diagnosis/*epidemiology
MH  - Spain/epidemiology
EDAT- 1999/06/12 00:00
MHDA- 1999/06/12 00:01
CRDT- 1999/06/12 00:00
PHST- 1999/06/12 00:00 [pubmed]
PHST- 1999/06/12 00:01 [medline]
PHST- 1999/06/12 00:00 [entrez]
PST - ppublish
SO  - Enferm Infecc Microbiol Clin. 1999 Apr;17(4):180-3.

PMID- 10650752
OWN - NLM
STAT- MEDLINE
DCOM- 20000210
LR  - 20061115
IS  - 1135-5727 (Print)
IS  - 1135-5727 (Linking)
VI  - 73
IP  - 5
DP  - 1999 Sep-Oct
TI  - [Current situation of measles in Spain. A seroepidemiological study].
PG  - 609-16
FAU - Pachón del Amo, I
AU  - Pachón del Amo I
AD  - Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Ministerio de 
      Sanidad y Consumo.
LA  - spa
PT  - Comparative Study
PT  - Journal Article
TT  - Situación del sarampión en España. Estudio seroepidemiológico.
PL  - Spain
TA  - Rev Esp Salud Publica
JT  - Revista espanola de salud publica
JID - 9600212
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Age Factors
MH  - Child
MH  - Child, Preschool
MH  - Female
MH  - Humans
MH  - Infant
MH  - Infant, Newborn
MH  - Male
MH  - Measles/*epidemiology
MH  - Seroepidemiologic Studies
MH  - Sex Factors
MH  - Spain/epidemiology
EDAT- 2000/01/29 00:00
MHDA- 2000/01/29 00:01
CRDT- 2000/01/29 00:00
PHST- 2000/01/29 00:00 [pubmed]
PHST- 2000/01/29 00:01 [medline]
PHST- 2000/01/29 00:00 [entrez]
PST - ppublish
SO  - Rev Esp Salud Publica. 1999 Sep-Oct;73(5):609-16.

PMID- 9924508
OWN - NLM
STAT- MEDLINE
DCOM- 19990204
LR  - 20190607
IS  - 1020-4989 (Print)
IS  - 1020-4989 (Linking)
VI  - 4
IP  - 4
DP  - 1998 Oct
TI  - [Resurgence of the measles epidemic: situation in Minas Gerais, Brazil].
PG  - 252-7
AB  - This study aims to describe the measles vaccination campaigns that have been carried 
      out in the state of Minas Gerais, Brazil, since 1988; to highlight their importance 
      in the control of the disease, and to pinpoint the age groups at risk during the 
      recent epidemic, which began in 1996, spread all over the country, and declined in 
      1998. However, the analysis includes only data up to September 1997. The methodology 
      used was based on the birth cohort analysis design. Data compared by cohorts 
      included target population and vaccination coverage for each campaign, and measles 
      incidence rates during the present epidemic. Results show that the more 
      opportunities for exposure to vaccination campaigns, the lesser the risk for having 
      measles in any birth cohort. In 1997, the relative risk for getting measles was 
      15.38 (IC 95%: 9.89 to 23.93) for the cohort under 2 years of age, which had not had 
      the opportunity to be exposed to any vaccination campaigns, as compared to cohorts 
      between 3 and 19 years of age with two or more opportunities of exposure to 
      vaccination campaigns. On the basis of the experiences analyzed, catch-up measles 
      vaccination campaigns as well as follow-up campaigns--particularly when routine 
      vaccination did not achieve sufficient coverage--have had an outstanding role in 
      controlling the measles epidemic in the state of Minas Gerais. We therefore suggest 
      making the measles vaccine immediately available to all birth cohorts that did not 
      have the opportunity for exposure to past vaccination campaigns and intensifying 
      epidemiological surveillance. Moreover, it is necessary to find ways to improve 
      routine vaccination coverage in order to achieve the 95% goal set by the National 
      Plan to Eliminate Measles by the Year 2000.
FAU - Oliveira, M T
AU  - Oliveira MT
AD  - Secretaría de Salud del Estado de Minas Gerais, Brasil. jelihovs@net.em.com.br
FAU - Caiaffa, W T
AU  - Caiaffa WT
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Resurgimiento de la epidemia de sarampión: situación de Minas Gerais, Brasil.
PL  - United States
TA  - Rev Panam Salud Publica
JT  - Revista panamericana de salud publica = Pan American journal of public health
JID - 9705400
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Adolescent
MH  - Brazil/epidemiology
MH  - Child
MH  - Child, Preschool
MH  - Cohort Studies
MH  - Female
MH  - Humans
MH  - *Immunization Schedule
MH  - Infant
MH  - Male
MH  - Measles/*epidemiology/immunology
MH  - Measles Vaccine/administration & dosage
MH  - Vaccination
EDAT- 1999/01/30 00:00
MHDA- 1999/01/30 00:01
CRDT- 1999/01/30 00:00
PHST- 1999/01/30 00:00 [pubmed]
PHST- 1999/01/30 00:01 [medline]
PHST- 1999/01/30 00:00 [entrez]
AID - S1020-49891998001000005 [pii]
AID - 10.1590/s1020-49891998001000005 [doi]
PST - ppublish
SO  - Rev Panam Salud Publica. 1998 Oct;4(4):252-7. doi: 10.1590/s1020-49891998001000005.

PMID- 11826525
OWN - NLM
STAT- MEDLINE
DCOM- 20020826
LR  - 20091111
IS  - 0375-0760 (Print)
IS  - 0375-0760 (Linking)
VI  - 52
IP  - 3
DP  - 2000 Sep-Dec
TI  - [Presence of measles virus antibodies in a group of patients with malignant 
      hemopathy].
PG  - 211-4
AB  - 225 monosera from patients (121 adults and 104 children) with different malignant 
      haemopathies from the Institute of Hematology were studied. The hemagglutination 
      inhibition (HI) technique and the neutralization technique were used to know the 
      presence of antimeasles antibodies. All these patients were under immunosuppression 
      treatment at the time of taking the specimen and children had received the triple 
      viral vaccine (measles, rubella, parotiditis) before the disease was diagnosed. It 
      was found that 51 (42.14%) of the adults' specimens were positive by HI and of the 
      25 negative specimens that underwent the neutralization technique, 18 (72%) proved 
      to be positive. Of the 104 sera corresponding to children, 31 (29.8%) specimens were 
      positive by HI, whereas 29 of the negative were studied by neutralization. 18.34% of 
      all the specimens continued to be negative by both methods. According with the 2 
      techniques used, the presence of measles virus antibodies was of 81.66% in children 
      and of 90.78% in adults.
FAU - Ribas, M A
AU  - Ribas MA
AD  - ciipk@ipk.sld.cu
FAU - Ustariz, C
AU  - Ustariz C
FAU - Torres, G
AU  - Torres G
FAU - García, D
AU  - García D
FAU - Tejero, Y
AU  - Tejero Y
FAU - Rodríguez, C
AU  - Rodríguez C
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Presencia de anticuerpos al virus del sarampión en un grupo de pacientes con 
      hemopatías malignas.
PL  - Cuba
TA  - Rev Cubana Med Trop
JT  - Revista cubana de medicina tropical
JID - 0074364
RN  - 0 (Antibodies, Viral)
SB  - IM
MH  - Adult
MH  - Antibodies, Viral/*blood
MH  - Child
MH  - Humans
MH  - Leukemia/*blood
MH  - Lymphoma/*blood
MH  - Measles virus/*immunology
EDAT- 2002/02/06 10:00
MHDA- 2002/08/27 10:01
CRDT- 2002/02/06 10:00
PHST- 2002/02/06 10:00 [pubmed]
PHST- 2002/08/27 10:01 [medline]
PHST- 2002/02/06 10:00 [entrez]
PST - ppublish
SO  - Rev Cubana Med Trop. 2000 Sep-Dec;52(3):211-4.

PMID- 9707824
OWN - NLM
STAT- MEDLINE
DCOM- 19980908
LR  - 20190921
IS  - 0213-9111 (Print)
IS  - 0213-9111 (Linking)
VI  - 12
IP  - 3
DP  - 1998 May-Jun
TI  - [Measles outbreaks: considerations apropos of the outbreaks investigated in 
      Catalonia (1990-1995)].
PG  - 133-7
AB  - OBJECTIVES: To determine the factors associated with outbreak size in Catalonia. 
      METHODS: Outbreaks over the period 1990-95 were investigated. A comparison was run 
      between outbreaks of more than 6 cases with respect to outbreaks of 2-6 cases in 
      function of the following variables: median age of cases, transmission setting and 
      year of presentation. Multiple logistic regression was used to asses the independent 
      effect of each variable, with the adjusted odds ratio (ORa) and their 95% confidence 
      interval (CI) being obtained. RESULTS: In all, 45 outbreaks were studied, with 595 
      cases of measles 39.5% of outbreaks occurred in the 6-10 age group. Outbreaks of 
      more than 6 cases had a higher likelihood of appearing in a school setting (ORa = 
      4.3, CI 95% 1.0-17.6); but there were no association with age (ORa = 2.1, CI 95% 
      0.5-9.2) or occurring prior to 1994 (ORa = 0.9, CI 95% 0.2-3.6). CONCLUSIONS: School 
      setting determines the outbreak size of measles and demands to apply specific 
      preventive strategies.
FAU - Godoy Carcía, P
AU  - Godoy Carcía P
AD  - Departamento de Sanidad y Seguridad Social, Generalidad de Cataluña.
FAU - Domínguez García, A
AU  - Domínguez García A
FAU - Salleras Sanmartí, L
AU  - Salleras Sanmartí L
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Brotes de sarampión: consideraciones a propósito de los brotes investigados en 
      Cataluña (1990-1995).
PL  - Spain
TA  - Gac Sanit
JT  - Gaceta sanitaria
JID - 8901623
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Age Factors
MH  - Child
MH  - Child, Preschool
MH  - *Disease Outbreaks
MH  - Humans
MH  - Infant
MH  - Infant, Newborn
MH  - Measles/*epidemiology/transmission
MH  - Spain/epidemiology
EDAT- 1998/08/26 00:00
MHDA- 1998/08/26 00:01
CRDT- 1998/08/26 00:00
PHST- 1998/08/26 00:00 [pubmed]
PHST- 1998/08/26 00:01 [medline]
PHST- 1998/08/26 00:00 [entrez]
AID - S0213-9111(98)76458-1 [pii]
AID - 10.1016/s0213-9111(98)76458-1 [doi]
PST - ppublish
SO  - Gac Sanit. 1998 May-Jun;12(3):133-7. doi: 10.1016/s0213-9111(98)76458-1.
